data_2mdu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mdu _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.541 0.21 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 18.1 p90 -132.75 -177.61 4.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.762 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 1.9 m-85 -132.69 131.38 41.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 120.838 0.351 . . . . 0.0 111.903 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.703 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 36.5 t80 -119.58 126.43 51.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.327 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.761 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.33 110.2 22.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -70.23 -22.61 62.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.692 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 8' ' ' ILE . 1.5 mm -72.22 -49.57 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -98.54 -21.01 16.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.342 0.592 . . . . 0.0 111.739 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.27 15.18 72.44 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.364 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -96.03 156.26 16.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.054 0.427 . . . . 0.0 110.835 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.703 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -166.14 146.69 6.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.046 0.538 . . . . 0.0 111.648 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -152.11 -175.46 5.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.999 0.904 . . . . 0.0 111.844 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.83 -10.64 47.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.623 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.453 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -91.51 -177.51 4.83 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.268 1.032 . . . . 0.0 110.757 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.508 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 12.8 ttm105 -50.04 153.39 2.35 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.154 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.679 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 2.6 Cg_endo -40.8 135.79 2.12 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.207 1.938 . . . . 0.0 110.269 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.452 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -67.35 56.2 0.05 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.116 0.96 . . . . 0.0 108.707 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 147.05 -3.59 0.93 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 113.848 -1.523 . . . . 0.0 114.358 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.679 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 50.31 51.39 16.86 Favored 'General case' 0 C--N 1.368 1.375 0 CA-C-N 120.214 2.007 . . . . 0.0 110.724 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.576 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -124.6 -169.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.117 1.437 . . . . 0.0 114.744 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.525 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -92.51 167.94 11.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.423 177.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.33 -34.97 4.19 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.706 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.761 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.8 m95 -57.92 138.51 55.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.899 1.279 . . . . 0.0 111.804 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -129.09 124.89 35.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 34.6 ttmt -85.09 114.16 22.03 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -127.13 172.16 10.78 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.908 0.861 . . . . 0.0 111.464 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.481 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 4.1 t-105 -85.21 147.75 26.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.311 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.961 179.518 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.841 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 121.493 0.663 . . . . 0.0 111.274 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.602 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 10.9 p90 -179.77 -173.5 0.25 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 -173.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.843 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.83 141.94 40.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 111.558 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.682 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.1 t80 -125.55 130.55 51.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.827 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.01 113.65 27.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -74.52 -22.17 59.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.728 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 8' ' ' ILE . 1.5 mm -72.56 -49.39 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.12 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 p -99.03 -20.96 16.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.265 0.555 . . . . 0.0 111.904 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.39 16.89 72.69 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -93.45 164.93 13.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.682 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 7.8 ptp180 -172.92 140.54 0.94 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.461 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -162.64 -177.07 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.344 1.068 . . . . 0.0 112.391 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -87.03 -15.46 38.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.204 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.461 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -83.5 -174.7 5.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.358 1.075 . . . . 0.0 111.987 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.441 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 19.4 ttp-105 -52.1 151.21 7.07 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 112.559 -2.11 . . . . 0.0 106.999 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . 40.3 Cg_exo -51.93 138.27 52.04 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 120.824 1.016 . . . . 0.0 109.582 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -64.67 62.07 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 135.36 1.83 3.07 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.815 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.485 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.11 59.89 3.76 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 119.579 1.689 . . . . 0.0 110.146 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -126.63 -168.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -177.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.55 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -96.87 172.85 7.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.456 -2.611 . . . . 0.0 107.056 177.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.84 -33.16 4.76 Favored Glycine 0 N--CA 1.481 1.661 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.634 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.827 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -58.66 136.92 57.79 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.518 1.527 . . . . 0.0 111.899 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.4 mp0 -148.02 103.57 3.49 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.605 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.843 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 19.6 ttpt -65.11 120.29 12.4 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.492 ' CD ' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -116.67 168.0 10.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.426 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.668 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 69.2 t-105 -105.94 42.99 1.17 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.19 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.6 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.5 m95 . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.715 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.3 p90 -174.73 165.95 3.71 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 120.612 0.244 . . . . 0.0 111.283 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.774 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.77 141.44 39.33 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.506 -173.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.672 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.3 t80 -123.69 129.58 51.32 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.591 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -102.88 110.51 22.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.15 -20.73 63.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.462 HG23 HD13 ' A' ' 8' ' ' ILE . 1.5 mm -73.62 -49.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.12 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.411 HG22 ' OD1' ' A' ' 6' ' ' ASN . 26.5 p -98.61 -22.28 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.279 0.562 . . . . 0.0 111.788 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.3 13.71 73.16 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.698 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -91.62 166.0 13.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.105 0.452 . . . . 0.0 110.075 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.672 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 4.0 ptp180 -172.57 141.79 1.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.441 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.48 -178.38 5.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.348 1.07 . . . . 0.0 112.095 177.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.82 -17.31 33.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.03 -1.896 . . . . 0.0 109.3 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.441 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -79.84 -174.89 4.62 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 122.396 1.093 . . . . 0.0 111.72 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.547 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 29.9 ttm180 -52.84 151.84 7.83 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.266 176.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.691 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.7 Cg_endo -49.02 136.46 29.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.67 1.58 . . . . 0.0 110.217 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -69.4 55.91 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 122.04 0.924 . . . . 0.0 108.566 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.46 -4.26 1.08 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.351 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.691 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.46 59.69 4.4 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 119.792 1.796 . . . . 0.0 109.917 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.566 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -134.02 -168.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -177.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.538 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 64.0 mttt -96.89 174.66 6.67 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.429 -2.623 . . . . 0.0 106.884 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.38 -33.22 4.63 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 118.858 -1.639 . . . . 0.0 109.825 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.5 m95 -60.15 136.74 58.12 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.356 1.462 . . . . 0.0 111.88 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.53 117.29 6.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.9 ttmt -69.71 124.32 23.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.189 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.496 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -124.51 174.4 7.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.581 0.705 . . . . 0.0 110.773 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.449 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 12.7 t-105 -87.86 144.85 26.36 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.066 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.715 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.6 p30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.419 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.1 m95 . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.682 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 2.1 p90 -177.02 170.6 2.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.445 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -108.09 142.59 38.04 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.1 t80 -127.05 127.62 45.01 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.287 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.4 t-20 -101.67 115.59 30.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -75.79 -22.03 56.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.466 HG21 HD12 ' A' ' 8' ' ' ILE . 1.5 mm -72.65 -49.36 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.0 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -99.61 -21.47 15.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.168 0.509 . . . . 0.0 111.92 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.9 70.95 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.2 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 9.6 mmmt -88.56 166.99 13.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 117.208 0.504 . . . . 0.0 109.703 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.536 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -168.16 142.14 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -173.71 -176.48 1.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.13 0.967 . . . . 0.0 111.9 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.01 -10.1 31.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.109 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -80.79 -176.6 5.92 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.495 1.14 . . . . 0.0 111.908 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 26.0 ttp-105 -55.93 146.15 49.99 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.928 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 1.9 Cg_endo -43.26 133.32 6.55 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 122.225 1.95 . . . . 0.0 111.017 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -66.23 59.51 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.269 1.033 . . . . 0.0 108.284 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 139.22 -2.62 2.62 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 113.528 -1.669 . . . . 0.0 114.2 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.671 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 49.99 58.95 4.9 Favored 'General case' 0 C--N 1.366 1.321 0 CA-C-N 119.939 1.87 . . . . 0.0 109.958 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.566 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -129.61 -168.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.551 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 4.1 mmmt -97.22 175.0 6.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 111.432 -2.622 . . . . 0.0 106.895 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 -33.54 4.4 Favored Glycine 0 N--CA 1.482 1.727 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.84 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.9 m95 -59.39 136.22 57.9 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.445 1.498 . . . . 0.0 111.867 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.7 114.25 5.27 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.6 ttmt -67.95 123.45 20.64 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -123.69 174.19 7.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.672 0.749 . . . . 0.0 111.017 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.443 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 8.9 t-105 -87.08 151.35 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.079 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.909 179.522 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 87.8 m95 . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.508 0.194 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.735 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.8 p90 -169.59 160.97 9.3 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 120.767 0.318 . . . . 0.0 111.175 178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.49 139.03 42.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.856 -173.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.669 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 33.0 t80 -121.76 129.46 52.7 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.295 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.829 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -103.51 100.45 10.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.29 -2.47 4.44 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.503 HG21 HD13 ' A' ' 8' ' ' ILE . 1.6 mm -87.2 -52.05 12.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 p -98.07 -23.36 15.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.288 0.566 . . . . 0.0 111.544 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 15.73 59.71 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.651 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 11.6 mmmt -92.31 160.32 15.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.385 0.592 . . . . 0.0 109.918 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.669 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -165.32 143.78 6.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.51 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -163.53 172.39 14.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.986 0.898 . . . . 0.0 112.235 177.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -81.43 -25.77 35.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.93 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -173.39 0.95 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.521 1.153 . . . . 0.0 111.764 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.712 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 12.9 ttp85 -52.95 155.64 4.08 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 112.387 -2.188 . . . . 0.0 107.999 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.712 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 11.2 Cg_endo -52.05 138.03 53.32 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.814 1.676 . . . . 0.0 110.479 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -71.53 54.69 0.23 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.063 0.935 . . . . 0.0 108.57 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.45 -3.73 0.89 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.453 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.628 ' HA ' ' CG ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.77 60.82 3.57 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.609 1.705 . . . . 0.0 109.993 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -135.2 -168.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.535 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 10.0 mttm -97.18 175.13 6.4 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.369 -2.651 . . . . 0.0 106.977 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 -33.85 4.29 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 118.923 -1.608 . . . . 0.0 109.836 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.829 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.0 m95 -58.8 138.97 56.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.289 1.436 . . . . 0.0 111.914 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.2 mt-10 -148.34 120.71 8.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.538 0.209 . . . . 0.0 110.682 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.5 ttmt -76.24 126.72 31.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.807 0.337 . . . . 0.0 110.601 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.449 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -129.07 175.07 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.697 0.761 . . . . 0.0 110.706 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.449 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 9.9 t-105 -89.12 143.96 26.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.695 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.735 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.9 p30 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.258 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.843 ' C ' ' HE3' ' A' ' 2' ' ' TRP 0.261 1.1 p-90 . . . . . 0 CA--C 1.563 1.475 0 CA-C-O 121.219 0.533 . . . . 0.0 111.656 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.823 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER 174.98 -155.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.925 -1.735 . . . . 0.0 112.956 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.571 ' CD1' ' C ' ' A' ' 3' ' ' PHE . 2.3 m-85 -150.69 96.44 2.36 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.74 0.781 . . . . 0.0 110.539 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.681 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 45.1 t80 -98.4 122.23 41.32 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.344 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.797 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.7 t-20 -99.11 106.91 19.17 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -63.7 -18.47 64.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.225 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 8' ' ' ILE . 1.4 mm -76.06 -50.1 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.06 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.457 HG22 ' OD1' ' A' ' 6' ' ' ASN . 27.6 p -97.76 -23.86 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.383 0.611 . . . . 0.0 111.661 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 6' ' ' ASN . . . 88.1 9.92 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.356 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 12.5 mmmt -93.6 160.57 14.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.485 0.642 . . . . 0.0 111.423 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.681 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.59 144.36 7.44 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 123.363 0.665 . . . . 0.0 111.981 -178.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -151.65 173.21 14.94 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.866 0.841 . . . . 0.0 110.648 177.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.651 ' HE1' ' CD1' ' A' ' 28' ' ' TRP . 41.3 m-85 -77.49 -28.79 52.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.72 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -74.14 -177.14 2.83 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.453 1.12 . . . . 0.0 110.691 178.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.62 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 20.5 ttm180 -47.75 157.91 0.56 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 112.457 -2.156 . . . . 0.0 108.907 176.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.659 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 7.6 Cg_endo -47.56 136.67 20.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.335 2.024 . . . . 0.0 110.321 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' CB ' ' HH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -71.84 50.99 0.2 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 159.74 -9.56 0.16 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 114.218 -1.356 . . . . 0.0 114.441 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.659 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 54.29 58.23 5.15 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 119.773 1.786 . . . . 0.0 110.79 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.592 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -140.52 -167.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 123.084 1.421 . . . . 0.0 114.812 -178.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.503 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -92.17 173.35 7.87 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.348 177.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 -36.44 3.54 Favored Glycine 0 N--CA 1.482 1.71 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.661 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.797 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 99.0 m95 -58.45 143.12 46.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.2 1.4 . . . . 0.0 112.091 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -136.97 139.12 41.25 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.823 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 29.9 tttt -92.0 121.58 33.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.297 0.57 . . . . 0.0 111.996 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 21.0 ttp180 179.41 83.95 0.01 OUTLIER 'General case' 0 C--N 1.353 0.741 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.177 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.795 ' HB2' ' O ' ' A' ' 2' ' ' TRP . 1.8 t90 -39.57 -19.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 112.394 -2.185 . . . . 0.0 112.507 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 27' ' ' ARG . 6.4 t70 . . . . . 0 C--N 1.308 -1.239 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.324 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 81.1 m95 . . . . . 0 CA--C 1.528 0.13 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -179.18 166.8 1.54 Allowed 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.707 0.289 . . . . 0.0 111.543 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.64 141.45 39.11 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.467 -173.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.664 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.1 t80 -123.55 130.42 52.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.906 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.826 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.05 111.94 24.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -71.8 -21.08 61.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.64 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.457 HG23 HD12 ' A' ' 8' ' ' ILE . 1.5 mm -73.42 -49.84 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.402 HG23 ' OD1' ' A' ' 6' ' ' ASN . 25.2 p -98.65 -21.98 16.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 111.821 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.09 72.01 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.535 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.551 ' HE3' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -93.47 165.98 12.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.958 0.503 . . . . 0.0 109.874 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.664 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 3.8 ptp180 -172.55 142.81 1.28 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.68 -177.81 5.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.295 1.045 . . . . 0.0 111.979 177.045 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -87.08 -16.54 35.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.37 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -81.53 -174.36 4.92 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 122.425 1.107 . . . . 0.0 111.773 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.413 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 26.5 ttm180 -51.3 150.55 6.05 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.919 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 19' ' ' GLY . 45.6 Cg_exo -51.67 138.69 49.39 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 109.44 -1.023 . . . . 0.0 109.44 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.71 61.74 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.26 1.028 . . . . 0.0 108.322 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 136.61 1.14 2.79 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.805 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.9 59.17 4.38 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 119.579 1.689 . . . . 0.0 110.216 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -127.87 -168.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.54 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -96.03 172.48 7.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.135 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.0 -32.89 4.91 Favored Glycine 0 N--CA 1.481 1.673 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.782 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.826 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.7 m95 -60.12 137.04 58.19 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.431 1.492 . . . . 0.0 111.967 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.82 116.64 5.9 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 29.0 tttt -68.84 123.83 22.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.503 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -122.96 174.16 7.35 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.53 0.681 . . . . 0.0 110.733 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.45 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 9.1 t-105 -86.56 150.46 24.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.107 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.833 179.625 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.473 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 81.8 m95 . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.604 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 29.4 p90 174.59 167.36 0.25 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.765 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.5 139.96 40.15 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.472 -175.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.683 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.0 t80 -118.43 129.62 55.5 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.827 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.6 t-20 -102.67 99.29 9.26 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -66.08 -2.15 3.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 8' ' ' ILE . 1.6 mm -87.19 -52.44 11.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -97.57 -23.6 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.342 0.591 . . . . 0.0 111.496 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.59 15.79 57.8 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.737 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -94.32 159.61 15.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.267 0.533 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.683 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.75 144.25 7.15 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.527 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -160.24 172.68 16.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.05 0.929 . . . . 0.0 112.969 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.3 t80 -80.85 -24.75 38.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.11 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -172.87 2.17 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.421 1.105 . . . . 0.0 111.833 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.673 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 18.5 ttp180 -51.93 157.07 2.22 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 112.42 -2.173 . . . . 0.0 107.948 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.673 ' HD2' ' CG ' ' A' ' 16' ' ' ARG . 10.8 Cg_endo -51.9 138.24 51.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.593 1.528 . . . . 0.0 110.267 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -71.36 54.56 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.37 -4.08 0.79 Allowed Glycine 0 CA--C 1.537 1.449 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.442 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.648 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.08 59.62 4.4 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 119.661 1.73 . . . . 0.0 109.961 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.569 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -134.94 -168.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.533 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 35.7 mttp -96.89 174.26 6.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.434 -2.621 . . . . 0.0 107.068 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.03 -31.76 5.2 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.881 -1.628 . . . . 0.0 109.931 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.827 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.9 m95 -61.13 137.05 58.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.313 1.445 . . . . 0.0 111.832 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.6 mp0 -151.55 110.34 3.85 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-O 120.581 0.229 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 1.8 tppt? -58.58 129.12 40.55 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.02 170.83 8.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.0 110.754 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.423 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 7.4 t-105 -107.69 101.97 11.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.592 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.487 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.954 ' HB2' ' HB3' ' A' ' 27' ' ' ARG 0.379 0.1 OUTLIER . . . . . 0 CA--C 1.598 2.789 0 CA-C-O 117.461 -1.256 . . . . 0.0 111.324 . . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.913 ' N ' ' CB ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -152.25 -171.15 3.85 Favored 'General case' 1 N--CA 1.547 4.424 0 C-N-CA 126.704 2.001 . . . . 0.0 111.839 -174.144 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 6.2 m-85 -64.65 121.38 14.36 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.041 -1.662 . . . . 0.0 111.617 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 28.8 t80 -113.74 121.3 43.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.54 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.647 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.2 t-20 -101.01 85.3 2.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 23.3 ptt180 -46.95 -32.96 4.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.463 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 1.6 mm -65.73 -44.47 93.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.902 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.55 HG22 ' CD2' ' A' ' 20' ' ' LEU . 32.2 p -101.77 -14.12 17.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 111.969 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' ASN . . . 75.88 13.66 82.9 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.686 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -81.72 165.17 21.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.893 0.347 . . . . 0.0 110.255 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.772 ' HD3' ' CE1' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -161.91 136.24 6.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.334 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -142.04 154.07 44.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.568 ' HD1' ' HB3' ' A' ' 29' ' ' ASP . 45.3 m-85 -80.23 -34.08 37.51 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.025 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.725 ' HG3' ' N ' ' A' ' 16' ' ' ARG . 3.3 tp10 -89.33 177.01 6.7 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.725 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 11.0 ttm105 -56.56 138.96 75.98 Favored Pre-proline 0 C--N 1.283 -2.292 0 CA-C-N 113.713 -1.585 . . . . 0.0 106.984 176.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.539 ' HG3' ' NE1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -12.17 145.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 1 C-N-CA 126.17 4.58 . . . . 0.0 117.969 -177.011 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -77.5 22.23 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.972 177.061 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.559 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 89.41 37.96 6.85 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.269 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 9.9 mt -154.63 91.8 1.42 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 119.211 -0.995 . . . . 0.0 113.151 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.712 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 2.2 t -95.04 -168.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 CA-C-O 121.889 0.852 . . . . 0.0 110.863 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.616 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 5.2 mttp 55.46 86.54 0.06 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.71 -15.36 4.1 Favored Glycine 0 C--N 1.296 -1.682 0 CA-C-N 111.447 -2.615 . . . . 0.0 112.247 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.712 ' CD1' ' HA ' ' A' ' 21' ' ' VAL . 39.8 m95 -62.33 141.01 58.51 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.545 1.172 . . . . 0.0 111.886 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.0 mp0 -138.31 102.02 4.53 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 27.2 ttpt -48.68 130.16 17.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.954 ' HB3' ' HB2' ' A' ' 2' ' ' TRP 0.301 14.9 mtp180 -120.66 176.66 5.41 Favored 'General case' 1 N--CA 1.362 -4.874 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 166.933 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.594 ' N ' ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -41.56 -35.33 0.71 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -172.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 2' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.111 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.855 ' CH2' ' HG3' ' A' ' 26' ' ' LYS 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 121.399 0.619 . . . . 0.0 110.65 . . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.3 p90 -178.37 172.07 1.54 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.21 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.784 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -100.3 143.99 29.84 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 124.098 0.874 . . . . 0.0 112.745 -175.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.701 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 39.7 t80 -127.56 129.77 47.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.372 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -103.16 102.29 12.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -67.34 -1.99 5.46 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 8' ' ' ILE . 1.6 mm -87.54 -52.49 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 p -97.68 -23.21 16.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.292 0.568 . . . . 0.0 111.526 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.37 59.83 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.727 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 2.3 mmmm -91.94 164.3 13.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 117.238 0.519 . . . . 0.0 109.632 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.701 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 21.9 ptt-85 -173.0 140.73 0.92 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.45 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -161.4 -177.47 6.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 122.339 1.066 . . . . 0.0 112.191 177.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -86.16 -16.49 37.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.281 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.27 5.16 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.396 1.093 . . . . 0.0 112.097 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.457 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 21.1 ttm105 -51.22 151.76 4.72 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.103 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 19' ' ' GLY . 31.2 Cg_exo -52.82 138.4 60.34 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 CA-C-N 119.842 0.979 . . . . 0.0 109.558 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -65.55 61.45 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 108.2 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 138.71 0.05 2.35 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.923 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.455 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 48.49 60.97 3.29 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.61 1.705 . . . . 0.0 110.257 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.592 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -131.09 -168.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 14.5 mttp -96.0 175.01 6.64 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.536 -2.575 . . . . 0.0 107.048 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.56 -34.23 4.1 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.71 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.5 m95 -58.15 133.92 56.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.308 1.443 . . . . 0.0 111.766 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.3 mp0 -156.22 105.7 2.33 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.855 ' HG3' ' CH2' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -72.0 154.42 41.17 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.755 0.788 . . . . 0.0 112.506 -178.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -124.16 151.75 43.63 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.525 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.494 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 55.3 t-105 -100.61 106.08 17.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.429 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 C--O 1.251 1.18 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.758 -179.251 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.494 ' HB3' ' CE ' ' A' ' 26' ' ' LYS . 70.5 m95 . . . . . 0 C--O 1.228 -0.056 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.528 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 0.2 OUTLIER 178.91 174.53 0.68 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.497 0.665 . . . . 0.0 111.817 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.919 ' HB2' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -104.5 163.99 12.06 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.298 -173.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 45.1 t80 -149.33 133.3 17.1 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.451 -1.405 . . . . 0.0 112.175 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.845 ' HB2' ' CE2' ' A' ' 24' ' ' TRP . 22.9 t-20 -105.25 128.27 53.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -82.38 -26.3 32.99 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -83.57 -45.52 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.43 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -104.4 -16.77 15.01 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 53.1 37.52 54.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.195 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.526 ' C ' ' HH2' ' A' ' 24' ' ' TRP . 22.7 mmmt -102.68 42.5 1.14 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.76 148.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.884 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.689 ' H ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -155.07 -157.51 0.76 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 123.31 1.529 . . . . 0.0 109.726 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -131.32 0.43 4.1 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.596 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.738 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -87.22 179.14 6.69 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.854 1.312 . . . . 0.0 113.894 -177.423 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.77 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 46.6 ttp180 -49.71 -34.75 10.15 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-N 111.953 -2.385 . . . . 0.0 116.947 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.77 ' CD ' ' N ' ' A' ' 16' ' ' ARG . 9.8 Cg_endo -80.59 170.82 15.34 Favored 'Trans proline' 0 CA--C 1.455 -3.453 1 C-N-CA 127.075 5.183 . . . . 0.0 107.636 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.983 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 3.3 pttt 65.19 11.26 7.07 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-O 123.079 1.419 . . . . 0.0 108.902 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.435 ' N ' ' C ' ' A' ' 17' ' ' PRO . . . -143.18 -48.76 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.553 HD13 ' HG3' ' A' ' 16' ' ' ARG . 5.2 mt -97.23 36.75 1.41 Allowed 'General case' 0 C--N 1.359 0.98 0 CA-C-O 122.038 0.923 . . . . 0.0 109.309 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.728 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 70.0 t -139.86 165.43 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.002 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.533 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -91.42 152.82 20.23 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.486 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.3 -27.15 7.9 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.983 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 95.1 m95 -69.61 144.31 53.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.484 1.514 . . . . 0.0 115.013 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 5' ' ' PHE . 4.8 mp0 -150.72 115.14 5.14 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 69.5 tttt -66.09 127.53 32.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -121.44 170.77 9.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.442 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 11.7 t-105 -89.74 141.5 28.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.97 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.788 179.436 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.403 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 86.7 m95 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 121.04 0.448 . . . . 0.0 112.163 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.71 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -163.04 160.45 24.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.809 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.736 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -104.36 131.9 51.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.054 -173.325 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.635 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.6 t80 -114.97 123.27 48.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.251 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.674 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 25.4 t-20 -102.16 92.82 4.92 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -53.83 -21.25 7.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.18 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 8' ' ' ILE . 1.5 mm -67.86 -49.42 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.56 ' CG2' HD21 ' A' ' 20' ' ' LEU . 20.2 p -105.27 -21.39 13.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 112.29 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.38 16.78 56.68 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.221 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 8.3 mmmm -86.82 155.91 20.1 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.383 0.591 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.635 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -161.78 135.68 6.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.18 179.92 8.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 122.152 0.977 . . . . 0.0 111.851 177.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CE2' ' O ' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -87.26 -16.27 35.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.201 175.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.506 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -94.65 -174.1 3.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.596 1.188 . . . . 0.0 111.822 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.522 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 45.9 ttp180 -66.54 155.0 89.94 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.251 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.735 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 25.0 Cg_exo -24.84 145.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 125.086 3.857 . . . . 0.0 115.402 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.88 30.68 0.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.511 ' C ' ' HG ' ' A' ' 20' ' ' LEU . . . 114.17 36.7 1.32 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-N 113.842 -1.526 . . . . 0.0 111.5 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.654 ' HB2' ' CZ2' ' A' ' 24' ' ' TRP . 2.8 mt -144.06 -161.72 1.33 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 117.964 0.882 . . . . 0.0 110.154 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.631 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -170.35 -43.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 122.023 0.916 . . . . 0.0 113.137 -178.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.534 ' HD3' ' HB ' ' A' ' 21' ' ' VAL . 3.2 mmtm -106.56 139.95 40.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.339 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.21 -24.37 20.97 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.735 ' CZ2' ' HA ' ' A' ' 17' ' ' PRO . 80.8 m95 -60.26 140.77 56.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.33 1.052 . . . . 0.0 112.936 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.01 105.14 3.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.751 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.71 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 12.2 ttpt -69.15 126.12 28.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.204 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.68 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.89 174.15 9.04 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 110.656 -178.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.519 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 6.6 t-105 -85.42 151.79 23.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.67 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.773 179.437 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.708 ' CE3' ' HG2' ' A' ' 26' ' ' LYS 0.284 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.723 0 CA-C-O 122.48 1.134 . . . . 0.0 110.135 . . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 30.6 p90 -137.2 -179.21 5.58 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.359 -2.201 . . . . 0.0 113.829 -173.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.717 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -102.19 138.19 39.47 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.614 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 32.5 t80 -116.88 117.29 29.32 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.589 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.771 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 20.5 t-20 -102.55 89.04 3.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 22.5 ptt180 -45.93 -29.68 1.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.719 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.468 HG23 HD13 ' A' ' 8' ' ' ILE . 1.5 mm -65.84 -45.56 91.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.488 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.406 HG22 ' HA2' ' A' ' 19' ' ' GLY . 30.5 p -101.48 -17.09 16.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 112.044 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.44 13.79 79.8 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.239 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 18' ' ' LYS . 6.1 mmmm -89.3 156.3 18.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 117.192 0.496 . . . . 0.0 109.854 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.614 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -154.51 131.65 11.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.515 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -167.81 173.03 8.64 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.061 0.934 . . . . 0.0 113.154 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.55 -23.47 37.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.099 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -176.43 1.85 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.846 1.307 . . . . 0.0 111.985 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.502 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 34.0 ttt-85 -62.51 151.44 83.23 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.048 -2.342 . . . . 0.0 109.529 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.631 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 2.0 Cg_endo -40.21 119.06 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 124.276 3.317 . . . . 0.0 117.264 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 15.4 mmtt -98.52 36.73 1.58 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 172.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -164.66 -30.58 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.377 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.2 mt 81.28 90.86 0.04 OUTLIER 'General case' 0 C--N 1.366 1.293 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.606 ' CA ' ' HD1' ' A' ' 24' ' ' TRP . 14.7 t 44.51 -49.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 119.615 3.191 . . . . 0.0 119.615 173.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -87.68 123.83 32.92 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.623 -178.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.84 -16.91 25.52 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.266 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.771 ' CZ3' ' HB2' ' A' ' 6' ' ' ASN . 81.2 m95 -69.82 143.7 52.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.01 88.55 1.32 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.833 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.708 ' HG2' ' CE3' ' A' ' 2' ' ' TRP . 52.3 tttt -63.63 127.31 30.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.363 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 2' ' ' TRP . 4.2 ttp180 -115.49 161.52 18.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.072 0.939 . . . . 0.0 111.447 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.706 ' CE3' ' HB2' ' A' ' 2' ' ' TRP . 61.2 t-105 -101.73 116.74 33.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.711 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.278 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.1 m95 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.831 0.348 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.681 ' CE2' ' HD2' ' A' ' 12' ' ' ARG . 1.8 p90 -160.93 -167.17 1.76 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.008 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.822 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 3.1 m-85 -128.09 142.57 51.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.599 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 38.0 t80 -123.69 124.25 42.33 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.787 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 18.3 t-20 -98.43 119.57 37.34 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -76.5 -25.83 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.412 HG23 HD13 ' A' ' 8' ' ' ILE . 1.6 mm -76.49 -49.81 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.207 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.0 p -100.21 -21.02 15.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.015 0.436 . . . . 0.0 112.053 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 66.1 30.38 76.8 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.757 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.18 46.42 0.99 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.681 ' HD2' ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -32.3 137.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.412 ' CG ' ' HG3' ' A' ' 17' ' ' PRO . 5.6 mt-30 -135.52 168.31 19.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.459 0.647 . . . . 0.0 110.726 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.43 -7.89 57.15 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.784 174.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.756 ' C ' ' HD3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.89 -164.45 0.8 Allowed 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.661 0.785 . . . . 0.0 110.035 178.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.5 ttm105 -101.38 65.08 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.183 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.756 ' HD3' ' C ' ' A' ' 15' ' ' GLU . 17.7 Cg_endo -88.14 -46.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 125.033 3.822 . . . . 0.0 111.03 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.906 ' HA ' ' CG ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -67.76 -18.12 64.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.018 178.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.0 -34.78 7.45 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 173.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 3.2 mt -67.99 -44.13 77.34 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.546 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -138.28 -177.27 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.11 167.37 12.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 111.443 -2.617 . . . . 0.0 109.392 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.11 -31.13 5.82 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.906 ' CG ' ' HA ' ' A' ' 18' ' ' LYS . 98.9 m95 -66.21 151.23 47.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.167 1.387 . . . . 0.0 112.599 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 5' ' ' PHE . 2.8 mp0 -153.67 109.94 3.32 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 32.0 ttmt -59.42 132.89 55.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -137.72 163.67 30.75 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.693 0.758 . . . . 0.0 111.17 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -77.5 151.6 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.539 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.663 178.754 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.533 ' HE3' ' HD2' ' A' ' 26' ' ' LYS . 77.3 m95 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.735 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER 178.33 173.32 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 178.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.927 ' CD2' ' HG3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -108.76 164.84 12.02 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.167 -174.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.711 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 52.3 t80 -149.53 135.4 18.74 Favored 'General case' 0 C--O 1.22 -0.487 0 O-C-N 121.993 -0.442 . . . . 0.0 111.921 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.79 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 23.1 t-20 -105.44 123.49 47.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -78.86 -23.0 45.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.521 HG21 HD11 ' A' ' 8' ' ' ILE . 1.5 mm -81.6 -46.87 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.632 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -102.46 -19.59 14.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 61.2 31.79 78.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.125 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 9' ' ' THR . 3.9 mmmm -114.23 61.77 0.67 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.485 ' HB2' ' HZ3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -37.54 136.89 0.47 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.71 0.804 . . . . 0.0 109.452 177.062 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.831 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -139.49 92.83 2.61 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.962 0.905 . . . . 0.0 113.078 -175.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.589 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 10.5 t80 -39.26 -25.58 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.797 -0.565 . . . . 0.0 111.086 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -57.38 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.105 0.955 . . . . 0.0 109.467 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.801 ' N ' ' HD2' ' A' ' 17' ' ' PRO . 24.2 ttm105 -46.54 -60.63 3.48 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.032 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.801 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 29.5 Cg_endo -65.81 157.2 60.24 Favored 'Trans proline' 0 CA--C 1.479 -2.266 1 C-N-CA 127.559 5.506 . . . . 0.0 109.301 178.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 1.03 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER 99.7 -12.19 0.04 OUTLIER 'General case' 0 N--CA 1.395 -3.206 0 CA-C-N 111.79 -2.459 . . . . 0.0 105.618 -171.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.67 -38.14 0.22 Allowed Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.226 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.57 ' CD1' ' HG3' ' A' ' 16' ' ' ARG . 4.0 mt -96.97 41.4 1.11 Allowed 'General case' 0 C--N 1.36 1.031 0 CA-C-N 118.212 1.006 . . . . 0.0 111.43 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.8 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 44.3 t -145.84 172.15 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.574 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -81.41 151.88 27.69 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.591 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.83 -29.71 4.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 1.03 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 97.2 m95 -67.64 146.91 53.38 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.624 1.57 . . . . 0.0 114.729 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.6 mp0 -151.29 106.62 3.33 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.1 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.722 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -60.61 129.31 40.91 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.29 173.59 7.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.425 0.631 . . . . 0.0 110.592 -179.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.443 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 6.5 t-105 -115.41 124.88 52.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.333 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.898 179.285 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.418 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 77.3 m95 . . . . . 0 CA--C 1.529 0.166 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.599 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 34.4 p90 176.52 165.76 0.46 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.64 140.65 39.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.987 -174.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.655 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.5 t80 -120.45 129.69 53.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.837 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.19 112.44 25.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -72.62 -20.69 61.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.543 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.441 HG22 HD12 ' A' ' 8' ' ' ILE . 1.5 mm -73.79 -50.0 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.063 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.403 HG23 ' OD1' ' A' ' 6' ' ' ASN . 24.4 p -98.61 -22.68 15.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.271 0.557 . . . . 0.0 111.866 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.69 15.12 71.48 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.946 -1.024 . . . . 0.0 113.711 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -95.05 158.1 15.61 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 117.326 0.563 . . . . 0.0 109.832 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.655 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.09 144.61 9.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.457 ' HG3' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -165.14 -179.85 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.473 1.13 . . . . 0.0 112.547 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.2 t80 -85.33 -16.95 38.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.283 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.62 5.37 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.382 1.087 . . . . 0.0 112.16 -179.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.583 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 23.4 ttp-105 -51.94 153.75 4.3 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 112.402 -2.181 . . . . 0.0 107.059 175.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.695 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.6 Cg_endo -49.86 136.7 35.74 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.531 1.487 . . . . 0.0 110.491 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.35 55.27 0.15 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.71 -5.03 0.8 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-N 113.933 -1.485 . . . . 0.0 114.431 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.695 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.24 59.94 4.17 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-N 119.798 1.799 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.567 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -135.52 -168.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.545 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 3.3 mttm -97.59 174.61 6.56 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 111.388 -2.642 . . . . 0.0 106.852 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.53 -33.15 4.69 Favored Glycine 0 N--CA 1.481 1.678 0 C-N-CA 118.811 -1.662 . . . . 0.0 109.782 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.837 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -59.23 137.46 57.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.42 1.488 . . . . 0.0 111.998 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -150.35 112.27 4.56 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.502 0.191 . . . . 0.0 110.673 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 68.5 tttt -66.05 128.97 38.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.31 165.64 14.59 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.792 0.806 . . . . 0.0 111.55 -179.388 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.407 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 13.6 t-105 -98.05 103.63 15.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.765 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.409 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.4 m95 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.964 0.412 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -162.49 -171.54 2.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.548 178.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 1.8 m-85 -133.54 137.34 45.51 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 122.629 0.372 . . . . 0.0 111.489 -175.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.631 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 32.6 t80 -122.97 125.6 45.59 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.771 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.781 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.3 t-20 -101.3 112.09 24.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.65 -23.35 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.829 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG21 HD13 ' A' ' 8' ' ' ILE . 1.5 mm -71.32 -49.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.959 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.2 p -98.58 -20.76 16.84 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.82 17.45 72.67 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.146 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -92.27 159.74 15.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.191 0.496 . . . . 0.0 110.105 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.631 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.34 144.56 4.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.395 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.556 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -161.08 -174.68 4.48 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.975 0.893 . . . . 0.0 112.027 178.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.71 -8.93 48.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.153 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -91.75 179.04 5.74 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.591 1.186 . . . . 0.0 111.584 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.569 ' HD3' ' CD1' ' A' ' 20' ' ' LEU . 24.4 ttm180 -52.09 145.02 19.31 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.371 175.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.603 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 6.8 Cg_exo -35.49 135.21 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.855 2.37 . . . . 0.0 111.776 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -65.78 58.55 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 141.54 -2.1 1.93 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.219 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 49.34 52.4 14.52 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 120.187 1.994 . . . . 0.0 110.448 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -122.52 -169.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 123.115 1.436 . . . . 0.0 114.789 -178.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.558 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -92.8 173.69 7.63 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 111.77 -2.468 . . . . 0.0 107.166 177.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.47 -36.34 3.45 Favored Glycine 0 N--CA 1.482 1.715 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.728 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.781 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -56.49 140.61 45.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.97 1.308 . . . . 0.0 111.682 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -142.75 108.77 5.19 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.55 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.4 ttpt -62.62 131.12 47.96 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.55 166.22 24.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.045 0.926 . . . . 0.0 111.615 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -84.64 148.07 26.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.453 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.828 179.478 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 81.0 m95 . . . . . 0 N--CA 1.457 -0.098 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.7 p90 -175.93 167.48 3.04 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.77 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.39 140.02 40.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.611 -173.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 29.6 t80 -120.8 128.81 53.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.404 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.794 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.28 106.3 17.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.82 -22.4 62.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.084 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.446 HG23 HD13 ' A' ' 8' ' ' ILE . 1.5 mm -69.64 -49.0 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.761 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -101.0 -19.51 15.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.231 0.538 . . . . 0.0 112.013 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 19.2 62.57 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.7 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.14 178.07 5.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 117.009 0.405 . . . . 0.0 110.078 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.573 ' HD3' ' CE2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -163.1 139.68 7.3 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.638 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -147.29 155.06 41.71 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -86.85 -29.9 21.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.277 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.21 -170.37 2.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.791 0.805 . . . . 0.0 111.689 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.638 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -38.88 124.12 1.21 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 113.332 -1.758 . . . . 0.0 107.763 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.56 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 87.6 Cg_exo -39.02 151.04 0.06 OUTLIER 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 122.847 2.365 . . . . 0.0 113.007 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 59.18 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 133.62 3.41 3.35 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.569 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.506 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 46.93 57.25 5.82 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-N 119.688 1.744 . . . . 0.0 109.867 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.569 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -120.49 -168.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.553 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -96.45 172.45 7.93 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 111.5 -2.591 . . . . 0.0 106.99 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.81 -31.29 5.65 Favored Glycine 0 N--CA 1.48 1.608 0 C-N-CA 118.97 -1.586 . . . . 0.0 109.768 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.794 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.6 m95 -62.85 132.83 53.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.084 1.354 . . . . 0.0 111.268 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -147.44 119.4 8.18 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.9 ttpt -70.4 127.21 31.96 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.338 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.5 171.5 11.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.585 0.707 . . . . 0.0 110.729 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.468 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 10.1 t-105 -85.62 144.77 27.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.613 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.707 179.069 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.4 m95 . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.716 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 0.9 OUTLIER -171.72 166.63 6.57 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.744 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -114.97 142.09 47.1 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.218 -174.065 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 32.1 t80 -128.38 129.35 46.09 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.413 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.809 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.9 t-20 -101.97 113.35 26.49 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -74.92 -22.79 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.445 HD13 HG23 ' A' ' 8' ' ' ILE . 1.5 mm -71.7 -49.49 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.028 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.32 -20.99 16.25 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.885 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 19.06 67.72 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.088 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.539 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -94.35 161.38 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 117.208 0.504 . . . . 0.0 109.8 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.17 145.91 10.35 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.501 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -166.56 172.42 10.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.921 0.867 . . . . 0.0 112.076 177.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -84.05 -24.47 30.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.168 176.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -173.66 1.07 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 122.469 1.128 . . . . 0.0 111.335 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.667 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 40.2 ttp180 -52.81 155.24 4.23 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.723 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.667 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 9.2 Cg_endo -50.67 137.36 41.77 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.702 1.602 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.84 56.16 0.13 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.075 0.94 . . . . 0.0 108.599 179.166 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.68 -3.14 1.31 Allowed Glycine 0 CA--C 1.536 1.349 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.356 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.646 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.05 58.36 5.63 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 119.751 1.775 . . . . 0.0 109.789 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.567 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -130.97 -168.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.534 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 8.0 mmmm -96.87 175.41 6.36 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.941 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.28 -33.34 4.34 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 118.85 -1.643 . . . . 0.0 109.805 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.809 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.8 m95 -59.34 135.42 57.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.273 1.429 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -148.61 117.05 6.53 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.014 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 20.6 ttpt -82.41 130.03 35.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.612 ' O ' ' HB2' ' A' ' 28' ' ' TRP . 16.4 ttp180 -129.37 -58.21 1.12 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.612 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 13.8 t-105 167.46 132.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.15 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 16.7 t70 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.68 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.862 ' CZ3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.564 1.495 0 N-CA-C 121.131 3.752 . . . . 0.0 121.131 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.854 ' HA ' ' HA ' ' A' ' 14' ' ' PHE 0.385 0.6 OUTLIER 156.92 -21.76 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.323 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER 2.98 114.36 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.606 2.362 . . . . 0.0 115.394 -175.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.3 t80 -91.74 123.1 34.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.596 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.759 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 16.6 t-20 -98.16 92.38 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -53.63 -23.88 12.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.518 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.428 HG23 HD12 ' A' ' 8' ' ' ILE . 1.5 mm -70.86 -48.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.236 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 p -99.52 -18.52 17.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.385 0.612 . . . . 0.0 111.922 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.56 69.77 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 114.856 -1.065 . . . . 0.0 113.038 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 10.2 mmmm -91.15 179.28 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.59 ' HA ' ' HZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -169.37 152.89 5.03 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.865 -178.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -153.59 126.68 8.43 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.854 ' HA ' ' HA ' ' A' ' 3' ' ' PHE . 2.1 t80 -63.64 -25.12 68.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -176.11 5.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 122.067 0.937 . . . . 0.0 110.169 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.619 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 15.4 ttm180 -50.46 132.07 26.05 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.788 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.0 Cg_exo -35.82 148.19 0.05 OUTLIER 'Trans proline' 0 CA--C 1.505 -0.964 0 C-N-CA 123.758 2.972 . . . . 0.0 113.986 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.446 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.31 53.54 0.14 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 143.34 -0.56 1.3 Allowed Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.167 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.707 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 49.76 52.53 14.42 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.886 1.843 . . . . 0.0 110.654 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -121.65 -168.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.532 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 18.7 mttt -92.54 172.97 8.03 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.894 -2.412 . . . . 0.0 107.684 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.33 -32.46 4.42 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.007 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.759 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -65.28 135.45 55.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.136 1.374 . . . . 0.0 112.431 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.502 ' C ' ' HA ' ' A' ' 4' ' ' TYR . 2.5 mp0 -148.32 98.47 2.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.784 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.667 ' N ' ' HA ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -68.48 172.39 6.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.863 1.316 . . . . 0.0 114.442 -176.234 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.605 ' H ' ' CB ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -126.95 160.79 29.98 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 111.964 -2.38 . . . . 0.0 105.853 177.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.862 ' HA ' ' CZ3' ' A' ' 2' ' ' TRP . 26.7 t-105 -104.22 55.56 0.72 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.702 1.239 . . . . 0.0 108.091 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.64 ' N ' ' HZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-N 111.634 -2.53 . . . . 0.0 112.948 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.486 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 65.2 m95 . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.672 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 0.2 OUTLIER 176.99 159.81 0.38 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.334 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.727 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -109.08 137.21 47.33 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.221 -173.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.588 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 24.4 t80 -116.09 124.9 51.56 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.716 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.803 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.9 t-20 -99.35 85.92 3.28 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -51.18 -22.93 2.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.156 -178.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.41 HG22 HD12 ' A' ' 8' ' ' ILE . 1.5 mm -67.73 -48.33 76.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.587 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.512 HG22 HD11 ' A' ' 20' ' ' LEU . 18.3 p -106.05 -20.85 13.29 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.15 56.8 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.573 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.632 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 3.1 mmmt -85.34 160.35 19.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.347 0.574 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.588 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.71 139.11 2.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -175.756 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.534 ' HG3' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.17 -179.63 7.22 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.296 1.046 . . . . 0.0 111.774 177.093 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -81.09 -17.1 51.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.775 176.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.468 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -93.35 -176.8 4.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 122.921 1.343 . . . . 0.0 112.761 -178.347 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.472 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -70.96 151.79 95.02 Favored Pre-proline 0 N--CA 1.425 -1.695 0 CA-C-N 111.799 -2.455 . . . . 0.0 107.051 176.166 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.805 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 40.6 Cg_exo -20.2 134.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 125.005 3.803 . . . . 0.0 116.58 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.632 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -58.17 -19.79 35.86 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.756 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.596 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 145.31 38.21 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 112.659 -2.064 . . . . 0.0 112.053 178.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 1.6 mt -151.5 54.09 0.84 Allowed 'General case' 0 C--N 1.366 1.311 0 CA-C-N 119.139 1.469 . . . . 0.0 113.975 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 2.8 m -19.89 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 119.654 3.205 . . . . 0.0 119.654 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -109.25 133.65 52.76 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.048 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.13 -19.82 22.24 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.805 ' CZ2' ' HA ' ' A' ' 17' ' ' PRO . 84.9 m95 -61.39 136.23 57.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -149.45 97.62 2.67 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.462 178.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 24.1 ttpt -58.53 135.18 57.24 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HD2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -125.49 144.93 50.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.627 0.727 . . . . 0.0 111.67 -178.506 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -72.78 124.85 26.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.216 179.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.073 -179.99 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 86.4 m95 . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 120.416 0.15 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -177.99 168.08 2.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.42 178.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.78 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.55 141.67 37.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.629 -173.745 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.666 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.8 t80 -124.42 128.78 49.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.747 -178.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.832 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.1 t-20 -102.42 99.28 9.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -66.12 -2.79 4.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 8' ' ' ILE . 1.6 mm -86.04 -51.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 p -98.62 -22.93 15.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.272 0.558 . . . . 0.0 111.579 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.89 57.41 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.495 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -90.43 168.85 11.54 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.196 0.498 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.666 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 16.6 ptt-85 -176.46 142.72 0.46 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.556 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -168.01 -174.81 2.47 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.961 0.886 . . . . 0.0 111.498 177.989 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -91.83 -10.62 39.13 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.973 177.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -175.93 6.05 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.566 1.174 . . . . 0.0 112.574 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.556 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 23.3 ttm180 -55.3 144.44 51.4 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 112.497 -2.138 . . . . 0.0 105.912 175.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 19' ' ' GLY . 75.1 Cg_exo -44.63 138.06 8.21 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 110.679 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.446 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -65.45 60.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.058 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 137.38 1.26 2.53 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.827 -178.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.545 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.92 61.1 3.14 Favored 'General case' 0 C--N 1.369 1.429 0 CA-C-N 119.901 1.85 . . . . 0.0 110.351 179.897 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -130.56 -168.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.606 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.528 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 3.2 mtpp -95.67 173.28 7.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 111.496 -2.593 . . . . 0.0 107.106 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.47 -31.84 5.28 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.002 -1.57 . . . . 0.0 109.732 -176.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.832 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.7 m95 -62.21 136.15 57.81 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.458 1.503 . . . . 0.0 111.82 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.8 mp0 -150.79 118.65 6.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.6 ttmt -68.26 125.74 27.36 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.965 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.494 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -126.44 171.2 11.22 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.635 0.731 . . . . 0.0 110.672 -179.535 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.494 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 8.2 t-105 -83.25 151.89 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.476 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.788 179.398 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.522 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.107 0.479 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -86.57 151.95 23.03 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.991 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 18.1 p90 -132.75 -177.61 4.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.762 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 1.9 m-85 -132.69 131.38 41.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 120.838 0.351 . . . . 0.0 111.903 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.703 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 36.5 t80 -119.58 126.43 51.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.327 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.761 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.33 110.2 22.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -70.23 -22.61 62.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.692 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 8' ' ' ILE . 1.5 mm -72.22 -49.57 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -98.54 -21.01 16.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.342 0.592 . . . . 0.0 111.739 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.27 15.18 72.44 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.364 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -96.03 156.26 16.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.054 0.427 . . . . 0.0 110.835 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.703 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -166.14 146.69 6.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.046 0.538 . . . . 0.0 111.648 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -152.11 -175.46 5.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.999 0.904 . . . . 0.0 111.844 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 1' ' ' ARG . 0.1 OUTLIER -88.83 -10.64 47.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.623 177.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.453 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -91.51 -177.51 4.83 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.268 1.032 . . . . 0.0 110.757 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.508 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 12.8 ttm105 -50.04 153.39 2.35 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.154 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.679 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 2.6 Cg_endo -40.8 135.79 2.12 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.207 1.938 . . . . 0.0 110.269 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -67.35 56.2 0.05 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.116 0.96 . . . . 0.0 108.707 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 147.05 -3.59 0.93 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 113.848 -1.523 . . . . 0.0 114.358 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.679 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 50.31 51.39 16.86 Favored 'General case' 0 C--N 1.368 1.375 0 CA-C-N 120.214 2.007 . . . . 0.0 110.724 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.576 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -124.6 -169.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.117 1.437 . . . . 0.0 114.744 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.525 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -92.51 167.94 11.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.423 177.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.33 -34.97 4.19 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.706 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.761 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.8 m95 -57.92 138.51 55.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.899 1.279 . . . . 0.0 111.804 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -129.09 124.89 35.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 34.6 ttmt -85.09 114.16 22.03 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -127.13 172.16 10.78 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.908 0.861 . . . . 0.0 111.464 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.481 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 4.1 t-105 -85.21 147.75 26.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.311 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.961 179.518 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.595 0.712 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.841 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -161.7 158.84 26.54 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.274 -174.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.602 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 10.9 p90 -179.77 -173.5 0.25 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 -173.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.843 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.83 141.94 40.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 111.558 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.682 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.1 t80 -125.55 130.55 51.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.827 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.01 113.65 27.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -74.52 -22.17 59.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.728 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 8' ' ' ILE . 1.5 mm -72.56 -49.39 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.12 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 p -99.03 -20.96 16.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.265 0.555 . . . . 0.0 111.904 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.39 16.89 72.69 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -93.45 164.93 13.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.682 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 7.8 ptp180 -172.92 140.54 0.94 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.461 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -162.64 -177.07 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.344 1.068 . . . . 0.0 112.391 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -87.03 -15.46 38.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.204 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.461 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -83.5 -174.7 5.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.358 1.075 . . . . 0.0 111.987 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 19.4 ttp-105 -52.1 151.21 7.07 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 112.559 -2.11 . . . . 0.0 106.999 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . 40.3 Cg_exo -51.93 138.27 52.04 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 120.824 1.016 . . . . 0.0 109.582 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -64.67 62.07 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 135.36 1.83 3.07 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.815 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.485 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.11 59.89 3.76 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 119.579 1.689 . . . . 0.0 110.146 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -126.63 -168.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -177.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.55 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -96.87 172.85 7.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.456 -2.611 . . . . 0.0 107.056 177.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.84 -33.16 4.76 Favored Glycine 0 N--CA 1.481 1.661 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.634 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.827 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -58.66 136.92 57.79 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.518 1.527 . . . . 0.0 111.899 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.4 mp0 -148.02 103.57 3.49 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.605 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.843 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 19.6 ttpt -65.11 120.29 12.4 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.492 ' CD ' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -116.67 168.0 10.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.426 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.668 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 69.2 t-105 -105.94 42.99 1.17 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.19 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.6 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.145 0.498 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -108.6 159.49 16.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.561 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.715 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.3 p90 -174.73 165.95 3.71 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 120.612 0.244 . . . . 0.0 111.283 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.774 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.77 141.44 39.33 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.506 -173.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.672 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.3 t80 -123.69 129.58 51.32 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.591 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -102.88 110.51 22.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.15 -20.73 63.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.462 HG23 HD13 ' A' ' 8' ' ' ILE . 1.5 mm -73.62 -49.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.12 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.411 HG22 ' OD1' ' A' ' 6' ' ' ASN . 26.5 p -98.61 -22.28 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.279 0.562 . . . . 0.0 111.788 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.3 13.71 73.16 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.698 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -91.62 166.0 13.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.105 0.452 . . . . 0.0 110.075 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.672 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 4.0 ptp180 -172.57 141.79 1.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.441 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.48 -178.38 5.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.348 1.07 . . . . 0.0 112.095 177.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.82 -17.31 33.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.03 -1.896 . . . . 0.0 109.3 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.441 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -79.84 -174.89 4.62 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 122.396 1.093 . . . . 0.0 111.72 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.547 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 29.9 ttm180 -52.84 151.84 7.83 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.266 176.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.691 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.7 Cg_endo -49.02 136.46 29.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.67 1.58 . . . . 0.0 110.217 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -69.4 55.91 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 122.04 0.924 . . . . 0.0 108.566 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.46 -4.26 1.08 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.351 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.691 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.46 59.69 4.4 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 119.792 1.796 . . . . 0.0 109.917 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.566 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -134.02 -168.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -177.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.538 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 64.0 mttt -96.89 174.66 6.67 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.429 -2.623 . . . . 0.0 106.884 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.38 -33.22 4.63 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 118.858 -1.639 . . . . 0.0 109.825 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.5 m95 -60.15 136.74 58.12 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.356 1.462 . . . . 0.0 111.88 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.53 117.29 6.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.9 ttmt -69.71 124.32 23.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.189 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.496 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -124.51 174.4 7.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.581 0.705 . . . . 0.0 110.773 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.449 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 12.7 t-105 -87.86 144.85 26.36 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.066 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.715 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.6 p30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.419 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.969 0.414 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -95.85 156.99 16.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.547 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.682 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 2.1 p90 -177.02 170.6 2.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.445 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -108.09 142.59 38.04 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.1 t80 -127.05 127.62 45.01 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.287 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.4 t-20 -101.67 115.59 30.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -75.79 -22.03 56.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.466 HG21 HD12 ' A' ' 8' ' ' ILE . 1.5 mm -72.65 -49.36 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.0 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -99.61 -21.47 15.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.168 0.509 . . . . 0.0 111.92 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.9 70.95 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.2 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 9.6 mmmt -88.56 166.99 13.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 117.208 0.504 . . . . 0.0 109.703 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.536 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -168.16 142.14 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -173.71 -176.48 1.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.13 0.967 . . . . 0.0 111.9 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.01 -10.1 31.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.109 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -80.79 -176.6 5.92 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.495 1.14 . . . . 0.0 111.908 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 26.0 ttp-105 -55.93 146.15 49.99 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.928 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 1.9 Cg_endo -43.26 133.32 6.55 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 122.225 1.95 . . . . 0.0 111.017 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -66.23 59.51 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.269 1.033 . . . . 0.0 108.284 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 139.22 -2.62 2.62 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 113.528 -1.669 . . . . 0.0 114.2 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.671 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 49.99 58.95 4.9 Favored 'General case' 0 C--N 1.366 1.321 0 CA-C-N 119.939 1.87 . . . . 0.0 109.958 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.566 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -129.61 -168.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.551 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 4.1 mmmt -97.22 175.0 6.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 111.432 -2.622 . . . . 0.0 106.895 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 -33.54 4.4 Favored Glycine 0 N--CA 1.482 1.727 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.84 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.9 m95 -59.39 136.22 57.9 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.445 1.498 . . . . 0.0 111.867 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.7 114.25 5.27 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.6 ttmt -67.95 123.45 20.64 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -123.69 174.19 7.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.672 0.749 . . . . 0.0 111.017 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.443 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 8.9 t-105 -87.08 151.35 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.079 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.909 179.522 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.085 0.469 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -105.44 157.58 17.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.016 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.735 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.8 p90 -169.59 160.97 9.3 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 120.767 0.318 . . . . 0.0 111.175 178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.49 139.03 42.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.856 -173.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.669 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 33.0 t80 -121.76 129.46 52.7 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.295 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.829 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -103.51 100.45 10.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.29 -2.47 4.44 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.503 HG21 HD13 ' A' ' 8' ' ' ILE . 1.6 mm -87.2 -52.05 12.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 p -98.07 -23.36 15.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.288 0.566 . . . . 0.0 111.544 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 15.73 59.71 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.651 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 11.6 mmmt -92.31 160.32 15.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.385 0.592 . . . . 0.0 109.918 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.669 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -165.32 143.78 6.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.51 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -163.53 172.39 14.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.986 0.898 . . . . 0.0 112.235 177.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -81.43 -25.77 35.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.93 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -173.39 0.95 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.521 1.153 . . . . 0.0 111.764 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.712 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 12.9 ttp85 -52.95 155.64 4.08 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 112.387 -2.188 . . . . 0.0 107.999 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.712 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 11.2 Cg_endo -52.05 138.03 53.32 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.814 1.676 . . . . 0.0 110.479 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -71.53 54.69 0.23 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.063 0.935 . . . . 0.0 108.57 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.45 -3.73 0.89 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.453 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.628 ' HA ' ' CG ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.77 60.82 3.57 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.609 1.705 . . . . 0.0 109.993 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -135.2 -168.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.535 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 10.0 mttm -97.18 175.13 6.4 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.369 -2.651 . . . . 0.0 106.977 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 -33.85 4.29 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 118.923 -1.608 . . . . 0.0 109.836 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.829 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.0 m95 -58.8 138.97 56.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.289 1.436 . . . . 0.0 111.914 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.2 mt-10 -148.34 120.71 8.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.538 0.209 . . . . 0.0 110.682 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.5 ttmt -76.24 126.72 31.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.807 0.337 . . . . 0.0 110.601 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.449 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -129.07 175.07 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.697 0.761 . . . . 0.0 110.706 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.449 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 9.9 t-105 -89.12 143.96 26.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.695 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.735 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.9 p30 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.258 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.922 ' HG2' ' CG ' ' A' ' 28' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.855 0.836 . . . . 0.0 110.91 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.843 ' C ' ' HE3' ' A' ' 2' ' ' TRP 0.261 1.1 p-90 -148.21 178.74 8.3 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.656 -175.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.823 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER 174.98 -155.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.925 -1.735 . . . . 0.0 112.956 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.571 ' CD1' ' C ' ' A' ' 3' ' ' PHE . 2.3 m-85 -150.69 96.44 2.36 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.74 0.781 . . . . 0.0 110.539 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.681 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 45.1 t80 -98.4 122.23 41.32 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.344 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.797 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.7 t-20 -99.11 106.91 19.17 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -63.7 -18.47 64.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.225 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 8' ' ' ILE . 1.4 mm -76.06 -50.1 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.06 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.457 HG22 ' OD1' ' A' ' 6' ' ' ASN . 27.6 p -97.76 -23.86 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.383 0.611 . . . . 0.0 111.661 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 6' ' ' ASN . . . 88.1 9.92 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.356 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 12.5 mmmt -93.6 160.57 14.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.485 0.642 . . . . 0.0 111.423 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.681 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.59 144.36 7.44 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 123.363 0.665 . . . . 0.0 111.981 -178.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -151.65 173.21 14.94 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.866 0.841 . . . . 0.0 110.648 177.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.651 ' HE1' ' CD1' ' A' ' 28' ' ' TRP . 41.3 m-85 -77.49 -28.79 52.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.72 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -74.14 -177.14 2.83 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.453 1.12 . . . . 0.0 110.691 178.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.62 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 20.5 ttm180 -47.75 157.91 0.56 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 112.457 -2.156 . . . . 0.0 108.907 176.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.659 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 7.6 Cg_endo -47.56 136.67 20.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.335 2.024 . . . . 0.0 110.321 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' CB ' ' HH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -71.84 50.99 0.2 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 159.74 -9.56 0.16 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 114.218 -1.356 . . . . 0.0 114.441 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.659 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 54.29 58.23 5.15 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 119.773 1.786 . . . . 0.0 110.79 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.592 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -140.52 -167.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 123.084 1.421 . . . . 0.0 114.812 -178.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.503 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -92.17 173.35 7.87 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.348 177.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 -36.44 3.54 Favored Glycine 0 N--CA 1.482 1.71 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.661 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.797 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 99.0 m95 -58.45 143.12 46.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.2 1.4 . . . . 0.0 112.091 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -136.97 139.12 41.25 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.823 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 29.9 tttt -92.0 121.58 33.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.297 0.57 . . . . 0.0 111.996 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 21.0 ttp180 179.41 83.95 0.01 OUTLIER 'General case' 0 C--N 1.353 0.741 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.177 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.922 ' CG ' ' HG2' ' A' ' 1' ' ' ARG . 1.8 t90 -39.57 -19.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 112.394 -2.185 . . . . 0.0 112.507 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 27' ' ' ARG . 6.4 t70 . . . . . 0 C--N 1.308 -1.239 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.324 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.003 0.43 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -104.4 159.17 15.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.599 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -179.18 166.8 1.54 Allowed 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.707 0.289 . . . . 0.0 111.543 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.64 141.45 39.11 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.467 -173.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.664 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.1 t80 -123.55 130.42 52.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.906 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.826 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.05 111.94 24.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -71.8 -21.08 61.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.64 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.457 HG23 HD12 ' A' ' 8' ' ' ILE . 1.5 mm -73.42 -49.84 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.402 HG23 ' OD1' ' A' ' 6' ' ' ASN . 25.2 p -98.65 -21.98 16.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 111.821 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.09 72.01 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.535 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.551 ' HE3' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -93.47 165.98 12.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.958 0.503 . . . . 0.0 109.874 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.664 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 3.8 ptp180 -172.55 142.81 1.28 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.68 -177.81 5.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.295 1.045 . . . . 0.0 111.979 177.045 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -87.08 -16.54 35.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.37 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -81.53 -174.36 4.92 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 122.425 1.107 . . . . 0.0 111.773 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.413 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 26.5 ttm180 -51.3 150.55 6.05 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.919 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 19' ' ' GLY . 45.6 Cg_exo -51.67 138.69 49.39 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 109.44 -1.023 . . . . 0.0 109.44 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.71 61.74 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.26 1.028 . . . . 0.0 108.322 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 136.61 1.14 2.79 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.805 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.9 59.17 4.38 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 119.579 1.689 . . . . 0.0 110.216 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -127.87 -168.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.54 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -96.03 172.48 7.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.135 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.0 -32.89 4.91 Favored Glycine 0 N--CA 1.481 1.673 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.782 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.826 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.7 m95 -60.12 137.04 58.19 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.431 1.492 . . . . 0.0 111.967 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.82 116.64 5.9 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 29.0 tttt -68.84 123.83 22.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.503 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -122.96 174.16 7.35 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.53 0.681 . . . . 0.0 110.733 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.45 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 9.1 t-105 -86.56 150.46 24.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.107 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.833 179.625 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.188 0.518 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.473 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 81.8 m95 -116.03 160.39 20.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.228 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.604 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 29.4 p90 174.59 167.36 0.25 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.765 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.5 139.96 40.15 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.472 -175.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.683 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.0 t80 -118.43 129.62 55.5 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.827 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.6 t-20 -102.67 99.29 9.26 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -66.08 -2.15 3.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 8' ' ' ILE . 1.6 mm -87.19 -52.44 11.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -97.57 -23.6 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.342 0.591 . . . . 0.0 111.496 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.59 15.79 57.8 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.737 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -94.32 159.61 15.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.267 0.533 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.683 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.75 144.25 7.15 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.527 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -160.24 172.68 16.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.05 0.929 . . . . 0.0 112.969 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.3 t80 -80.85 -24.75 38.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.11 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -172.87 2.17 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.421 1.105 . . . . 0.0 111.833 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.673 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 18.5 ttp180 -51.93 157.07 2.22 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 112.42 -2.173 . . . . 0.0 107.948 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.673 ' HD2' ' CG ' ' A' ' 16' ' ' ARG . 10.8 Cg_endo -51.9 138.24 51.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.593 1.528 . . . . 0.0 110.267 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -71.36 54.56 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.37 -4.08 0.79 Allowed Glycine 0 CA--C 1.537 1.449 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.442 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.648 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.08 59.62 4.4 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 119.661 1.73 . . . . 0.0 109.961 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.569 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -134.94 -168.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.533 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 35.7 mttp -96.89 174.26 6.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.434 -2.621 . . . . 0.0 107.068 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.03 -31.76 5.2 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.881 -1.628 . . . . 0.0 109.931 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.827 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.9 m95 -61.13 137.05 58.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.313 1.445 . . . . 0.0 111.832 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.6 mp0 -151.55 110.34 3.85 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-O 120.581 0.229 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 1.8 tppt? -58.58 129.12 40.55 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.02 170.83 8.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.0 110.754 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.423 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 7.4 t-105 -107.69 101.97 11.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.592 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.487 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.761 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 15.3 ttm105 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.86 0.362 . . . . 0.0 110.656 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.954 ' HB2' ' HB3' ' A' ' 27' ' ' ARG 0.379 0.1 OUTLIER -113.61 179.16 4.04 Favored 'General case' 0 CA--C 1.598 2.789 0 CA-C-O 117.461 -1.256 . . . . 0.0 111.324 -178.343 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.913 ' N ' ' CB ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -152.25 -171.15 3.85 Favored 'General case' 1 N--CA 1.547 4.424 0 C-N-CA 126.704 2.001 . . . . 0.0 111.839 -174.144 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 6.2 m-85 -64.65 121.38 14.36 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.041 -1.662 . . . . 0.0 111.617 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 28.8 t80 -113.74 121.3 43.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.54 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.647 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.2 t-20 -101.01 85.3 2.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 23.3 ptt180 -46.95 -32.96 4.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.463 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 1.6 mm -65.73 -44.47 93.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.902 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.55 HG22 ' CD2' ' A' ' 20' ' ' LEU . 32.2 p -101.77 -14.12 17.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 111.969 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' ASN . . . 75.88 13.66 82.9 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.686 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -81.72 165.17 21.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.893 0.347 . . . . 0.0 110.255 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.772 ' HD3' ' CE1' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -161.91 136.24 6.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.334 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -142.04 154.07 44.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.568 ' HD1' ' HB3' ' A' ' 29' ' ' ASP . 45.3 m-85 -80.23 -34.08 37.51 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.025 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.725 ' HG3' ' N ' ' A' ' 16' ' ' ARG . 3.3 tp10 -89.33 177.01 6.7 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.725 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 11.0 ttm105 -56.56 138.96 75.98 Favored Pre-proline 0 C--N 1.283 -2.292 0 CA-C-N 113.713 -1.585 . . . . 0.0 106.984 176.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.539 ' HG3' ' NE1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -12.17 145.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 1 C-N-CA 126.17 4.58 . . . . 0.0 117.969 -177.011 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -77.5 22.23 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.972 177.061 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.559 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 89.41 37.96 6.85 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.269 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 9.9 mt -154.63 91.8 1.42 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 119.211 -0.995 . . . . 0.0 113.151 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.712 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 2.2 t -95.04 -168.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 CA-C-O 121.889 0.852 . . . . 0.0 110.863 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.616 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 5.2 mttp 55.46 86.54 0.06 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.71 -15.36 4.1 Favored Glycine 0 C--N 1.296 -1.682 0 CA-C-N 111.447 -2.615 . . . . 0.0 112.247 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.712 ' CD1' ' HA ' ' A' ' 21' ' ' VAL . 39.8 m95 -62.33 141.01 58.51 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.545 1.172 . . . . 0.0 111.886 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.0 mp0 -138.31 102.02 4.53 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 27.2 ttpt -48.68 130.16 17.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.954 ' HB3' ' HB2' ' A' ' 2' ' ' TRP 0.301 14.9 mtp180 -120.66 176.66 5.41 Favored 'General case' 1 N--CA 1.362 -4.874 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 166.933 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.761 ' CE3' ' HA ' ' A' ' 1' ' ' ARG . 0.0 OUTLIER -41.56 -35.33 0.71 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -172.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 2' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.111 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.393 0.616 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.855 ' CH2' ' HG3' ' A' ' 26' ' ' LYS 0.256 0.0 OUTLIER -167.88 161.08 12.82 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.65 -174.359 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.3 p90 -178.37 172.07 1.54 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.21 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.784 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -100.3 143.99 29.84 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 124.098 0.874 . . . . 0.0 112.745 -175.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.701 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 39.7 t80 -127.56 129.77 47.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.372 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -103.16 102.29 12.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -67.34 -1.99 5.46 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 8' ' ' ILE . 1.6 mm -87.54 -52.49 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 p -97.68 -23.21 16.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.292 0.568 . . . . 0.0 111.526 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.37 59.83 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.727 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 2.3 mmmm -91.94 164.3 13.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 117.238 0.519 . . . . 0.0 109.632 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.701 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 21.9 ptt-85 -173.0 140.73 0.92 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.45 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -161.4 -177.47 6.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 122.339 1.066 . . . . 0.0 112.191 177.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -86.16 -16.49 37.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.281 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.27 5.16 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.396 1.093 . . . . 0.0 112.097 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.457 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 21.1 ttm105 -51.22 151.76 4.72 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.103 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 19' ' ' GLY . 31.2 Cg_exo -52.82 138.4 60.34 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 CA-C-N 119.842 0.979 . . . . 0.0 109.558 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -65.55 61.45 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 108.2 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 138.71 0.05 2.35 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.923 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.455 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 48.49 60.97 3.29 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.61 1.705 . . . . 0.0 110.257 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.592 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -131.09 -168.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 14.5 mttp -96.0 175.01 6.64 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.536 -2.575 . . . . 0.0 107.048 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.56 -34.23 4.1 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.71 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.5 m95 -58.15 133.92 56.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.308 1.443 . . . . 0.0 111.766 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.3 mp0 -156.22 105.7 2.33 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.855 ' HG3' ' CH2' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -72.0 154.42 41.17 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.755 0.788 . . . . 0.0 112.506 -178.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -124.16 151.75 43.63 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.525 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.494 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 55.3 t-105 -100.61 106.08 17.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.429 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 C--O 1.251 1.18 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.758 -179.251 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.064 0.459 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.494 ' HB3' ' CE ' ' A' ' 26' ' ' LYS . 70.5 m95 -116.99 158.86 23.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.725 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.528 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 0.2 OUTLIER 178.91 174.53 0.68 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.497 0.665 . . . . 0.0 111.817 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.919 ' HB2' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -104.5 163.99 12.06 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.298 -173.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 45.1 t80 -149.33 133.3 17.1 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.451 -1.405 . . . . 0.0 112.175 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.845 ' HB2' ' CE2' ' A' ' 24' ' ' TRP . 22.9 t-20 -105.25 128.27 53.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -82.38 -26.3 32.99 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -83.57 -45.52 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.43 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -104.4 -16.77 15.01 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 53.1 37.52 54.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.195 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' C ' ' HH2' ' A' ' 24' ' ' TRP . 22.7 mmmt -102.68 42.5 1.14 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.76 148.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.884 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.689 ' H ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -155.07 -157.51 0.76 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 123.31 1.529 . . . . 0.0 109.726 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -131.32 0.43 4.1 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.596 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.738 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -87.22 179.14 6.69 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.854 1.312 . . . . 0.0 113.894 -177.423 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.77 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 46.6 ttp180 -49.71 -34.75 10.15 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-N 111.953 -2.385 . . . . 0.0 116.947 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.77 ' CD ' ' N ' ' A' ' 16' ' ' ARG . 9.8 Cg_endo -80.59 170.82 15.34 Favored 'Trans proline' 0 CA--C 1.455 -3.453 1 C-N-CA 127.075 5.183 . . . . 0.0 107.636 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.983 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 3.3 pttt 65.19 11.26 7.07 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-O 123.079 1.419 . . . . 0.0 108.902 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.435 ' N ' ' C ' ' A' ' 17' ' ' PRO . . . -143.18 -48.76 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.553 HD13 ' HG3' ' A' ' 16' ' ' ARG . 5.2 mt -97.23 36.75 1.41 Allowed 'General case' 0 C--N 1.359 0.98 0 CA-C-O 122.038 0.923 . . . . 0.0 109.309 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.728 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 70.0 t -139.86 165.43 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.002 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.533 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -91.42 152.82 20.23 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.486 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.3 -27.15 7.9 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.983 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 95.1 m95 -69.61 144.31 53.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.484 1.514 . . . . 0.0 115.013 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 5' ' ' PHE . 4.8 mp0 -150.72 115.14 5.14 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 69.5 tttt -66.09 127.53 32.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -121.44 170.77 9.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.442 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 11.7 t-105 -89.74 141.5 28.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.97 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.788 179.436 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.552 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 17.6 mtm180 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.044 0.45 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.403 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 86.7 m95 -103.94 151.77 22.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.163 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.71 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -163.04 160.45 24.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.809 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.736 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -104.36 131.9 51.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.054 -173.325 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.635 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.6 t80 -114.97 123.27 48.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.251 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.674 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 25.4 t-20 -102.16 92.82 4.92 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -53.83 -21.25 7.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.18 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 8' ' ' ILE . 1.5 mm -67.86 -49.42 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.56 ' CG2' HD21 ' A' ' 20' ' ' LEU . 20.2 p -105.27 -21.39 13.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 112.29 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.38 16.78 56.68 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.221 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 8.3 mmmm -86.82 155.91 20.1 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.383 0.591 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.635 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -161.78 135.68 6.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.18 179.92 8.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 122.152 0.977 . . . . 0.0 111.851 177.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 1' ' ' ARG . 0.3 OUTLIER -87.26 -16.27 35.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.201 175.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.506 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -94.65 -174.1 3.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.596 1.188 . . . . 0.0 111.822 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.522 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 45.9 ttp180 -66.54 155.0 89.94 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.251 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.735 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 25.0 Cg_exo -24.84 145.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 125.086 3.857 . . . . 0.0 115.402 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.88 30.68 0.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.511 ' C ' ' HG ' ' A' ' 20' ' ' LEU . . . 114.17 36.7 1.32 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-N 113.842 -1.526 . . . . 0.0 111.5 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.654 ' HB2' ' CZ2' ' A' ' 24' ' ' TRP . 2.8 mt -144.06 -161.72 1.33 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 117.964 0.882 . . . . 0.0 110.154 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.631 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -170.35 -43.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 122.023 0.916 . . . . 0.0 113.137 -178.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.534 ' HD3' ' HB ' ' A' ' 21' ' ' VAL . 3.2 mmtm -106.56 139.95 40.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.339 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.21 -24.37 20.97 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.735 ' CZ2' ' HA ' ' A' ' 17' ' ' PRO . 80.8 m95 -60.26 140.77 56.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.33 1.052 . . . . 0.0 112.936 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.01 105.14 3.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.751 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.71 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 12.2 ttpt -69.15 126.12 28.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.204 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.68 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.89 174.15 9.04 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 110.656 -178.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.519 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 6.6 t-105 -85.42 151.79 23.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.67 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.773 179.437 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.465 0.65 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.708 ' CE3' ' HG2' ' A' ' 26' ' ' LYS 0.284 0.0 OUTLIER -168.83 124.85 0.94 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.135 -173.766 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 30.6 p90 -137.2 -179.21 5.58 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.359 -2.201 . . . . 0.0 113.829 -173.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.717 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -102.19 138.19 39.47 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.614 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 32.5 t80 -116.88 117.29 29.32 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.589 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.771 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 20.5 t-20 -102.55 89.04 3.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 22.5 ptt180 -45.93 -29.68 1.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.719 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.468 HG23 HD13 ' A' ' 8' ' ' ILE . 1.5 mm -65.84 -45.56 91.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.488 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.406 HG22 ' HA2' ' A' ' 19' ' ' GLY . 30.5 p -101.48 -17.09 16.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 112.044 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.44 13.79 79.8 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.239 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 18' ' ' LYS . 6.1 mmmm -89.3 156.3 18.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 117.192 0.496 . . . . 0.0 109.854 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.614 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -154.51 131.65 11.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.515 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -167.81 173.03 8.64 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.061 0.934 . . . . 0.0 113.154 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.55 -23.47 37.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.099 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -176.43 1.85 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.846 1.307 . . . . 0.0 111.985 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.502 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 34.0 ttt-85 -62.51 151.44 83.23 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.048 -2.342 . . . . 0.0 109.529 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.631 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 2.0 Cg_endo -40.21 119.06 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 124.276 3.317 . . . . 0.0 117.264 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 15.4 mmtt -98.52 36.73 1.58 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 172.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -164.66 -30.58 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.377 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.2 mt 81.28 90.86 0.04 OUTLIER 'General case' 0 C--N 1.366 1.293 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.606 ' CA ' ' HD1' ' A' ' 24' ' ' TRP . 14.7 t 44.51 -49.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 119.615 3.191 . . . . 0.0 119.615 173.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -87.68 123.83 32.92 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.623 -178.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.84 -16.91 25.52 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.266 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.771 ' CZ3' ' HB2' ' A' ' 6' ' ' ASN . 81.2 m95 -69.82 143.7 52.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.01 88.55 1.32 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.833 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.708 ' HG2' ' CE3' ' A' ' 2' ' ' TRP . 52.3 tttt -63.63 127.31 30.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.363 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 2' ' ' TRP . 4.2 ttp180 -115.49 161.52 18.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.072 0.939 . . . . 0.0 111.447 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.706 ' CE3' ' HB2' ' A' ' 2' ' ' TRP . 61.2 t-105 -101.73 116.74 33.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.711 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.278 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.934 0.397 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -51.55 155.32 1.59 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.718 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.681 ' CE2' ' HD2' ' A' ' 12' ' ' ARG . 1.8 p90 -160.93 -167.17 1.76 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.008 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.822 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 3.1 m-85 -128.09 142.57 51.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 38.0 t80 -123.69 124.25 42.33 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.787 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 18.3 t-20 -98.43 119.57 37.34 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -76.5 -25.83 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.412 HG23 HD13 ' A' ' 8' ' ' ILE . 1.6 mm -76.49 -49.81 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.207 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.0 p -100.21 -21.02 15.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.015 0.436 . . . . 0.0 112.053 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 66.1 30.38 76.8 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.757 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.18 46.42 0.99 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.681 ' HD2' ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -32.3 137.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.412 ' CG ' ' HG3' ' A' ' 17' ' ' PRO . 5.6 mt-30 -135.52 168.31 19.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.459 0.647 . . . . 0.0 110.726 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.43 -7.89 57.15 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.784 174.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.756 ' C ' ' HD3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.89 -164.45 0.8 Allowed 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.661 0.785 . . . . 0.0 110.035 178.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.5 ttm105 -101.38 65.08 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.183 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.756 ' HD3' ' C ' ' A' ' 15' ' ' GLU . 17.7 Cg_endo -88.14 -46.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 125.033 3.822 . . . . 0.0 111.03 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.906 ' HA ' ' CG ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -67.76 -18.12 64.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.018 178.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.0 -34.78 7.45 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 173.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 3.2 mt -67.99 -44.13 77.34 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.546 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -138.28 -177.27 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.11 167.37 12.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 111.443 -2.617 . . . . 0.0 109.392 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.11 -31.13 5.82 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.906 ' CG ' ' HA ' ' A' ' 18' ' ' LYS . 98.9 m95 -66.21 151.23 47.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.167 1.387 . . . . 0.0 112.599 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 5' ' ' PHE . 2.8 mp0 -153.67 109.94 3.32 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 32.0 ttmt -59.42 132.89 55.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -137.72 163.67 30.75 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.693 0.758 . . . . 0.0 111.17 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -77.5 151.6 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.539 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.663 178.754 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.241 0.543 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.533 ' HE3' ' HD2' ' A' ' 26' ' ' LYS . 77.3 m95 -114.5 155.96 25.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.533 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.735 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER 178.33 173.32 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 178.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.927 ' CD2' ' HG3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -108.76 164.84 12.02 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.167 -174.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.711 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 52.3 t80 -149.53 135.4 18.74 Favored 'General case' 0 C--O 1.22 -0.487 0 O-C-N 121.993 -0.442 . . . . 0.0 111.921 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.79 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 23.1 t-20 -105.44 123.49 47.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -78.86 -23.0 45.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.521 HG21 HD11 ' A' ' 8' ' ' ILE . 1.5 mm -81.6 -46.87 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.632 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -102.46 -19.59 14.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 61.2 31.79 78.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.125 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 9' ' ' THR . 3.9 mmmm -114.23 61.77 0.67 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.485 ' HB2' ' HZ3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -37.54 136.89 0.47 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.71 0.804 . . . . 0.0 109.452 177.062 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.831 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -139.49 92.83 2.61 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.962 0.905 . . . . 0.0 113.078 -175.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.589 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 10.5 t80 -39.26 -25.58 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.797 -0.565 . . . . 0.0 111.086 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -57.38 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.105 0.955 . . . . 0.0 109.467 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.801 ' N ' ' HD2' ' A' ' 17' ' ' PRO . 24.2 ttm105 -46.54 -60.63 3.48 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.032 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.801 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 29.5 Cg_endo -65.81 157.2 60.24 Favored 'Trans proline' 0 CA--C 1.479 -2.266 1 C-N-CA 127.559 5.506 . . . . 0.0 109.301 178.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 1.03 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER 99.7 -12.19 0.04 OUTLIER 'General case' 0 N--CA 1.395 -3.206 0 CA-C-N 111.79 -2.459 . . . . 0.0 105.618 -171.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.67 -38.14 0.22 Allowed Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.226 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.57 ' CD1' ' HG3' ' A' ' 16' ' ' ARG . 4.0 mt -96.97 41.4 1.11 Allowed 'General case' 0 C--N 1.36 1.031 0 CA-C-N 118.212 1.006 . . . . 0.0 111.43 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.8 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 44.3 t -145.84 172.15 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.574 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -81.41 151.88 27.69 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.591 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.83 -29.71 4.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 1.03 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 97.2 m95 -67.64 146.91 53.38 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.624 1.57 . . . . 0.0 114.729 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.6 mp0 -151.29 106.62 3.33 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.1 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.722 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -60.61 129.31 40.91 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.29 173.59 7.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.425 0.631 . . . . 0.0 110.592 -179.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.443 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 6.5 t-105 -115.41 124.88 52.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.333 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.898 179.285 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.064 0.459 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.418 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 77.3 m95 -117.6 160.23 21.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.081 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.599 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 34.4 p90 176.52 165.76 0.46 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.64 140.65 39.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.987 -174.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.655 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.5 t80 -120.45 129.69 53.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.837 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.19 112.44 25.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -72.62 -20.69 61.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.543 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.441 HG22 HD12 ' A' ' 8' ' ' ILE . 1.5 mm -73.79 -50.0 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.063 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.403 HG23 ' OD1' ' A' ' 6' ' ' ASN . 24.4 p -98.61 -22.68 15.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.271 0.557 . . . . 0.0 111.866 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.69 15.12 71.48 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.946 -1.024 . . . . 0.0 113.711 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -95.05 158.1 15.61 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 117.326 0.563 . . . . 0.0 109.832 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.655 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.09 144.61 9.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.457 ' HG3' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -165.14 -179.85 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.473 1.13 . . . . 0.0 112.547 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.2 t80 -85.33 -16.95 38.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.283 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.62 5.37 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.382 1.087 . . . . 0.0 112.16 -179.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.583 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 23.4 ttp-105 -51.94 153.75 4.3 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 112.402 -2.181 . . . . 0.0 107.059 175.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.695 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.6 Cg_endo -49.86 136.7 35.74 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.531 1.487 . . . . 0.0 110.491 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.35 55.27 0.15 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.71 -5.03 0.8 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-N 113.933 -1.485 . . . . 0.0 114.431 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.695 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.24 59.94 4.17 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-N 119.798 1.799 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.567 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -135.52 -168.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.545 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 3.3 mttm -97.59 174.61 6.56 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 111.388 -2.642 . . . . 0.0 106.852 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.53 -33.15 4.69 Favored Glycine 0 N--CA 1.481 1.678 0 C-N-CA 118.811 -1.662 . . . . 0.0 109.782 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.837 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -59.23 137.46 57.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.42 1.488 . . . . 0.0 111.998 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -150.35 112.27 4.56 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.502 0.191 . . . . 0.0 110.673 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 68.5 tttt -66.05 128.97 38.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.31 165.64 14.59 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.792 0.806 . . . . 0.0 111.55 -179.388 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.407 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 13.6 t-105 -98.05 103.63 15.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.765 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.409 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.507 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 8.9 mtt180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.145 0.498 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -112.11 153.74 26.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.956 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -162.49 -171.54 2.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.548 178.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 1.8 m-85 -133.54 137.34 45.51 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 122.629 0.372 . . . . 0.0 111.489 -175.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.631 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 32.6 t80 -122.97 125.6 45.59 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.771 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.781 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.3 t-20 -101.3 112.09 24.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.65 -23.35 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.829 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG21 HD13 ' A' ' 8' ' ' ILE . 1.5 mm -71.32 -49.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.959 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.2 p -98.58 -20.76 16.84 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.82 17.45 72.67 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.146 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -92.27 159.74 15.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.191 0.496 . . . . 0.0 110.105 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.631 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.34 144.56 4.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.395 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.556 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -161.08 -174.68 4.48 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.975 0.893 . . . . 0.0 112.027 178.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 1' ' ' ARG . 0.7 OUTLIER -90.71 -8.93 48.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.153 177.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -91.75 179.04 5.74 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.591 1.186 . . . . 0.0 111.584 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.569 ' HD3' ' CD1' ' A' ' 20' ' ' LEU . 24.4 ttm180 -52.09 145.02 19.31 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.371 175.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.603 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 6.8 Cg_exo -35.49 135.21 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.855 2.37 . . . . 0.0 111.776 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -65.78 58.55 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 141.54 -2.1 1.93 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.219 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 49.34 52.4 14.52 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 120.187 1.994 . . . . 0.0 110.448 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -122.52 -169.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 123.115 1.436 . . . . 0.0 114.789 -178.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.558 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -92.8 173.69 7.63 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 111.77 -2.468 . . . . 0.0 107.166 177.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.47 -36.34 3.45 Favored Glycine 0 N--CA 1.482 1.715 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.728 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.781 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -56.49 140.61 45.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.97 1.308 . . . . 0.0 111.682 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -142.75 108.77 5.19 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.55 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.4 ttpt -62.62 131.12 47.96 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.55 166.22 24.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.045 0.926 . . . . 0.0 111.615 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -84.64 148.07 26.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.453 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.828 179.478 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.178 0.513 . . . . 0.0 111.18 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.45 ' N ' ' HD2' ' A' ' 1' ' ' ARG . 81.0 m95 -113.45 156.33 23.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.063 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.7 p90 -175.93 167.48 3.04 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.77 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.39 140.02 40.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.611 -173.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 29.6 t80 -120.8 128.81 53.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.404 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.794 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.28 106.3 17.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.82 -22.4 62.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.084 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.446 HG23 HD13 ' A' ' 8' ' ' ILE . 1.5 mm -69.64 -49.0 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.761 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -101.0 -19.51 15.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.231 0.538 . . . . 0.0 112.013 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 19.2 62.57 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.7 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.14 178.07 5.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 117.009 0.405 . . . . 0.0 110.078 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.573 ' HD3' ' CE2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -163.1 139.68 7.3 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.638 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -147.29 155.06 41.71 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -86.85 -29.9 21.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.277 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.21 -170.37 2.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.791 0.805 . . . . 0.0 111.689 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.638 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -38.88 124.12 1.21 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 113.332 -1.758 . . . . 0.0 107.763 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.56 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 87.6 Cg_exo -39.02 151.04 0.06 OUTLIER 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 122.847 2.365 . . . . 0.0 113.007 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 59.18 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 133.62 3.41 3.35 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.569 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.506 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 46.93 57.25 5.82 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-N 119.688 1.744 . . . . 0.0 109.867 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.569 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -120.49 -168.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.553 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -96.45 172.45 7.93 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 111.5 -2.591 . . . . 0.0 106.99 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.81 -31.29 5.65 Favored Glycine 0 N--CA 1.48 1.608 0 C-N-CA 118.97 -1.586 . . . . 0.0 109.768 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.794 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.6 m95 -62.85 132.83 53.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.084 1.354 . . . . 0.0 111.268 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -147.44 119.4 8.18 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.9 ttpt -70.4 127.21 31.96 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.338 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.5 171.5 11.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.585 0.707 . . . . 0.0 110.729 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.468 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 10.1 t-105 -85.62 144.77 27.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.613 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' A' ' 1' ' ' ARG . 6.0 t70 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.707 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.964 0.411 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -98.82 160.92 13.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.397 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.716 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 0.9 OUTLIER -171.72 166.63 6.57 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.744 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -114.97 142.09 47.1 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.218 -174.065 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 32.1 t80 -128.38 129.35 46.09 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.413 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.809 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.9 t-20 -101.97 113.35 26.49 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -74.92 -22.79 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.445 HD13 HG23 ' A' ' 8' ' ' ILE . 1.5 mm -71.7 -49.49 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.028 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.32 -20.99 16.25 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.885 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 19.06 67.72 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.088 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.539 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -94.35 161.38 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 117.208 0.504 . . . . 0.0 109.8 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.17 145.91 10.35 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.501 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -166.56 172.42 10.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.921 0.867 . . . . 0.0 112.076 177.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -84.05 -24.47 30.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.168 176.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -173.66 1.07 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 122.469 1.128 . . . . 0.0 111.335 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.667 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 40.2 ttp180 -52.81 155.24 4.23 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.723 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.667 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 9.2 Cg_endo -50.67 137.36 41.77 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.702 1.602 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.84 56.16 0.13 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.075 0.94 . . . . 0.0 108.599 179.166 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.68 -3.14 1.31 Allowed Glycine 0 CA--C 1.536 1.349 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.356 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.646 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.05 58.36 5.63 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 119.751 1.775 . . . . 0.0 109.789 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.567 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -130.97 -168.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.534 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 8.0 mmmm -96.87 175.41 6.36 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.941 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.28 -33.34 4.34 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 118.85 -1.643 . . . . 0.0 109.805 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.809 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.8 m95 -59.34 135.42 57.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.273 1.429 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -148.61 117.05 6.53 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.014 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 20.6 ttpt -82.41 130.03 35.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.612 ' O ' ' HB2' ' A' ' 28' ' ' TRP . 16.4 ttp180 -129.37 -58.21 1.12 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.612 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 13.8 t-105 167.46 132.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.15 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 16.7 t70 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.68 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.737 ' C ' ' HG3' ' A' ' 26' ' ' LYS . 24.8 ttm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.758 0.789 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.862 ' CZ3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -128.42 128.41 44.39 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 121.131 3.752 . . . . 0.0 121.131 -173.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.854 ' HA ' ' HA ' ' A' ' 14' ' ' PHE 0.385 0.6 OUTLIER 156.92 -21.76 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.323 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER 2.98 114.36 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.606 2.362 . . . . 0.0 115.394 -175.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.3 t80 -91.74 123.1 34.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.596 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.759 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 16.6 t-20 -98.16 92.38 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -53.63 -23.88 12.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.518 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.428 HG23 HD12 ' A' ' 8' ' ' ILE . 1.5 mm -70.86 -48.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.236 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 p -99.52 -18.52 17.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.385 0.612 . . . . 0.0 111.922 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.56 69.77 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 114.856 -1.065 . . . . 0.0 113.038 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 10.2 mmmm -91.15 179.28 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.59 ' HA ' ' HZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -169.37 152.89 5.03 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.865 -178.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -153.59 126.68 8.43 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.854 ' HA ' ' HA ' ' A' ' 3' ' ' PHE . 2.1 t80 -63.64 -25.12 68.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -176.11 5.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 122.067 0.937 . . . . 0.0 110.169 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.619 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 15.4 ttm180 -50.46 132.07 26.05 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.788 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.0 Cg_exo -35.82 148.19 0.05 OUTLIER 'Trans proline' 0 CA--C 1.505 -0.964 0 C-N-CA 123.758 2.972 . . . . 0.0 113.986 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.446 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.31 53.54 0.14 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 143.34 -0.56 1.3 Allowed Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.167 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.707 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 49.76 52.53 14.42 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.886 1.843 . . . . 0.0 110.654 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -121.65 -168.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.532 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 18.7 mttt -92.54 172.97 8.03 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.894 -2.412 . . . . 0.0 107.684 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.33 -32.46 4.42 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.007 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.759 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -65.28 135.45 55.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.136 1.374 . . . . 0.0 112.431 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.502 ' C ' ' HA ' ' A' ' 4' ' ' TYR . 2.5 mp0 -148.32 98.47 2.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.784 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.737 ' HG3' ' C ' ' A' ' 1' ' ' ARG . 0.0 OUTLIER -68.48 172.39 6.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.863 1.316 . . . . 0.0 114.442 -176.234 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.605 ' H ' ' CB ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -126.95 160.79 29.98 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 111.964 -2.38 . . . . 0.0 105.853 177.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.862 ' HA ' ' CZ3' ' A' ' 2' ' ' TRP . 26.7 t-105 -104.22 55.56 0.72 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.702 1.239 . . . . 0.0 108.091 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.64 ' N ' ' HZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-N 111.634 -2.53 . . . . 0.0 112.948 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.278 0.561 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.486 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 65.2 m95 -118.58 161.63 19.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.533 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.672 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 0.2 OUTLIER 176.99 159.81 0.38 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.334 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.727 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -109.08 137.21 47.33 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.221 -173.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.588 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 24.4 t80 -116.09 124.9 51.56 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.716 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.803 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.9 t-20 -99.35 85.92 3.28 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -51.18 -22.93 2.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.156 -178.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.41 HG22 HD12 ' A' ' 8' ' ' ILE . 1.5 mm -67.73 -48.33 76.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.587 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.512 HG22 HD11 ' A' ' 20' ' ' LEU . 18.3 p -106.05 -20.85 13.29 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.15 56.8 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.573 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.632 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 3.1 mmmt -85.34 160.35 19.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.347 0.574 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.588 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.71 139.11 2.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -175.756 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.534 ' HG3' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.17 -179.63 7.22 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.296 1.046 . . . . 0.0 111.774 177.093 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -81.09 -17.1 51.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.775 176.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -93.35 -176.8 4.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 122.921 1.343 . . . . 0.0 112.761 -178.347 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -70.96 151.79 95.02 Favored Pre-proline 0 N--CA 1.425 -1.695 0 CA-C-N 111.799 -2.455 . . . . 0.0 107.051 176.166 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.805 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 40.6 Cg_exo -20.2 134.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 125.005 3.803 . . . . 0.0 116.58 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.632 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -58.17 -19.79 35.86 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.756 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.596 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 145.31 38.21 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 112.659 -2.064 . . . . 0.0 112.053 178.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 1.6 mt -151.5 54.09 0.84 Allowed 'General case' 0 C--N 1.366 1.311 0 CA-C-N 119.139 1.469 . . . . 0.0 113.975 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 2.8 m -19.89 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 119.654 3.205 . . . . 0.0 119.654 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -109.25 133.65 52.76 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.048 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.13 -19.82 22.24 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.805 ' CZ2' ' HA ' ' A' ' 17' ' ' PRO . 84.9 m95 -61.39 136.23 57.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -149.45 97.62 2.67 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.462 178.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 24.1 ttpt -58.53 135.18 57.24 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HD2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -125.49 144.93 50.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.627 0.727 . . . . 0.0 111.67 -178.506 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -72.78 124.85 26.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.216 179.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.073 -179.99 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.051 0.453 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -100.52 157.84 16.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.774 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -177.99 168.08 2.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.42 178.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.78 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.55 141.67 37.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.629 -173.745 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.666 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.8 t80 -124.42 128.78 49.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.747 -178.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.832 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.1 t-20 -102.42 99.28 9.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -66.12 -2.79 4.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 8' ' ' ILE . 1.6 mm -86.04 -51.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 p -98.62 -22.93 15.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.272 0.558 . . . . 0.0 111.579 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.89 57.41 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.495 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -90.43 168.85 11.54 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.196 0.498 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.666 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 16.6 ptt-85 -176.46 142.72 0.46 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.556 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -168.01 -174.81 2.47 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.961 0.886 . . . . 0.0 111.498 177.989 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -91.83 -10.62 39.13 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.973 177.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -175.93 6.05 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.566 1.174 . . . . 0.0 112.574 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.556 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 23.3 ttm180 -55.3 144.44 51.4 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 112.497 -2.138 . . . . 0.0 105.912 175.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 19' ' ' GLY . 75.1 Cg_exo -44.63 138.06 8.21 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 110.679 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.446 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -65.45 60.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.058 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 137.38 1.26 2.53 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.827 -178.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.545 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.92 61.1 3.14 Favored 'General case' 0 C--N 1.369 1.429 0 CA-C-N 119.901 1.85 . . . . 0.0 110.351 179.897 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' C ' ' HD1' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -130.56 -168.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.606 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.528 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 3.2 mtpp -95.67 173.28 7.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 111.496 -2.593 . . . . 0.0 107.106 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.47 -31.84 5.28 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.002 -1.57 . . . . 0.0 109.732 -176.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.832 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.7 m95 -62.21 136.15 57.81 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.458 1.503 . . . . 0.0 111.82 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.8 mp0 -150.79 118.65 6.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.6 ttmt -68.26 125.74 27.36 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.965 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.494 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -126.44 171.2 11.22 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.635 0.731 . . . . 0.0 110.672 -179.535 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.494 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 8.2 t-105 -83.25 151.89 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.476 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.788 179.398 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.541 0.21 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 18.1 p90 -132.75 -177.61 4.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.762 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 1.9 m-85 -132.69 131.38 41.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 120.838 0.351 . . . . 0.0 111.903 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.729 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 36.5 t80 -119.58 126.43 51.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.327 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.771 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.33 110.2 22.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -70.23 -22.61 62.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.692 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.22 -49.57 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -98.54 -21.01 16.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.342 0.592 . . . . 0.0 111.739 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.27 15.18 72.44 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.364 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -96.03 156.26 16.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.054 0.427 . . . . 0.0 110.835 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.729 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -166.14 146.69 6.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.046 0.538 . . . . 0.0 111.648 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -152.11 -175.46 5.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.999 0.904 . . . . 0.0 111.844 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.83 -10.64 47.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.623 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -91.51 -177.51 4.83 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.268 1.032 . . . . 0.0 110.757 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.499 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 12.8 ttm105 -50.04 153.39 2.35 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.154 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 2.6 Cg_endo -40.8 135.79 2.12 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.207 1.938 . . . . 0.0 110.269 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.452 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -67.35 56.2 0.05 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.116 0.96 . . . . 0.0 108.707 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 147.05 -3.59 0.93 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 113.848 -1.523 . . . . 0.0 114.358 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.707 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 50.31 51.39 16.86 Favored 'General case' 0 C--N 1.368 1.375 0 CA-C-N 120.214 2.007 . . . . 0.0 110.724 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -124.6 -169.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.117 1.437 . . . . 0.0 114.744 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.753 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -92.51 167.94 11.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.423 177.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.33 -34.97 4.19 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.706 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.771 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.8 m95 -57.92 138.51 55.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.899 1.279 . . . . 0.0 111.804 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -129.09 124.89 35.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 34.6 ttmt -85.09 114.16 22.03 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -127.13 172.16 10.78 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.908 0.861 . . . . 0.0 111.464 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.534 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 4.1 t-105 -85.21 147.75 26.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.311 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.961 179.518 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.876 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 121.493 0.663 . . . . 0.0 111.274 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 10.9 p90 -179.77 -173.5 0.25 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 -173.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.81 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.83 141.94 40.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 111.558 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.717 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.1 t80 -125.55 130.55 51.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.838 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.01 113.65 27.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -74.52 -22.17 59.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.728 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.56 -49.39 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.12 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 p -99.03 -20.96 16.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.265 0.555 . . . . 0.0 111.904 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.39 16.89 72.69 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 15.7 mmmt -93.45 164.93 13.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.717 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 7.8 ptp180 -172.92 140.54 0.94 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.519 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -162.64 -177.07 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.344 1.068 . . . . 0.0 112.391 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -87.03 -15.46 38.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.204 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.519 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -83.5 -174.7 5.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.358 1.075 . . . . 0.0 111.987 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HD2' HD12 ' A' ' 20' ' ' LEU . 19.4 ttp-105 -52.1 151.21 7.07 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 112.559 -2.11 . . . . 0.0 106.999 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . 40.3 Cg_exo -51.93 138.27 52.04 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 120.824 1.016 . . . . 0.0 109.582 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -64.67 62.07 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 135.36 1.83 3.07 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.815 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' A' ' 16' ' ' ARG . 0.7 OUTLIER 47.11 59.89 3.76 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 119.579 1.689 . . . . 0.0 110.146 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.781 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -126.63 -168.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -177.501 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.781 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -96.87 172.85 7.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.456 -2.611 . . . . 0.0 107.056 177.483 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.84 -33.16 4.76 Favored Glycine 0 N--CA 1.481 1.661 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.634 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.838 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -58.66 136.92 57.79 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.518 1.527 . . . . 0.0 111.899 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.4 mp0 -148.02 103.57 3.49 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.605 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.876 ' HG2' ' CZ3' ' A' ' 2' ' ' TRP . 19.6 ttpt -65.11 120.29 12.4 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -116.67 168.0 10.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.426 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.668 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 69.2 t-105 -105.94 42.99 1.17 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.19 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.6 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.5 m95 . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.731 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.3 p90 -174.73 165.95 3.71 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 120.612 0.244 . . . . 0.0 111.283 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.774 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.77 141.44 39.33 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.506 -173.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.706 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.3 t80 -123.69 129.58 51.32 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.591 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.831 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -102.88 110.51 22.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.15 -20.73 63.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.62 -49.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.12 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 p -98.61 -22.28 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.279 0.562 . . . . 0.0 111.788 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.3 13.71 73.16 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.698 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 12.0 mmmt -91.62 166.0 13.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.105 0.452 . . . . 0.0 110.075 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.706 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 4.0 ptp180 -172.57 141.79 1.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.499 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.48 -178.38 5.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.348 1.07 . . . . 0.0 112.095 177.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.82 -17.31 33.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.03 -1.896 . . . . 0.0 109.3 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -79.84 -174.89 4.62 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 122.396 1.093 . . . . 0.0 111.72 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.538 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 29.9 ttm180 -52.84 151.84 7.83 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.266 176.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.726 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.7 Cg_endo -49.02 136.46 29.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.67 1.58 . . . . 0.0 110.217 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -69.4 55.91 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 122.04 0.924 . . . . 0.0 108.566 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 146.46 -4.26 1.08 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.351 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.726 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.46 59.69 4.4 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 119.792 1.796 . . . . 0.0 109.917 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -134.02 -168.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -177.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.759 ' H ' HG12 ' A' ' 21' ' ' VAL . 64.0 mttt -96.89 174.66 6.67 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.429 -2.623 . . . . 0.0 106.884 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.38 -33.22 4.63 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 118.858 -1.639 . . . . 0.0 109.825 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.831 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.5 m95 -60.15 136.74 58.12 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.356 1.462 . . . . 0.0 111.88 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.53 117.29 6.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.683 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.9 ttmt -69.71 124.32 23.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.189 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -124.51 174.4 7.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.581 0.705 . . . . 0.0 110.773 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.44 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 12.7 t-105 -87.86 144.85 26.36 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.066 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.731 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.6 p30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.419 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.1 m95 . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.711 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 2.1 p90 -177.02 170.6 2.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.445 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -108.09 142.59 38.04 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.1 t80 -127.05 127.62 45.01 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.287 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.829 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.4 t-20 -101.67 115.59 30.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -75.79 -22.03 56.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.65 -49.36 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.0 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -99.61 -21.47 15.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.168 0.509 . . . . 0.0 111.92 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.9 70.95 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.2 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 9.6 mmmt -88.56 166.99 13.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 117.208 0.504 . . . . 0.0 109.703 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -168.16 142.14 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -173.71 -176.48 1.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.13 0.967 . . . . 0.0 111.9 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.01 -10.1 31.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.109 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -80.79 -176.6 5.92 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.495 1.14 . . . . 0.0 111.908 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 26.0 ttp-105 -55.93 146.15 49.99 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.928 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.704 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 1.9 Cg_endo -43.26 133.32 6.55 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 122.225 1.95 . . . . 0.0 111.017 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.522 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -66.23 59.51 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.269 1.033 . . . . 0.0 108.284 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 139.22 -2.62 2.62 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 113.528 -1.669 . . . . 0.0 114.2 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.704 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 49.99 58.95 4.9 Favored 'General case' 0 C--N 1.366 1.321 0 CA-C-N 119.939 1.87 . . . . 0.0 109.958 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -129.61 -168.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.775 ' H ' HG12 ' A' ' 21' ' ' VAL . 4.1 mmmt -97.22 175.0 6.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 111.432 -2.622 . . . . 0.0 106.895 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 -33.54 4.4 Favored Glycine 0 N--CA 1.482 1.727 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.84 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.829 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.9 m95 -59.39 136.22 57.9 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.445 1.498 . . . . 0.0 111.867 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.7 114.25 5.27 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.711 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.6 ttmt -67.95 123.45 20.64 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.499 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -123.69 174.19 7.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.672 0.749 . . . . 0.0 111.017 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.433 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 8.9 t-105 -87.08 151.35 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.079 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.909 179.522 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 87.8 m95 . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.508 0.194 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.749 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.8 p90 -169.59 160.97 9.3 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 120.767 0.318 . . . . 0.0 111.175 178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.49 139.03 42.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.856 -173.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.691 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 33.0 t80 -121.76 129.46 52.7 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.295 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.841 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -103.51 100.45 10.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.29 -2.47 4.44 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.2 -52.05 12.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 p -98.07 -23.36 15.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.288 0.566 . . . . 0.0 111.544 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 15.73 59.71 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.651 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 11.6 mmmt -92.31 160.32 15.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.385 0.592 . . . . 0.0 109.918 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.691 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -165.32 143.78 6.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.51 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -163.53 172.39 14.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.986 0.898 . . . . 0.0 112.235 177.76 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -81.43 -25.77 35.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.93 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -173.39 0.95 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.521 1.153 . . . . 0.0 111.764 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.728 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 12.9 ttp85 -52.95 155.64 4.08 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 112.387 -2.188 . . . . 0.0 107.999 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 11.2 Cg_endo -52.05 138.03 53.32 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.814 1.676 . . . . 0.0 110.479 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -71.53 54.69 0.23 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.063 0.935 . . . . 0.0 108.57 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.45 -3.73 0.89 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.453 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.77 60.82 3.57 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.609 1.705 . . . . 0.0 109.993 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -135.2 -168.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.449 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.761 ' H ' HG12 ' A' ' 21' ' ' VAL . 10.0 mttm -97.18 175.13 6.4 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.369 -2.651 . . . . 0.0 106.977 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 -33.85 4.29 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 118.923 -1.608 . . . . 0.0 109.836 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.841 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.0 m95 -58.8 138.97 56.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.289 1.436 . . . . 0.0 111.914 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.2 mt-10 -148.34 120.71 8.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.538 0.209 . . . . 0.0 110.682 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.5 ttmt -76.24 126.72 31.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.807 0.337 . . . . 0.0 110.601 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -129.07 175.07 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.697 0.761 . . . . 0.0 110.706 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.511 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 9.9 t-105 -89.12 143.96 26.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.695 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.749 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.9 p30 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.258 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.913 ' HB2' ' HG2' ' A' ' 26' ' ' LYS 0.261 1.1 p-90 . . . . . 0 CA--C 1.563 1.475 0 CA-C-O 121.219 0.533 . . . . 0.0 111.656 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.878 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER 174.98 -155.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.925 -1.735 . . . . 0.0 112.956 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.571 ' CD1' ' C ' ' A' ' 3' ' ' PHE . 2.3 m-85 -150.69 96.44 2.36 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.74 0.781 . . . . 0.0 110.539 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.702 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 45.1 t80 -98.4 122.23 41.32 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.344 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.805 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.7 t-20 -99.11 106.91 19.17 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -63.7 -18.47 64.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.225 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mm -76.06 -50.1 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.06 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.6 p -97.76 -23.86 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.383 0.611 . . . . 0.0 111.661 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.1 9.92 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.356 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 12.5 mmmt -93.6 160.57 14.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.485 0.642 . . . . 0.0 111.423 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.702 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.59 144.36 7.44 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 123.363 0.665 . . . . 0.0 111.981 -178.067 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -151.65 173.21 14.94 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.866 0.841 . . . . 0.0 110.648 177.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.664 ' HE1' ' CD1' ' A' ' 28' ' ' TRP . 41.3 m-85 -77.49 -28.79 52.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.72 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -74.14 -177.14 2.83 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.453 1.12 . . . . 0.0 110.691 178.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.617 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 20.5 ttm180 -47.75 157.91 0.56 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 112.457 -2.156 . . . . 0.0 108.907 176.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.688 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 7.6 Cg_endo -47.56 136.67 20.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.335 2.024 . . . . 0.0 110.321 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' CB ' ' HH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -71.84 50.99 0.2 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 159.74 -9.56 0.16 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 114.218 -1.356 . . . . 0.0 114.441 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.688 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 54.29 58.23 5.15 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 119.773 1.786 . . . . 0.0 110.79 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -140.52 -167.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 123.084 1.421 . . . . 0.0 114.812 -178.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.73 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -92.17 173.35 7.87 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.348 177.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 -36.44 3.54 Favored Glycine 0 N--CA 1.482 1.71 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.661 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.805 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 99.0 m95 -58.45 143.12 46.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.2 1.4 . . . . 0.0 112.091 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -136.97 139.12 41.25 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.913 ' HG2' ' HB2' ' A' ' 2' ' ' TRP . 29.9 tttt -92.0 121.58 33.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.297 0.57 . . . . 0.0 111.996 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 21.0 ttp180 179.41 83.95 0.01 OUTLIER 'General case' 0 C--N 1.353 0.741 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.177 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.822 ' HB2' ' O ' ' A' ' 2' ' ' TRP . 1.8 t90 -39.57 -19.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 112.394 -2.185 . . . . 0.0 112.507 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 27' ' ' ARG . 6.4 t70 . . . . . 0 C--N 1.308 -1.239 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.324 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.413 ' CD2' ' HE3' ' A' ' 26' ' ' LYS . 81.1 m95 . . . . . 0 CA--C 1.528 0.13 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.67 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -179.18 166.8 1.54 Allowed 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.707 0.289 . . . . 0.0 111.543 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.64 141.45 39.11 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.467 -173.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.697 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.1 t80 -123.55 130.42 52.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.906 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.838 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.05 111.94 24.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -71.8 -21.08 61.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.64 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.42 -49.84 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 p -98.65 -21.98 16.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 111.821 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.09 72.01 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.535 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HE3' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -93.47 165.98 12.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.958 0.503 . . . . 0.0 109.874 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.697 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 3.8 ptp180 -172.55 142.81 1.28 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.501 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.68 -177.81 5.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.295 1.045 . . . . 0.0 111.979 177.045 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -87.08 -16.54 35.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.37 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -81.53 -174.36 4.92 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 122.425 1.107 . . . . 0.0 111.773 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.454 ' HD3' HD12 ' A' ' 20' ' ' LEU . 26.5 ttm180 -51.3 150.55 6.05 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.919 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 19' ' ' GLY . 45.6 Cg_exo -51.67 138.69 49.39 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 109.44 -1.023 . . . . 0.0 109.44 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.57 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.71 61.74 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.26 1.028 . . . . 0.0 108.322 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 136.61 1.14 2.79 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.805 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.474 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.9 59.17 4.38 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 119.579 1.689 . . . . 0.0 110.216 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -127.87 -168.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.779 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -96.03 172.48 7.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.135 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.0 -32.89 4.91 Favored Glycine 0 N--CA 1.481 1.673 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.782 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.838 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.7 m95 -60.12 137.04 58.19 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.431 1.492 . . . . 0.0 111.967 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.82 116.64 5.9 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 29.0 tttt -68.84 123.83 22.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -122.96 174.16 7.35 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.53 0.681 . . . . 0.0 110.733 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.442 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 9.1 t-105 -86.56 150.46 24.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.107 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.833 179.625 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 26' ' ' LYS . 81.8 m95 . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.611 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 29.4 p90 174.59 167.36 0.25 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.765 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.5 139.96 40.15 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.472 -175.037 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.708 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.0 t80 -118.43 129.62 55.5 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.84 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.6 t-20 -102.67 99.29 9.26 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -66.08 -2.15 3.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.19 -52.44 11.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -97.57 -23.6 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.342 0.591 . . . . 0.0 111.496 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.59 15.79 57.8 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.737 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -94.32 159.61 15.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.267 0.533 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.708 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.75 144.25 7.15 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.527 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -160.24 172.68 16.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.05 0.929 . . . . 0.0 112.969 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.3 t80 -80.85 -24.75 38.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.11 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -172.87 2.17 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.421 1.105 . . . . 0.0 111.833 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.666 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 18.5 ttp180 -51.93 157.07 2.22 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 112.42 -2.173 . . . . 0.0 107.948 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.676 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 10.8 Cg_endo -51.9 138.24 51.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.593 1.528 . . . . 0.0 110.267 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -71.36 54.56 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 148.37 -4.08 0.79 Allowed Glycine 0 CA--C 1.537 1.449 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.442 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.676 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.08 59.62 4.4 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 119.661 1.73 . . . . 0.0 109.961 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.76 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -134.94 -168.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.76 ' H ' HG12 ' A' ' 21' ' ' VAL . 35.7 mttp -96.89 174.26 6.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.434 -2.621 . . . . 0.0 107.068 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.03 -31.76 5.2 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.881 -1.628 . . . . 0.0 109.931 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.84 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.9 m95 -61.13 137.05 58.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.313 1.445 . . . . 0.0 111.832 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.6 mp0 -151.55 110.34 3.85 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-O 120.581 0.229 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 1.8 tppt? -58.58 129.12 40.55 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.02 170.83 8.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.0 110.754 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.408 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 7.4 t-105 -107.69 101.97 11.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.592 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.487 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 1.094 ' HB2' ' HB3' ' A' ' 27' ' ' ARG 0.379 0.1 OUTLIER . . . . . 0 CA--C 1.598 2.789 0 CA-C-O 117.461 -1.256 . . . . 0.0 111.324 . . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.913 ' N ' ' CB ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -152.25 -171.15 3.85 Favored 'General case' 1 N--CA 1.547 4.424 0 C-N-CA 126.704 2.001 . . . . 0.0 111.839 -174.144 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 6.2 m-85 -64.65 121.38 14.36 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.041 -1.662 . . . . 0.0 111.617 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 28.8 t80 -113.74 121.3 43.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.54 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.653 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.2 t-20 -101.01 85.3 2.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 23.3 ptt180 -46.95 -32.96 4.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.471 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 1.6 mm -65.73 -44.47 93.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.902 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 1.058 HG21 HD22 ' A' ' 20' ' ' LEU . 32.2 p -101.77 -14.12 17.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 111.969 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' ASN . . . 75.88 13.66 82.9 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.686 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' HD13 ' A' ' 20' ' ' LEU . 21.7 mmmt -81.72 165.17 21.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.893 0.347 . . . . 0.0 110.255 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.799 ' HD3' ' CE1' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -161.91 136.24 6.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.334 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.04 154.07 44.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.597 ' HD1' ' HB3' ' A' ' 29' ' ' ASP . 45.3 m-85 -80.23 -34.08 37.51 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.025 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 16' ' ' ARG . 3.3 tp10 -89.33 177.01 6.7 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.742 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 11.0 ttm105 -56.56 138.96 75.98 Favored Pre-proline 0 C--N 1.283 -2.292 0 CA-C-N 113.713 -1.585 . . . . 0.0 106.984 176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.548 ' HG3' ' NE1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -12.17 145.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 1 C-N-CA 126.17 4.58 . . . . 0.0 117.969 -177.011 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -77.5 22.23 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.972 177.061 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.59 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 89.41 37.96 6.85 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.269 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.058 HD22 HG21 ' A' ' 9' ' ' THR . 9.9 mt -154.63 91.8 1.42 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 119.211 -0.995 . . . . 0.0 113.151 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.989 HG13 ' HD1' ' A' ' 24' ' ' TRP . 2.2 t -95.04 -168.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 CA-C-O 121.889 0.852 . . . . 0.0 110.863 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.92 ' H ' HG12 ' A' ' 21' ' ' VAL . 5.2 mttp 55.46 86.54 0.06 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.71 -15.36 4.1 Favored Glycine 0 C--N 1.296 -1.682 0 CA-C-N 111.447 -2.615 . . . . 0.0 112.247 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.989 ' HD1' HG13 ' A' ' 21' ' ' VAL . 39.8 m95 -62.33 141.01 58.51 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.545 1.172 . . . . 0.0 111.886 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.0 mp0 -138.31 102.02 4.53 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 27.2 ttpt -48.68 130.16 17.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 1.094 ' HB3' ' HB2' ' A' ' 2' ' ' TRP 0.301 14.9 mtp180 -120.66 176.66 5.41 Favored 'General case' 1 N--CA 1.362 -4.874 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 166.933 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.594 ' N ' ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -41.56 -35.33 0.71 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -172.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 2' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.111 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.92 ' CH2' ' HG3' ' A' ' 26' ' ' LYS 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 121.399 0.619 . . . . 0.0 110.65 . . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.3 p90 -178.37 172.07 1.54 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.21 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.784 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -100.3 143.99 29.84 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 124.098 0.874 . . . . 0.0 112.745 -175.255 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.735 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 39.7 t80 -127.56 129.77 47.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.372 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.831 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -103.16 102.29 12.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -67.34 -1.99 5.46 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.54 -52.49 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 p -97.68 -23.21 16.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.292 0.568 . . . . 0.0 111.526 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.37 59.83 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.727 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 2.3 mmmm -91.94 164.3 13.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 117.238 0.519 . . . . 0.0 109.632 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.735 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 21.9 ptt-85 -173.0 140.73 0.92 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.505 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -161.4 -177.47 6.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 122.339 1.066 . . . . 0.0 112.191 177.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -86.16 -16.49 37.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.281 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.505 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.27 5.16 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.396 1.093 . . . . 0.0 112.097 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 21.1 ttm105 -51.22 151.76 4.72 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.103 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 19' ' ' GLY . 31.2 Cg_exo -52.82 138.4 60.34 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 CA-C-N 119.842 0.979 . . . . 0.0 109.558 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -65.55 61.45 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 108.2 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 138.71 0.05 2.35 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.923 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 48.49 60.97 3.29 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.61 1.705 . . . . 0.0 110.257 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.769 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -131.09 -168.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.769 ' H ' HG12 ' A' ' 21' ' ' VAL . 14.5 mttp -96.0 175.01 6.64 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.536 -2.575 . . . . 0.0 107.048 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.56 -34.23 4.1 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.71 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.831 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.5 m95 -58.15 133.92 56.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.308 1.443 . . . . 0.0 111.766 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.3 mp0 -156.22 105.7 2.33 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.92 ' HG3' ' CH2' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -72.0 154.42 41.17 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.755 0.788 . . . . 0.0 112.506 -178.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -124.16 151.75 43.63 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.525 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.494 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 55.3 t-105 -100.61 106.08 17.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.429 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 C--O 1.251 1.18 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.758 -179.251 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.512 ' HB3' ' CE ' ' A' ' 26' ' ' LYS . 70.5 m95 . . . . . 0 C--O 1.228 -0.056 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 178.91 174.53 0.68 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.497 0.665 . . . . 0.0 111.817 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.962 ' HB2' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -104.5 163.99 12.06 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.298 -173.251 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 45.1 t80 -149.33 133.3 17.1 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.451 -1.405 . . . . 0.0 112.175 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.87 ' HB2' ' CE2' ' A' ' 24' ' ' TRP . 22.9 t-20 -105.25 128.27 53.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -82.38 -26.3 32.99 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -83.57 -45.52 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -104.4 -16.77 15.01 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 53.1 37.52 54.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.195 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.529 ' C ' ' HH2' ' A' ' 24' ' ' TRP . 22.7 mmmt -102.68 42.5 1.14 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.76 148.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.884 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.769 ' H ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -155.07 -157.51 0.76 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 123.31 1.529 . . . . 0.0 109.726 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -131.32 0.43 4.1 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.596 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.736 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -87.22 179.14 6.69 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.854 1.312 . . . . 0.0 113.894 -177.423 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.879 ' HG3' HD12 ' A' ' 20' ' ' LEU . 46.6 ttp180 -49.71 -34.75 10.15 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-N 111.953 -2.385 . . . . 0.0 116.947 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.77 ' CD ' ' N ' ' A' ' 16' ' ' ARG . 9.8 Cg_endo -80.59 170.82 15.34 Favored 'Trans proline' 0 CA--C 1.455 -3.453 1 C-N-CA 127.075 5.183 . . . . 0.0 107.636 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 1.127 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 3.3 pttt 65.19 11.26 7.07 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-O 123.079 1.419 . . . . 0.0 108.902 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.435 ' N ' ' C ' ' A' ' 17' ' ' PRO . . . -143.18 -48.76 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.879 HD12 ' HG3' ' A' ' 16' ' ' ARG . 5.2 mt -97.23 36.75 1.41 Allowed 'General case' 0 C--N 1.359 0.98 0 CA-C-O 122.038 0.923 . . . . 0.0 109.309 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.842 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 70.0 t -139.86 165.43 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.002 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.564 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -91.42 152.82 20.23 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.486 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.3 -27.15 7.9 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 1.127 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 95.1 m95 -69.61 144.31 53.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.484 1.514 . . . . 0.0 115.013 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 5' ' ' PHE . 4.8 mp0 -150.72 115.14 5.14 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 69.5 tttt -66.09 127.53 32.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -121.44 170.77 9.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.431 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 11.7 t-105 -89.74 141.5 28.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.97 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.788 179.436 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.403 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 86.7 m95 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 121.04 0.448 . . . . 0.0 112.163 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -163.04 160.45 24.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.809 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.736 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -104.36 131.9 51.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.054 -173.325 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.664 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.6 t80 -114.97 123.27 48.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.251 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.705 ' CG ' HD13 ' A' ' 20' ' ' LEU . 25.4 t-20 -102.16 92.82 4.92 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -53.83 -21.25 7.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.18 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -67.86 -49.42 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.65 HG21 HD21 ' A' ' 20' ' ' LEU . 20.2 p -105.27 -21.39 13.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 112.29 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.38 16.78 56.68 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.221 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 8.3 mmmm -86.82 155.91 20.1 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.383 0.591 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.664 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -161.78 135.68 6.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.578 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.18 179.92 8.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 122.152 0.977 . . . . 0.0 111.851 177.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CE2' ' O ' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -87.26 -16.27 35.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.201 175.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.578 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -94.65 -174.1 3.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.596 1.188 . . . . 0.0 111.822 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 45.9 ttp180 -66.54 155.0 89.94 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.251 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.674 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 25.0 Cg_exo -24.84 145.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 125.086 3.857 . . . . 0.0 115.402 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -87.88 30.68 0.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.384 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.55 ' C ' ' HG ' ' A' ' 20' ' ' LEU . . . 114.17 36.7 1.32 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-N 113.842 -1.526 . . . . 0.0 111.5 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.768 ' C ' HG22 ' A' ' 21' ' ' VAL . 2.8 mt -144.06 -161.72 1.33 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 117.964 0.882 . . . . 0.0 110.154 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.768 HG22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -170.35 -43.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 122.023 0.916 . . . . 0.0 113.137 -178.432 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.571 ' HD3' ' HB ' ' A' ' 21' ' ' VAL . 3.2 mmtm -106.56 139.95 40.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.339 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.21 -24.37 20.97 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.686 ' CE3' ' HB2' ' A' ' 6' ' ' ASN . 80.8 m95 -60.26 140.77 56.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.33 1.052 . . . . 0.0 112.936 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.01 105.14 3.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.751 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 12.2 ttpt -69.15 126.12 28.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.204 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.686 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.89 174.15 9.04 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 110.656 -178.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.525 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 6.6 t-105 -85.42 151.79 23.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.67 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.773 179.437 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.73 ' CE3' ' HG2' ' A' ' 26' ' ' LYS 0.284 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.723 0 CA-C-O 122.48 1.134 . . . . 0.0 110.135 . . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.725 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 30.6 p90 -137.2 -179.21 5.58 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.359 -2.201 . . . . 0.0 113.829 -173.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.717 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -102.19 138.19 39.47 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 32.5 t80 -116.88 117.29 29.32 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.589 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.779 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 20.5 t-20 -102.55 89.04 3.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 22.5 ptt180 -45.93 -29.68 1.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.719 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.432 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 1.5 mm -65.84 -45.56 91.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.488 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.633 HG21 ' HA2' ' A' ' 19' ' ' GLY . 30.5 p -101.48 -17.09 16.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 112.044 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.44 13.79 79.8 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.239 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 18' ' ' LYS . 6.1 mmmm -89.3 156.3 18.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 117.192 0.496 . . . . 0.0 109.854 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.641 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -154.51 131.65 11.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.515 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -167.81 173.03 8.64 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.061 0.934 . . . . 0.0 113.154 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.55 -23.47 37.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.099 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -72.34 -176.43 1.85 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.846 1.307 . . . . 0.0 111.985 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 34.0 ttt-85 -62.51 151.44 83.23 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.048 -2.342 . . . . 0.0 109.529 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.556 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 2.0 Cg_endo -40.21 119.06 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 124.276 3.317 . . . . 0.0 117.264 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 15.4 mmtt -98.52 36.73 1.58 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 172.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -164.66 -30.58 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.377 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.65 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.2 mt 81.28 90.86 0.04 OUTLIER 'General case' 0 C--N 1.366 1.293 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.649 ' HA ' ' HD1' ' A' ' 24' ' ' TRP . 14.7 t 44.51 -49.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 119.615 3.191 . . . . 0.0 119.615 173.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.476 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -87.68 123.83 32.92 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.623 -178.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.84 -16.91 25.52 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.266 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.779 ' CZ3' ' HB2' ' A' ' 6' ' ' ASN . 81.2 m95 -69.82 143.7 52.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.01 88.55 1.32 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.833 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.73 ' HG2' ' CE3' ' A' ' 2' ' ' TRP . 52.3 tttt -63.63 127.31 30.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.363 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 2' ' ' TRP . 4.2 ttp180 -115.49 161.52 18.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.072 0.939 . . . . 0.0 111.447 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.681 ' CE3' ' HB2' ' A' ' 2' ' ' TRP . 61.2 t-105 -101.73 116.74 33.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.711 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.278 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.1 m95 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.831 0.348 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.679 ' CE2' ' HD2' ' A' ' 12' ' ' ARG . 1.8 p90 -160.93 -167.17 1.76 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.008 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.877 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 3.1 m-85 -128.09 142.57 51.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.648 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 38.0 t80 -123.69 124.25 42.33 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.795 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 18.3 t-20 -98.43 119.57 37.34 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -76.5 -25.83 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -76.49 -49.81 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.207 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.0 p -100.21 -21.02 15.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.015 0.436 . . . . 0.0 112.053 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.629 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 66.1 30.38 76.8 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.757 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.18 46.42 0.99 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.679 ' HD2' ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -32.3 137.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 17' ' ' PRO . 6.0 mt-30 -135.52 168.31 19.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.459 0.647 . . . . 0.0 110.726 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.43 -7.89 57.15 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.784 174.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.814 ' C ' ' HD3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.89 -164.45 0.8 Allowed 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.661 0.785 . . . . 0.0 110.035 178.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.5 ttm105 -101.38 65.08 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.183 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.814 ' HD3' ' C ' ' A' ' 15' ' ' GLU . 17.7 Cg_endo -88.14 -46.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 125.033 3.822 . . . . 0.0 111.03 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.954 ' HA ' ' CB ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -67.76 -18.12 64.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.018 178.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.0 -34.78 7.45 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 173.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 3.2 mt -67.99 -44.13 77.34 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -138.28 -177.27 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.579 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -90.11 167.37 12.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 111.443 -2.617 . . . . 0.0 109.392 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.11 -31.13 5.82 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.954 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 98.9 m95 -66.21 151.23 47.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.167 1.387 . . . . 0.0 112.599 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 5' ' ' PHE . 2.8 mp0 -153.67 109.94 3.32 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 32.0 ttmt -59.42 132.89 55.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -137.72 163.67 30.75 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.693 0.758 . . . . 0.0 111.17 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -77.5 151.6 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.539 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.663 178.754 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.53 ' HE3' ' HD2' ' A' ' 26' ' ' LYS . 77.3 m95 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.75 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER 178.33 173.32 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 178.505 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.973 ' CD2' ' HG3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -108.76 164.84 12.02 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.167 -174.167 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 52.3 t80 -149.53 135.4 18.74 Favored 'General case' 0 C--O 1.22 -0.487 0 O-C-N 121.993 -0.442 . . . . 0.0 111.921 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.814 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 23.1 t-20 -105.44 123.49 47.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -78.86 -23.0 45.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -81.6 -46.87 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.632 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -102.46 -19.59 14.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 61.2 31.79 78.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.125 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 9' ' ' THR . 3.9 mmmm -114.23 61.77 0.67 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.474 ' HA ' ' HZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -37.54 136.89 0.47 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.71 0.804 . . . . 0.0 109.452 177.062 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.891 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -139.49 92.83 2.61 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.962 0.905 . . . . 0.0 113.078 -175.096 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.608 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 10.5 t80 -39.26 -25.58 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.797 -0.565 . . . . 0.0 111.086 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.633 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -57.38 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.105 0.955 . . . . 0.0 109.467 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.805 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 24.2 ttm105 -46.54 -60.63 3.48 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.032 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 16' ' ' ARG . 29.5 Cg_endo -65.81 157.2 60.24 Favored 'Trans proline' 0 CA--C 1.479 -2.266 1 C-N-CA 127.559 5.506 . . . . 0.0 109.301 178.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 1.05 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER 99.7 -12.19 0.04 OUTLIER 'General case' 0 N--CA 1.395 -3.206 0 CA-C-N 111.79 -2.459 . . . . 0.0 105.618 -171.266 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.67 -38.14 0.22 Allowed Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.226 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.758 HD12 ' HG3' ' A' ' 16' ' ' ARG . 4.0 mt -96.97 41.4 1.11 Allowed 'General case' 0 C--N 1.36 1.031 0 CA-C-N 118.212 1.006 . . . . 0.0 111.43 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.941 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 44.3 t -145.84 172.15 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.574 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -81.41 151.88 27.69 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.591 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.83 -29.71 4.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 1.05 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 97.2 m95 -67.64 146.91 53.38 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.624 1.57 . . . . 0.0 114.729 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.6 mp0 -151.29 106.62 3.33 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.1 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -60.61 129.31 40.91 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.29 173.59 7.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.425 0.631 . . . . 0.0 110.592 -179.52 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.442 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 6.5 t-105 -115.41 124.88 52.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.333 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.898 179.285 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.421 ' O ' ' HD1' ' A' ' 14' ' ' PHE . 77.3 m95 . . . . . 0 CA--C 1.529 0.166 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 34.4 p90 176.52 165.76 0.46 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.64 140.65 39.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.987 -174.444 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.683 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.5 t80 -120.45 129.69 53.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.849 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.19 112.44 25.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -72.62 -20.69 61.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.543 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.79 -50.0 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.063 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 p -98.61 -22.68 15.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.271 0.557 . . . . 0.0 111.866 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.69 15.12 71.48 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.946 -1.024 . . . . 0.0 113.711 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 9.0 mmmm -95.05 158.1 15.61 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 117.326 0.563 . . . . 0.0 109.832 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.683 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.09 144.61 9.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -165.14 -179.85 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.473 1.13 . . . . 0.0 112.547 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.2 t80 -85.33 -16.95 38.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.283 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.506 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.62 5.37 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.382 1.087 . . . . 0.0 112.16 -179.218 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.589 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 23.4 ttp-105 -51.94 153.75 4.3 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 112.402 -2.181 . . . . 0.0 107.059 175.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.727 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.6 Cg_endo -49.86 136.7 35.74 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.531 1.487 . . . . 0.0 110.491 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.35 55.27 0.15 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.013 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 148.71 -5.03 0.8 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-N 113.933 -1.485 . . . . 0.0 114.431 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.727 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.24 59.94 4.17 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-N 119.798 1.799 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.762 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -135.52 -168.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.505 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.762 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.3 mttm -97.59 174.61 6.56 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 111.388 -2.642 . . . . 0.0 106.852 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.53 -33.15 4.69 Favored Glycine 0 N--CA 1.481 1.678 0 C-N-CA 118.811 -1.662 . . . . 0.0 109.782 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.849 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -59.23 137.46 57.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.42 1.488 . . . . 0.0 111.998 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -150.35 112.27 4.56 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.502 0.191 . . . . 0.0 110.673 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 68.5 tttt -66.05 128.97 38.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.31 165.64 14.59 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.792 0.806 . . . . 0.0 111.55 -179.388 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -98.05 103.63 15.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.765 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.409 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.4 m95 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.964 0.412 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -162.49 -171.54 2.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.548 178.258 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 1.8 m-85 -133.54 137.34 45.51 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 122.629 0.372 . . . . 0.0 111.489 -175.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.657 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 32.6 t80 -122.97 125.6 45.59 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.771 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.789 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.3 t-20 -101.3 112.09 24.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.65 -23.35 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.829 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -71.32 -49.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.959 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.2 p -98.58 -20.76 16.84 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.82 17.45 72.67 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.146 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -92.27 159.74 15.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.191 0.496 . . . . 0.0 110.105 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.657 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.34 144.56 4.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.395 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -161.08 -174.68 4.48 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.975 0.893 . . . . 0.0 112.027 178.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.71 -8.93 48.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.153 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -91.75 179.04 5.74 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.591 1.186 . . . . 0.0 111.584 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.573 ' HD3' ' CD1' ' A' ' 20' ' ' LEU . 24.4 ttm180 -52.09 145.02 19.31 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.371 175.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.627 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 6.8 Cg_exo -35.49 135.21 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.855 2.37 . . . . 0.0 111.776 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -65.78 58.55 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 141.54 -2.1 1.93 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.219 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.627 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 49.34 52.4 14.52 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 120.187 1.994 . . . . 0.0 110.448 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -122.52 -169.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 123.115 1.436 . . . . 0.0 114.789 -178.465 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.779 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -92.8 173.69 7.63 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 111.77 -2.468 . . . . 0.0 107.166 177.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.47 -36.34 3.45 Favored Glycine 0 N--CA 1.482 1.715 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.728 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.789 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -56.49 140.61 45.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.97 1.308 . . . . 0.0 111.682 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -142.75 108.77 5.19 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.55 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.4 ttpt -62.62 131.12 47.96 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.55 166.22 24.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.045 0.926 . . . . 0.0 111.615 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -84.64 148.07 26.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.453 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.828 179.478 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 81.0 m95 . . . . . 0 N--CA 1.457 -0.098 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.671 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.7 p90 -175.93 167.48 3.04 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.77 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.39 140.02 40.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.611 -173.805 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 29.6 t80 -120.8 128.81 53.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.404 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.805 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.28 106.3 17.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.82 -22.4 62.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.084 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -69.64 -49.0 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.761 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -101.0 -19.51 15.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.231 0.538 . . . . 0.0 112.013 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 19.2 62.57 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.7 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.14 178.07 5.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 117.009 0.405 . . . . 0.0 110.078 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.576 ' HD3' ' CE2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -163.1 139.68 7.3 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.479 ' OE1' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -147.29 155.06 41.71 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -86.85 -29.9 21.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.277 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.21 -170.37 2.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.791 0.805 . . . . 0.0 111.689 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.479 ' O ' ' OE1' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -38.88 124.12 1.21 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 113.332 -1.758 . . . . 0.0 107.763 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.569 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 87.6 Cg_exo -39.02 151.04 0.06 OUTLIER 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 122.847 2.365 . . . . 0.0 113.007 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 59.18 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 133.62 3.41 3.35 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.569 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 46.93 57.25 5.82 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-N 119.688 1.744 . . . . 0.0 109.867 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.803 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -120.49 -168.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.326 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.803 ' H ' HG12 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -96.45 172.45 7.93 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 111.5 -2.591 . . . . 0.0 106.99 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.81 -31.29 5.65 Favored Glycine 0 N--CA 1.48 1.608 0 C-N-CA 118.97 -1.586 . . . . 0.0 109.768 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.805 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.6 m95 -62.85 132.83 53.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.084 1.354 . . . . 0.0 111.268 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -147.44 119.4 8.18 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.9 ttpt -70.4 127.21 31.96 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.338 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.5 171.5 11.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.585 0.707 . . . . 0.0 110.729 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.455 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 10.1 t-105 -85.62 144.77 27.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.613 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.707 179.069 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.4 m95 . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -171.72 166.63 6.57 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.744 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -114.97 142.09 47.1 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.218 -174.065 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 32.1 t80 -128.38 129.35 46.09 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.413 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.9 t-20 -101.97 113.35 26.49 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -74.92 -22.79 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -71.7 -49.49 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.028 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.32 -20.99 16.25 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.885 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 19.06 67.72 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.088 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -94.35 161.38 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 117.208 0.504 . . . . 0.0 109.8 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.56 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.17 145.91 10.35 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.501 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -166.56 172.42 10.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.921 0.867 . . . . 0.0 112.076 177.361 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -84.05 -24.47 30.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.168 176.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -173.66 1.07 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 122.469 1.128 . . . . 0.0 111.335 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.677 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 40.2 ttp180 -52.81 155.24 4.23 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.723 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.677 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 9.2 Cg_endo -50.67 137.36 41.77 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.702 1.602 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.84 56.16 0.13 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.075 0.94 . . . . 0.0 108.599 179.166 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 144.68 -3.14 1.31 Allowed Glycine 0 CA--C 1.536 1.349 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.356 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.674 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.05 58.36 5.63 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 119.751 1.775 . . . . 0.0 109.789 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -130.97 -168.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.526 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.776 ' H ' HG12 ' A' ' 21' ' ' VAL . 8.0 mmmm -96.87 175.41 6.36 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.941 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.28 -33.34 4.34 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 118.85 -1.643 . . . . 0.0 109.805 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.8 m95 -59.34 135.42 57.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.273 1.429 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -148.61 117.05 6.53 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.014 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 20.6 ttpt -82.41 130.03 35.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 28' ' ' TRP . 16.4 ttp180 -129.37 -58.21 1.12 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.639 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 13.8 t-105 167.46 132.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.15 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 16.7 t70 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.68 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.899 ' CZ3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.564 1.495 0 N-CA-C 121.131 3.752 . . . . 0.0 121.131 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.87 ' HA ' ' HA ' ' A' ' 14' ' ' PHE 0.385 0.6 OUTLIER 156.92 -21.76 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.323 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER 2.98 114.36 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.606 2.362 . . . . 0.0 115.394 -175.678 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.3 t80 -91.74 123.1 34.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.596 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.764 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 16.6 t-20 -98.16 92.38 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -53.63 -23.88 12.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.518 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.86 -48.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.236 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 p -99.52 -18.52 17.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.385 0.612 . . . . 0.0 111.922 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.56 69.77 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 114.856 -1.065 . . . . 0.0 113.038 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 10.2 mmmm -91.15 179.28 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -169.37 152.89 5.03 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.865 -178.413 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -153.59 126.68 8.43 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.87 ' HA ' ' HA ' ' A' ' 3' ' ' PHE . 2.1 t80 -63.64 -25.12 68.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -176.11 5.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 122.067 0.937 . . . . 0.0 110.169 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.619 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 15.4 ttm180 -50.46 132.07 26.05 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.788 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.729 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.0 Cg_exo -35.82 148.19 0.05 OUTLIER 'Trans proline' 0 CA--C 1.505 -0.964 0 C-N-CA 123.758 2.972 . . . . 0.0 113.986 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.31 53.54 0.14 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 143.34 -0.56 1.3 Allowed Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.167 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.729 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 49.76 52.53 14.42 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.886 1.843 . . . . 0.0 110.654 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.783 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -121.65 -168.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.783 ' H ' HG12 ' A' ' 21' ' ' VAL . 18.7 mttt -92.54 172.97 8.03 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.894 -2.412 . . . . 0.0 107.684 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.33 -32.46 4.42 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.007 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.764 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -65.28 135.45 55.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.136 1.374 . . . . 0.0 112.431 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.502 ' C ' ' HA ' ' A' ' 4' ' ' TYR . 2.5 mp0 -148.32 98.47 2.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.784 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.663 ' N ' ' HA ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -68.48 172.39 6.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.863 1.316 . . . . 0.0 114.442 -176.234 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.668 ' H ' ' CB ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -126.95 160.79 29.98 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 111.964 -2.38 . . . . 0.0 105.853 177.044 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.899 ' HA ' ' CZ3' ' A' ' 2' ' ' TRP . 26.7 t-105 -104.22 55.56 0.72 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.702 1.239 . . . . 0.0 108.091 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.645 ' N ' ' HZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-N 111.634 -2.53 . . . . 0.0 112.948 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.489 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 65.2 m95 . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.719 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 176.99 159.81 0.38 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.334 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.727 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -109.08 137.21 47.33 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.221 -173.841 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 24.4 t80 -116.09 124.9 51.56 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.716 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.9 t-20 -99.35 85.92 3.28 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.54 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -51.18 -22.93 2.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.156 -178.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -67.73 -48.33 76.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.587 -178.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.686 HG21 ' CD1' ' A' ' 20' ' ' LEU . 18.3 p -106.05 -20.85 13.29 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.15 56.8 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.573 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.657 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 3.1 mmmt -85.34 160.35 19.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.347 0.574 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.615 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.71 139.11 2.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -175.756 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.554 ' HG3' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.17 -179.63 7.22 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.296 1.046 . . . . 0.0 111.774 177.093 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 20.4 t80 -81.09 -17.1 51.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.775 176.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -93.35 -176.8 4.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 122.921 1.343 . . . . 0.0 112.761 -178.347 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.477 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -70.96 151.79 95.02 Favored Pre-proline 0 N--CA 1.425 -1.695 0 CA-C-N 111.799 -2.455 . . . . 0.0 107.051 176.166 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.751 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 40.6 Cg_exo -20.2 134.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 125.005 3.803 . . . . 0.0 116.58 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -58.17 -19.79 35.86 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.756 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.622 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 145.31 38.21 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 112.659 -2.064 . . . . 0.0 112.053 178.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 9' ' ' THR . 1.6 mt -151.5 54.09 0.84 Allowed 'General case' 0 C--N 1.366 1.311 0 CA-C-N 119.139 1.469 . . . . 0.0 113.975 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.637 HG23 ' CD ' ' A' ' 22' ' ' LYS . 2.8 m -19.89 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 119.654 3.205 . . . . 0.0 119.654 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.637 ' CD ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -109.25 133.65 52.76 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.048 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.13 -19.82 22.24 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CZ3' ' HB2' ' A' ' 6' ' ' ASN . 84.9 m95 -61.39 136.23 57.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -149.45 97.62 2.67 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.462 178.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.719 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 24.1 ttpt -58.53 135.18 57.24 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HD2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -125.49 144.93 50.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.627 0.727 . . . . 0.0 111.67 -178.506 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -72.78 124.85 26.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.216 179.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.073 -179.99 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 86.4 m95 . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 120.416 0.15 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -177.99 168.08 2.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.42 178.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.78 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.55 141.67 37.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.629 -173.745 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.699 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.8 t80 -124.42 128.78 49.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.747 -178.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.845 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.1 t-20 -102.42 99.28 9.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -66.12 -2.79 4.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -86.04 -51.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 p -98.62 -22.93 15.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.272 0.558 . . . . 0.0 111.579 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.89 57.41 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.495 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -90.43 168.85 11.54 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.196 0.498 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.699 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 16.6 ptt-85 -176.46 142.72 0.46 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.209 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.556 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -168.01 -174.81 2.47 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.961 0.886 . . . . 0.0 111.498 177.989 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -91.83 -10.62 39.13 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.973 177.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -175.93 6.05 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.566 1.174 . . . . 0.0 112.574 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.556 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 23.3 ttm180 -55.3 144.44 51.4 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 112.497 -2.138 . . . . 0.0 105.912 175.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 19' ' ' GLY . 75.1 Cg_exo -44.63 138.06 8.21 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 110.679 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.446 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -65.45 60.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.058 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 137.38 1.26 2.53 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.827 -178.369 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.556 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.92 61.1 3.14 Favored 'General case' 0 C--N 1.369 1.429 0 CA-C-N 119.901 1.85 . . . . 0.0 110.351 179.897 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -130.56 -168.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.606 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.766 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.2 mtpp -95.67 173.28 7.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 111.496 -2.593 . . . . 0.0 107.106 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.47 -31.84 5.28 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.002 -1.57 . . . . 0.0 109.732 -176.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.845 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.7 m95 -62.21 136.15 57.81 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.458 1.503 . . . . 0.0 111.82 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.8 mp0 -150.79 118.65 6.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.6 ttmt -68.26 125.74 27.36 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.965 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.563 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -126.44 171.2 11.22 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.635 0.731 . . . . 0.0 110.672 -179.535 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.563 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 8.2 t-105 -83.25 151.89 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.476 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.788 179.398 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.541 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.107 0.479 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -86.57 151.95 23.03 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.991 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 18.1 p90 -132.75 -177.61 4.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.762 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 1.9 m-85 -132.69 131.38 41.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 120.838 0.351 . . . . 0.0 111.903 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.729 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 36.5 t80 -119.58 126.43 51.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.327 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.771 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.33 110.2 22.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -70.23 -22.61 62.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.692 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.22 -49.57 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -98.54 -21.01 16.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.342 0.592 . . . . 0.0 111.739 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.27 15.18 72.44 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.364 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -96.03 156.26 16.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.054 0.427 . . . . 0.0 110.835 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.729 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -166.14 146.69 6.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.046 0.538 . . . . 0.0 111.648 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -152.11 -175.46 5.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.999 0.904 . . . . 0.0 111.844 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 1' ' ' ARG . 0.1 OUTLIER -88.83 -10.64 47.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.623 177.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -91.51 -177.51 4.83 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.268 1.032 . . . . 0.0 110.757 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.499 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 12.8 ttm105 -50.04 153.39 2.35 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.154 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 2.6 Cg_endo -40.8 135.79 2.12 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.207 1.938 . . . . 0.0 110.269 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -67.35 56.2 0.05 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.116 0.96 . . . . 0.0 108.707 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 147.05 -3.59 0.93 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 113.848 -1.523 . . . . 0.0 114.358 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.707 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 50.31 51.39 16.86 Favored 'General case' 0 C--N 1.368 1.375 0 CA-C-N 120.214 2.007 . . . . 0.0 110.724 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -124.6 -169.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.117 1.437 . . . . 0.0 114.744 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.753 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -92.51 167.94 11.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.423 177.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.33 -34.97 4.19 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.706 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.771 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.8 m95 -57.92 138.51 55.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.899 1.279 . . . . 0.0 111.804 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -129.09 124.89 35.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 34.6 ttmt -85.09 114.16 22.03 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -127.13 172.16 10.78 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.908 0.861 . . . . 0.0 111.464 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.534 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 4.1 t-105 -85.21 147.75 26.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.311 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.961 179.518 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.595 0.712 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.876 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -161.7 158.84 26.54 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.274 -174.422 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 10.9 p90 -179.77 -173.5 0.25 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 -173.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.81 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.83 141.94 40.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 111.558 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.717 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.1 t80 -125.55 130.55 51.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.838 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.01 113.65 27.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -74.52 -22.17 59.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.728 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.56 -49.39 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.12 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 p -99.03 -20.96 16.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.265 0.555 . . . . 0.0 111.904 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.39 16.89 72.69 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 15.7 mmmt -93.45 164.93 13.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.717 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 7.8 ptp180 -172.92 140.54 0.94 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -162.64 -177.07 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.344 1.068 . . . . 0.0 112.391 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -87.03 -15.46 38.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.204 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.519 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -83.5 -174.7 5.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.358 1.075 . . . . 0.0 111.987 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HD2' HD12 ' A' ' 20' ' ' LEU . 19.4 ttp-105 -52.1 151.21 7.07 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 112.559 -2.11 . . . . 0.0 106.999 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . 40.3 Cg_exo -51.93 138.27 52.04 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 120.824 1.016 . . . . 0.0 109.582 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -64.67 62.07 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 135.36 1.83 3.07 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.815 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' A' ' 16' ' ' ARG . 0.7 OUTLIER 47.11 59.89 3.76 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 119.579 1.689 . . . . 0.0 110.146 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.781 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -126.63 -168.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -177.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.781 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -96.87 172.85 7.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.456 -2.611 . . . . 0.0 107.056 177.483 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.84 -33.16 4.76 Favored Glycine 0 N--CA 1.481 1.661 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.634 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.838 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -58.66 136.92 57.79 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.518 1.527 . . . . 0.0 111.899 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.4 mp0 -148.02 103.57 3.49 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.605 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.876 ' HG2' ' CZ3' ' A' ' 2' ' ' TRP . 19.6 ttpt -65.11 120.29 12.4 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -116.67 168.0 10.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.426 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.668 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 69.2 t-105 -105.94 42.99 1.17 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.19 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.6 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.145 0.498 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -108.6 159.49 16.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.561 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.731 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.3 p90 -174.73 165.95 3.71 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 120.612 0.244 . . . . 0.0 111.283 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.774 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.77 141.44 39.33 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.506 -173.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.706 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.3 t80 -123.69 129.58 51.32 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.591 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.831 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -102.88 110.51 22.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.15 -20.73 63.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.62 -49.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.12 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 p -98.61 -22.28 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.279 0.562 . . . . 0.0 111.788 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.3 13.71 73.16 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.698 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 12.0 mmmt -91.62 166.0 13.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.105 0.452 . . . . 0.0 110.075 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.706 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 4.0 ptp180 -172.57 141.79 1.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.499 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.48 -178.38 5.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.348 1.07 . . . . 0.0 112.095 177.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.82 -17.31 33.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.03 -1.896 . . . . 0.0 109.3 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -79.84 -174.89 4.62 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 122.396 1.093 . . . . 0.0 111.72 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.538 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 29.9 ttm180 -52.84 151.84 7.83 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.266 176.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.726 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.7 Cg_endo -49.02 136.46 29.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.67 1.58 . . . . 0.0 110.217 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -69.4 55.91 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 122.04 0.924 . . . . 0.0 108.566 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 146.46 -4.26 1.08 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.351 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.726 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.46 59.69 4.4 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 119.792 1.796 . . . . 0.0 109.917 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -134.02 -168.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -177.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.759 ' H ' HG12 ' A' ' 21' ' ' VAL . 64.0 mttt -96.89 174.66 6.67 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.429 -2.623 . . . . 0.0 106.884 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.38 -33.22 4.63 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 118.858 -1.639 . . . . 0.0 109.825 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.831 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.5 m95 -60.15 136.74 58.12 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.356 1.462 . . . . 0.0 111.88 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.53 117.29 6.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.683 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.9 ttmt -69.71 124.32 23.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.189 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -124.51 174.4 7.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.581 0.705 . . . . 0.0 110.773 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.44 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 12.7 t-105 -87.86 144.85 26.36 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.066 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.731 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.6 p30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.419 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.969 0.414 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -95.85 156.99 16.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.547 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.711 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 2.1 p90 -177.02 170.6 2.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.445 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -108.09 142.59 38.04 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.1 t80 -127.05 127.62 45.01 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.287 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.829 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.4 t-20 -101.67 115.59 30.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -75.79 -22.03 56.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.65 -49.36 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.0 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -99.61 -21.47 15.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.168 0.509 . . . . 0.0 111.92 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.9 70.95 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.2 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 9.6 mmmt -88.56 166.99 13.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 117.208 0.504 . . . . 0.0 109.703 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -168.16 142.14 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -173.71 -176.48 1.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.13 0.967 . . . . 0.0 111.9 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.01 -10.1 31.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.109 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -80.79 -176.6 5.92 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.495 1.14 . . . . 0.0 111.908 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 26.0 ttp-105 -55.93 146.15 49.99 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.928 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.704 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 1.9 Cg_endo -43.26 133.32 6.55 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 122.225 1.95 . . . . 0.0 111.017 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.522 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -66.23 59.51 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.269 1.033 . . . . 0.0 108.284 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 139.22 -2.62 2.62 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 113.528 -1.669 . . . . 0.0 114.2 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.704 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 49.99 58.95 4.9 Favored 'General case' 0 C--N 1.366 1.321 0 CA-C-N 119.939 1.87 . . . . 0.0 109.958 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -129.61 -168.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.775 ' H ' HG12 ' A' ' 21' ' ' VAL . 4.1 mmmt -97.22 175.0 6.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 111.432 -2.622 . . . . 0.0 106.895 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 -33.54 4.4 Favored Glycine 0 N--CA 1.482 1.727 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.84 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.829 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.9 m95 -59.39 136.22 57.9 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.445 1.498 . . . . 0.0 111.867 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.7 114.25 5.27 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.711 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.6 ttmt -67.95 123.45 20.64 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.499 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -123.69 174.19 7.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.672 0.749 . . . . 0.0 111.017 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.433 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 8.9 t-105 -87.08 151.35 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.079 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.909 179.522 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.085 0.469 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -105.44 157.58 17.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.016 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.749 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.8 p90 -169.59 160.97 9.3 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 120.767 0.318 . . . . 0.0 111.175 178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.49 139.03 42.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.856 -173.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.691 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 33.0 t80 -121.76 129.46 52.7 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.295 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.841 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -103.51 100.45 10.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.29 -2.47 4.44 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.2 -52.05 12.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 p -98.07 -23.36 15.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.288 0.566 . . . . 0.0 111.544 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 15.73 59.71 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.651 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 11.6 mmmt -92.31 160.32 15.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.385 0.592 . . . . 0.0 109.918 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.691 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -165.32 143.78 6.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.51 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -163.53 172.39 14.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.986 0.898 . . . . 0.0 112.235 177.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -81.43 -25.77 35.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.93 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -173.39 0.95 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.521 1.153 . . . . 0.0 111.764 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.728 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 12.9 ttp85 -52.95 155.64 4.08 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 112.387 -2.188 . . . . 0.0 107.999 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 11.2 Cg_endo -52.05 138.03 53.32 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.814 1.676 . . . . 0.0 110.479 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -71.53 54.69 0.23 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.063 0.935 . . . . 0.0 108.57 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.45 -3.73 0.89 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.453 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.77 60.82 3.57 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.609 1.705 . . . . 0.0 109.993 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -135.2 -168.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.449 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.761 ' H ' HG12 ' A' ' 21' ' ' VAL . 10.0 mttm -97.18 175.13 6.4 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.369 -2.651 . . . . 0.0 106.977 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 -33.85 4.29 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 118.923 -1.608 . . . . 0.0 109.836 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.841 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.0 m95 -58.8 138.97 56.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.289 1.436 . . . . 0.0 111.914 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.2 mt-10 -148.34 120.71 8.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.538 0.209 . . . . 0.0 110.682 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.5 ttmt -76.24 126.72 31.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.807 0.337 . . . . 0.0 110.601 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -129.07 175.07 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.697 0.761 . . . . 0.0 110.706 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.511 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 9.9 t-105 -89.12 143.96 26.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.695 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.749 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.9 p30 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.258 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.933 ' HG2' ' CG ' ' A' ' 28' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.855 0.836 . . . . 0.0 110.91 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.913 ' HB2' ' HG2' ' A' ' 26' ' ' LYS 0.261 1.1 p-90 -148.21 178.74 8.3 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.656 -175.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.878 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER 174.98 -155.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.925 -1.735 . . . . 0.0 112.956 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.571 ' CD1' ' C ' ' A' ' 3' ' ' PHE . 2.3 m-85 -150.69 96.44 2.36 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.74 0.781 . . . . 0.0 110.539 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.702 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 45.1 t80 -98.4 122.23 41.32 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.344 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.805 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.7 t-20 -99.11 106.91 19.17 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -63.7 -18.47 64.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.225 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mm -76.06 -50.1 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.06 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.6 p -97.76 -23.86 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.383 0.611 . . . . 0.0 111.661 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.1 9.92 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.356 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 12.5 mmmt -93.6 160.57 14.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.485 0.642 . . . . 0.0 111.423 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.702 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.59 144.36 7.44 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 123.363 0.665 . . . . 0.0 111.981 -178.067 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -151.65 173.21 14.94 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.866 0.841 . . . . 0.0 110.648 177.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.664 ' HE1' ' CD1' ' A' ' 28' ' ' TRP . 41.3 m-85 -77.49 -28.79 52.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.72 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -74.14 -177.14 2.83 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.453 1.12 . . . . 0.0 110.691 178.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.617 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 20.5 ttm180 -47.75 157.91 0.56 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 112.457 -2.156 . . . . 0.0 108.907 176.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.688 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 7.6 Cg_endo -47.56 136.67 20.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.335 2.024 . . . . 0.0 110.321 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' CB ' ' HH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -71.84 50.99 0.2 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 159.74 -9.56 0.16 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 114.218 -1.356 . . . . 0.0 114.441 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.688 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 54.29 58.23 5.15 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 119.773 1.786 . . . . 0.0 110.79 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -140.52 -167.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 123.084 1.421 . . . . 0.0 114.812 -178.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.73 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -92.17 173.35 7.87 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.348 177.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 -36.44 3.54 Favored Glycine 0 N--CA 1.482 1.71 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.661 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.805 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 99.0 m95 -58.45 143.12 46.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.2 1.4 . . . . 0.0 112.091 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -136.97 139.12 41.25 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.913 ' HG2' ' HB2' ' A' ' 2' ' ' TRP . 29.9 tttt -92.0 121.58 33.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.297 0.57 . . . . 0.0 111.996 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 21.0 ttp180 179.41 83.95 0.01 OUTLIER 'General case' 0 C--N 1.353 0.741 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.177 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.933 ' CG ' ' HG2' ' A' ' 1' ' ' ARG . 1.8 t90 -39.57 -19.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 112.394 -2.185 . . . . 0.0 112.507 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 27' ' ' ARG . 6.4 t70 . . . . . 0 C--N 1.308 -1.239 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.324 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.003 0.43 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.413 ' CD2' ' HE3' ' A' ' 26' ' ' LYS . 81.1 m95 -104.4 159.17 15.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.599 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.67 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -179.18 166.8 1.54 Allowed 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.707 0.289 . . . . 0.0 111.543 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.64 141.45 39.11 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.467 -173.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.697 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.1 t80 -123.55 130.42 52.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.906 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.838 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.05 111.94 24.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -71.8 -21.08 61.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.64 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.42 -49.84 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 p -98.65 -21.98 16.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 111.821 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.09 72.01 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.535 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HE3' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -93.47 165.98 12.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.958 0.503 . . . . 0.0 109.874 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.697 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 3.8 ptp180 -172.55 142.81 1.28 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.501 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.68 -177.81 5.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.295 1.045 . . . . 0.0 111.979 177.045 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -87.08 -16.54 35.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.37 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -81.53 -174.36 4.92 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 122.425 1.107 . . . . 0.0 111.773 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.454 ' HD3' HD12 ' A' ' 20' ' ' LEU . 26.5 ttm180 -51.3 150.55 6.05 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.919 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 19' ' ' GLY . 45.6 Cg_exo -51.67 138.69 49.39 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 109.44 -1.023 . . . . 0.0 109.44 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.57 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.71 61.74 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.26 1.028 . . . . 0.0 108.322 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 136.61 1.14 2.79 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.805 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.474 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.9 59.17 4.38 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 119.579 1.689 . . . . 0.0 110.216 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -127.87 -168.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.779 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -96.03 172.48 7.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.135 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.0 -32.89 4.91 Favored Glycine 0 N--CA 1.481 1.673 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.782 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.838 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.7 m95 -60.12 137.04 58.19 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.431 1.492 . . . . 0.0 111.967 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.82 116.64 5.9 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 29.0 tttt -68.84 123.83 22.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -122.96 174.16 7.35 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.53 0.681 . . . . 0.0 110.733 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.442 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 9.1 t-105 -86.56 150.46 24.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.107 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.833 179.625 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.188 0.518 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 26' ' ' LYS . 81.8 m95 -116.03 160.39 20.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.228 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.611 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 29.4 p90 174.59 167.36 0.25 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.765 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.5 139.96 40.15 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.472 -175.037 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.708 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.0 t80 -118.43 129.62 55.5 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.84 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.6 t-20 -102.67 99.29 9.26 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -66.08 -2.15 3.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.19 -52.44 11.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -97.57 -23.6 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.342 0.591 . . . . 0.0 111.496 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.59 15.79 57.8 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.737 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -94.32 159.61 15.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.267 0.533 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.708 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.75 144.25 7.15 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.527 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -160.24 172.68 16.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.05 0.929 . . . . 0.0 112.969 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.3 t80 -80.85 -24.75 38.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.11 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -172.87 2.17 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.421 1.105 . . . . 0.0 111.833 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.666 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 18.5 ttp180 -51.93 157.07 2.22 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 112.42 -2.173 . . . . 0.0 107.948 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.676 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 10.8 Cg_endo -51.9 138.24 51.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.593 1.528 . . . . 0.0 110.267 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -71.36 54.56 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 148.37 -4.08 0.79 Allowed Glycine 0 CA--C 1.537 1.449 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.442 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.676 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.08 59.62 4.4 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 119.661 1.73 . . . . 0.0 109.961 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.76 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -134.94 -168.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.76 ' H ' HG12 ' A' ' 21' ' ' VAL . 35.7 mttp -96.89 174.26 6.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.434 -2.621 . . . . 0.0 107.068 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.03 -31.76 5.2 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.881 -1.628 . . . . 0.0 109.931 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.84 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.9 m95 -61.13 137.05 58.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.313 1.445 . . . . 0.0 111.832 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.6 mp0 -151.55 110.34 3.85 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-O 120.581 0.229 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 1.8 tppt? -58.58 129.12 40.55 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.02 170.83 8.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.0 110.754 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.408 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 7.4 t-105 -107.69 101.97 11.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.592 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.487 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.752 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 15.3 ttm105 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.86 0.362 . . . . 0.0 110.656 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 1.094 ' HB2' ' HB3' ' A' ' 27' ' ' ARG 0.379 0.1 OUTLIER -113.61 179.16 4.04 Favored 'General case' 0 CA--C 1.598 2.789 0 CA-C-O 117.461 -1.256 . . . . 0.0 111.324 -178.343 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.913 ' N ' ' CB ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -152.25 -171.15 3.85 Favored 'General case' 1 N--CA 1.547 4.424 0 C-N-CA 126.704 2.001 . . . . 0.0 111.839 -174.144 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 6.2 m-85 -64.65 121.38 14.36 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.041 -1.662 . . . . 0.0 111.617 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 28.8 t80 -113.74 121.3 43.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.54 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.653 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.2 t-20 -101.01 85.3 2.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 23.3 ptt180 -46.95 -32.96 4.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.471 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 1.6 mm -65.73 -44.47 93.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.902 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 1.058 HG21 HD22 ' A' ' 20' ' ' LEU . 32.2 p -101.77 -14.12 17.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 111.969 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' ASN . . . 75.88 13.66 82.9 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.686 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' HD13 ' A' ' 20' ' ' LEU . 21.7 mmmt -81.72 165.17 21.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.893 0.347 . . . . 0.0 110.255 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.799 ' HD3' ' CE1' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -161.91 136.24 6.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.334 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.04 154.07 44.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.597 ' HD1' ' HB3' ' A' ' 29' ' ' ASP . 45.3 m-85 -80.23 -34.08 37.51 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.025 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 16' ' ' ARG . 3.3 tp10 -89.33 177.01 6.7 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.742 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 11.0 ttm105 -56.56 138.96 75.98 Favored Pre-proline 0 C--N 1.283 -2.292 0 CA-C-N 113.713 -1.585 . . . . 0.0 106.984 176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.548 ' HG3' ' NE1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -12.17 145.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 1 C-N-CA 126.17 4.58 . . . . 0.0 117.969 -177.011 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -77.5 22.23 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.972 177.061 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.59 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 89.41 37.96 6.85 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.269 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.058 HD22 HG21 ' A' ' 9' ' ' THR . 9.9 mt -154.63 91.8 1.42 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 119.211 -0.995 . . . . 0.0 113.151 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.989 HG13 ' HD1' ' A' ' 24' ' ' TRP . 2.2 t -95.04 -168.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 CA-C-O 121.889 0.852 . . . . 0.0 110.863 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.92 ' H ' HG12 ' A' ' 21' ' ' VAL . 5.2 mttp 55.46 86.54 0.06 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.71 -15.36 4.1 Favored Glycine 0 C--N 1.296 -1.682 0 CA-C-N 111.447 -2.615 . . . . 0.0 112.247 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.989 ' HD1' HG13 ' A' ' 21' ' ' VAL . 39.8 m95 -62.33 141.01 58.51 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.545 1.172 . . . . 0.0 111.886 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.0 mp0 -138.31 102.02 4.53 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 27.2 ttpt -48.68 130.16 17.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 1.094 ' HB3' ' HB2' ' A' ' 2' ' ' TRP 0.301 14.9 mtp180 -120.66 176.66 5.41 Favored 'General case' 1 N--CA 1.362 -4.874 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 166.933 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.752 ' CE3' ' HA ' ' A' ' 1' ' ' ARG . 0.0 OUTLIER -41.56 -35.33 0.71 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -172.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 2' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.111 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.393 0.616 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.92 ' CH2' ' HG3' ' A' ' 26' ' ' LYS 0.256 0.0 OUTLIER -167.88 161.08 12.82 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.65 -174.359 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.3 p90 -178.37 172.07 1.54 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.21 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.784 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -100.3 143.99 29.84 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 124.098 0.874 . . . . 0.0 112.745 -175.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.735 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 39.7 t80 -127.56 129.77 47.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.372 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.831 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -103.16 102.29 12.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -67.34 -1.99 5.46 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.54 -52.49 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 p -97.68 -23.21 16.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.292 0.568 . . . . 0.0 111.526 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.37 59.83 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.727 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 2.3 mmmm -91.94 164.3 13.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 117.238 0.519 . . . . 0.0 109.632 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.735 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 21.9 ptt-85 -173.0 140.73 0.92 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.505 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -161.4 -177.47 6.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 122.339 1.066 . . . . 0.0 112.191 177.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -86.16 -16.49 37.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.281 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.505 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.27 5.16 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.396 1.093 . . . . 0.0 112.097 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 21.1 ttm105 -51.22 151.76 4.72 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.103 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 19' ' ' GLY . 31.2 Cg_exo -52.82 138.4 60.34 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 CA-C-N 119.842 0.979 . . . . 0.0 109.558 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -65.55 61.45 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 108.2 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 138.71 0.05 2.35 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.923 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 48.49 60.97 3.29 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.61 1.705 . . . . 0.0 110.257 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.769 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -131.09 -168.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.769 ' H ' HG12 ' A' ' 21' ' ' VAL . 14.5 mttp -96.0 175.01 6.64 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.536 -2.575 . . . . 0.0 107.048 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.56 -34.23 4.1 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.71 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.831 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.5 m95 -58.15 133.92 56.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.308 1.443 . . . . 0.0 111.766 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.3 mp0 -156.22 105.7 2.33 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.92 ' HG3' ' CH2' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -72.0 154.42 41.17 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.755 0.788 . . . . 0.0 112.506 -178.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -124.16 151.75 43.63 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.525 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.494 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 55.3 t-105 -100.61 106.08 17.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.429 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 C--O 1.251 1.18 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.758 -179.251 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.064 0.459 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.512 ' HB3' ' CE ' ' A' ' 26' ' ' LYS . 70.5 m95 -116.99 158.86 23.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.725 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 178.91 174.53 0.68 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.497 0.665 . . . . 0.0 111.817 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.962 ' HB2' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -104.5 163.99 12.06 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.298 -173.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 45.1 t80 -149.33 133.3 17.1 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.451 -1.405 . . . . 0.0 112.175 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.87 ' HB2' ' CE2' ' A' ' 24' ' ' TRP . 22.9 t-20 -105.25 128.27 53.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -82.38 -26.3 32.99 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -83.57 -45.52 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -104.4 -16.77 15.01 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 53.1 37.52 54.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.195 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.529 ' C ' ' HH2' ' A' ' 24' ' ' TRP . 22.7 mmmt -102.68 42.5 1.14 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.76 148.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.884 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.769 ' H ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -155.07 -157.51 0.76 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 123.31 1.529 . . . . 0.0 109.726 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -131.32 0.43 4.1 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.596 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.736 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -87.22 179.14 6.69 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.854 1.312 . . . . 0.0 113.894 -177.423 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.879 ' HG3' HD12 ' A' ' 20' ' ' LEU . 46.6 ttp180 -49.71 -34.75 10.15 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-N 111.953 -2.385 . . . . 0.0 116.947 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.77 ' CD ' ' N ' ' A' ' 16' ' ' ARG . 9.8 Cg_endo -80.59 170.82 15.34 Favored 'Trans proline' 0 CA--C 1.455 -3.453 1 C-N-CA 127.075 5.183 . . . . 0.0 107.636 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 1.127 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 3.3 pttt 65.19 11.26 7.07 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-O 123.079 1.419 . . . . 0.0 108.902 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.435 ' N ' ' C ' ' A' ' 17' ' ' PRO . . . -143.18 -48.76 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.879 HD12 ' HG3' ' A' ' 16' ' ' ARG . 5.2 mt -97.23 36.75 1.41 Allowed 'General case' 0 C--N 1.359 0.98 0 CA-C-O 122.038 0.923 . . . . 0.0 109.309 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.842 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 70.0 t -139.86 165.43 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.002 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.564 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -91.42 152.82 20.23 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.486 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.3 -27.15 7.9 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 1.127 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 95.1 m95 -69.61 144.31 53.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.484 1.514 . . . . 0.0 115.013 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 5' ' ' PHE . 4.8 mp0 -150.72 115.14 5.14 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 69.5 tttt -66.09 127.53 32.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -121.44 170.77 9.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.431 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 11.7 t-105 -89.74 141.5 28.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.97 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.788 179.436 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.563 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 17.6 mtm180 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.044 0.45 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.403 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 86.7 m95 -103.94 151.77 22.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.163 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -163.04 160.45 24.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.809 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.736 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -104.36 131.9 51.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.054 -173.325 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.664 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.6 t80 -114.97 123.27 48.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.251 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.705 ' CG ' HD13 ' A' ' 20' ' ' LEU . 25.4 t-20 -102.16 92.82 4.92 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -53.83 -21.25 7.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.18 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -67.86 -49.42 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.65 HG21 HD21 ' A' ' 20' ' ' LEU . 20.2 p -105.27 -21.39 13.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 112.29 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.38 16.78 56.68 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.221 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 8.3 mmmm -86.82 155.91 20.1 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.383 0.591 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.664 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -161.78 135.68 6.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.578 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.18 179.92 8.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 122.152 0.977 . . . . 0.0 111.851 177.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 1' ' ' ARG . 0.3 OUTLIER -87.26 -16.27 35.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.201 175.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.578 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -94.65 -174.1 3.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.596 1.188 . . . . 0.0 111.822 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 45.9 ttp180 -66.54 155.0 89.94 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.251 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.674 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 25.0 Cg_exo -24.84 145.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 125.086 3.857 . . . . 0.0 115.402 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -87.88 30.68 0.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.384 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.55 ' C ' ' HG ' ' A' ' 20' ' ' LEU . . . 114.17 36.7 1.32 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-N 113.842 -1.526 . . . . 0.0 111.5 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.768 ' C ' HG22 ' A' ' 21' ' ' VAL . 2.8 mt -144.06 -161.72 1.33 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 117.964 0.882 . . . . 0.0 110.154 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.768 HG22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -170.35 -43.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 122.023 0.916 . . . . 0.0 113.137 -178.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.571 ' HD3' ' HB ' ' A' ' 21' ' ' VAL . 3.2 mmtm -106.56 139.95 40.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.339 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.21 -24.37 20.97 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.686 ' CE3' ' HB2' ' A' ' 6' ' ' ASN . 80.8 m95 -60.26 140.77 56.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.33 1.052 . . . . 0.0 112.936 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.01 105.14 3.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.751 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 12.2 ttpt -69.15 126.12 28.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.204 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.686 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.89 174.15 9.04 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 110.656 -178.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.525 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 6.6 t-105 -85.42 151.79 23.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.67 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.773 179.437 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.414 ' HD2' ' H ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.465 0.65 . . . . 0.0 111.198 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.73 ' CE3' ' HG2' ' A' ' 26' ' ' LYS 0.284 0.0 OUTLIER -168.83 124.85 0.94 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.135 -173.766 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.725 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 30.6 p90 -137.2 -179.21 5.58 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.359 -2.201 . . . . 0.0 113.829 -173.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.717 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -102.19 138.19 39.47 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 32.5 t80 -116.88 117.29 29.32 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.589 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.779 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 20.5 t-20 -102.55 89.04 3.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 22.5 ptt180 -45.93 -29.68 1.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.719 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.432 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 1.5 mm -65.84 -45.56 91.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.488 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.633 HG21 ' HA2' ' A' ' 19' ' ' GLY . 30.5 p -101.48 -17.09 16.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 112.044 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.44 13.79 79.8 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.239 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 18' ' ' LYS . 6.1 mmmm -89.3 156.3 18.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 117.192 0.496 . . . . 0.0 109.854 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.641 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -154.51 131.65 11.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.515 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -167.81 173.03 8.64 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.061 0.934 . . . . 0.0 113.154 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.55 -23.47 37.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.099 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -72.34 -176.43 1.85 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.846 1.307 . . . . 0.0 111.985 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 34.0 ttt-85 -62.51 151.44 83.23 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.048 -2.342 . . . . 0.0 109.529 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.556 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 2.0 Cg_endo -40.21 119.06 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 124.276 3.317 . . . . 0.0 117.264 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 15.4 mmtt -98.52 36.73 1.58 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 172.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -164.66 -30.58 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.377 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.65 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.2 mt 81.28 90.86 0.04 OUTLIER 'General case' 0 C--N 1.366 1.293 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.649 ' HA ' ' HD1' ' A' ' 24' ' ' TRP . 14.7 t 44.51 -49.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 119.615 3.191 . . . . 0.0 119.615 173.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.476 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -87.68 123.83 32.92 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.623 -178.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.84 -16.91 25.52 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.266 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.779 ' CZ3' ' HB2' ' A' ' 6' ' ' ASN . 81.2 m95 -69.82 143.7 52.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.01 88.55 1.32 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.833 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.73 ' HG2' ' CE3' ' A' ' 2' ' ' TRP . 52.3 tttt -63.63 127.31 30.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.363 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 2' ' ' TRP . 4.2 ttp180 -115.49 161.52 18.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.072 0.939 . . . . 0.0 111.447 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.681 ' CE3' ' HB2' ' A' ' 2' ' ' TRP . 61.2 t-105 -101.73 116.74 33.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.711 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.278 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.934 0.397 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -51.55 155.32 1.59 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.718 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.679 ' CE2' ' HD2' ' A' ' 12' ' ' ARG . 1.8 p90 -160.93 -167.17 1.76 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.008 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.877 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 3.1 m-85 -128.09 142.57 51.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.648 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 38.0 t80 -123.69 124.25 42.33 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.795 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 18.3 t-20 -98.43 119.57 37.34 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -76.5 -25.83 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -76.49 -49.81 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.207 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.0 p -100.21 -21.02 15.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.015 0.436 . . . . 0.0 112.053 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.629 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 66.1 30.38 76.8 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.757 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.18 46.42 0.99 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.679 ' HD2' ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -32.3 137.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 17' ' ' PRO . 6.0 mt-30 -135.52 168.31 19.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.459 0.647 . . . . 0.0 110.726 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.43 -7.89 57.15 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.784 174.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.814 ' C ' ' HD3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.89 -164.45 0.8 Allowed 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.661 0.785 . . . . 0.0 110.035 178.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.5 ttm105 -101.38 65.08 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.183 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.814 ' HD3' ' C ' ' A' ' 15' ' ' GLU . 17.7 Cg_endo -88.14 -46.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 125.033 3.822 . . . . 0.0 111.03 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.954 ' HA ' ' CB ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -67.76 -18.12 64.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.018 178.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.0 -34.78 7.45 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 173.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 3.2 mt -67.99 -44.13 77.34 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -138.28 -177.27 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.579 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -90.11 167.37 12.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 111.443 -2.617 . . . . 0.0 109.392 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.11 -31.13 5.82 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.954 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 98.9 m95 -66.21 151.23 47.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.167 1.387 . . . . 0.0 112.599 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 5' ' ' PHE . 2.8 mp0 -153.67 109.94 3.32 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 32.0 ttmt -59.42 132.89 55.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -137.72 163.67 30.75 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.693 0.758 . . . . 0.0 111.17 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -77.5 151.6 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.539 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.663 178.754 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.241 0.543 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.53 ' HE3' ' HD2' ' A' ' 26' ' ' LYS . 77.3 m95 -114.5 155.96 25.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.533 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.75 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER 178.33 173.32 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 178.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.973 ' CD2' ' HG3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -108.76 164.84 12.02 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.167 -174.167 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 52.3 t80 -149.53 135.4 18.74 Favored 'General case' 0 C--O 1.22 -0.487 0 O-C-N 121.993 -0.442 . . . . 0.0 111.921 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.814 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 23.1 t-20 -105.44 123.49 47.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -78.86 -23.0 45.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -81.6 -46.87 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.632 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -102.46 -19.59 14.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 61.2 31.79 78.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.125 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 9' ' ' THR . 3.9 mmmm -114.23 61.77 0.67 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.474 ' HA ' ' HZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -37.54 136.89 0.47 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.71 0.804 . . . . 0.0 109.452 177.062 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.891 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -139.49 92.83 2.61 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.962 0.905 . . . . 0.0 113.078 -175.096 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.608 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 10.5 t80 -39.26 -25.58 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.797 -0.565 . . . . 0.0 111.086 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.633 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -57.38 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.105 0.955 . . . . 0.0 109.467 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.805 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 24.2 ttm105 -46.54 -60.63 3.48 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.032 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 16' ' ' ARG . 29.5 Cg_endo -65.81 157.2 60.24 Favored 'Trans proline' 0 CA--C 1.479 -2.266 1 C-N-CA 127.559 5.506 . . . . 0.0 109.301 178.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 1.05 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER 99.7 -12.19 0.04 OUTLIER 'General case' 0 N--CA 1.395 -3.206 0 CA-C-N 111.79 -2.459 . . . . 0.0 105.618 -171.266 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.67 -38.14 0.22 Allowed Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.226 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.758 HD12 ' HG3' ' A' ' 16' ' ' ARG . 4.0 mt -96.97 41.4 1.11 Allowed 'General case' 0 C--N 1.36 1.031 0 CA-C-N 118.212 1.006 . . . . 0.0 111.43 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.941 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 44.3 t -145.84 172.15 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.574 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -81.41 151.88 27.69 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.591 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.83 -29.71 4.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 1.05 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 97.2 m95 -67.64 146.91 53.38 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.624 1.57 . . . . 0.0 114.729 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.6 mp0 -151.29 106.62 3.33 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.1 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -60.61 129.31 40.91 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.29 173.59 7.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.425 0.631 . . . . 0.0 110.592 -179.52 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.442 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 6.5 t-105 -115.41 124.88 52.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.333 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.898 179.285 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.064 0.459 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.421 ' O ' ' HD1' ' A' ' 14' ' ' PHE . 77.3 m95 -117.6 160.23 21.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.081 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 34.4 p90 176.52 165.76 0.46 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.64 140.65 39.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.987 -174.444 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.683 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.5 t80 -120.45 129.69 53.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.849 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.19 112.44 25.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -72.62 -20.69 61.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.543 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.79 -50.0 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.063 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 p -98.61 -22.68 15.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.271 0.557 . . . . 0.0 111.866 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.69 15.12 71.48 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.946 -1.024 . . . . 0.0 113.711 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 9.0 mmmm -95.05 158.1 15.61 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 117.326 0.563 . . . . 0.0 109.832 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.683 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.09 144.61 9.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -165.14 -179.85 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.473 1.13 . . . . 0.0 112.547 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.2 t80 -85.33 -16.95 38.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.283 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.506 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.62 5.37 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.382 1.087 . . . . 0.0 112.16 -179.218 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.589 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 23.4 ttp-105 -51.94 153.75 4.3 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 112.402 -2.181 . . . . 0.0 107.059 175.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.727 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.6 Cg_endo -49.86 136.7 35.74 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.531 1.487 . . . . 0.0 110.491 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.35 55.27 0.15 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.013 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 148.71 -5.03 0.8 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-N 113.933 -1.485 . . . . 0.0 114.431 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.727 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.24 59.94 4.17 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-N 119.798 1.799 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.762 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -135.52 -168.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.505 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.762 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.3 mttm -97.59 174.61 6.56 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 111.388 -2.642 . . . . 0.0 106.852 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.53 -33.15 4.69 Favored Glycine 0 N--CA 1.481 1.678 0 C-N-CA 118.811 -1.662 . . . . 0.0 109.782 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.849 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -59.23 137.46 57.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.42 1.488 . . . . 0.0 111.998 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -150.35 112.27 4.56 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.502 0.191 . . . . 0.0 110.673 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 68.5 tttt -66.05 128.97 38.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.31 165.64 14.59 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.792 0.806 . . . . 0.0 111.55 -179.388 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -98.05 103.63 15.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.765 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.409 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.518 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 8.9 mtt180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.145 0.498 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -112.11 153.74 26.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.956 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -162.49 -171.54 2.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.548 178.258 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 1.8 m-85 -133.54 137.34 45.51 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 122.629 0.372 . . . . 0.0 111.489 -175.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.657 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 32.6 t80 -122.97 125.6 45.59 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.771 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.789 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.3 t-20 -101.3 112.09 24.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.65 -23.35 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.829 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -71.32 -49.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.959 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.2 p -98.58 -20.76 16.84 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.82 17.45 72.67 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.146 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -92.27 159.74 15.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.191 0.496 . . . . 0.0 110.105 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.657 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.34 144.56 4.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.395 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -161.08 -174.68 4.48 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.975 0.893 . . . . 0.0 112.027 178.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 1' ' ' ARG . 0.7 OUTLIER -90.71 -8.93 48.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.153 177.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -91.75 179.04 5.74 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.591 1.186 . . . . 0.0 111.584 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.573 ' HD3' ' CD1' ' A' ' 20' ' ' LEU . 24.4 ttm180 -52.09 145.02 19.31 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.371 175.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.627 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 6.8 Cg_exo -35.49 135.21 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.855 2.37 . . . . 0.0 111.776 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -65.78 58.55 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 141.54 -2.1 1.93 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.219 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.627 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 49.34 52.4 14.52 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 120.187 1.994 . . . . 0.0 110.448 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -122.52 -169.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 123.115 1.436 . . . . 0.0 114.789 -178.465 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.779 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -92.8 173.69 7.63 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 111.77 -2.468 . . . . 0.0 107.166 177.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.47 -36.34 3.45 Favored Glycine 0 N--CA 1.482 1.715 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.728 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.789 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -56.49 140.61 45.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.97 1.308 . . . . 0.0 111.682 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -142.75 108.77 5.19 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.55 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.4 ttpt -62.62 131.12 47.96 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.55 166.22 24.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.045 0.926 . . . . 0.0 111.615 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -84.64 148.07 26.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.453 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.828 179.478 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' A' ' 29' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.178 0.513 . . . . 0.0 111.18 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.467 ' N ' ' HD2' ' A' ' 1' ' ' ARG . 81.0 m95 -113.45 156.33 23.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.063 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.671 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.7 p90 -175.93 167.48 3.04 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.77 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.39 140.02 40.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.611 -173.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 29.6 t80 -120.8 128.81 53.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.404 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.805 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.28 106.3 17.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.82 -22.4 62.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.084 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -69.64 -49.0 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.761 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -101.0 -19.51 15.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.231 0.538 . . . . 0.0 112.013 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 19.2 62.57 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.7 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.14 178.07 5.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 117.009 0.405 . . . . 0.0 110.078 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.576 ' HD3' ' CE2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -163.1 139.68 7.3 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.479 ' OE1' ' O ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -147.29 155.06 41.71 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -86.85 -29.9 21.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.277 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.21 -170.37 2.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.791 0.805 . . . . 0.0 111.689 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.479 ' O ' ' OE1' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -38.88 124.12 1.21 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 113.332 -1.758 . . . . 0.0 107.763 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.569 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 87.6 Cg_exo -39.02 151.04 0.06 OUTLIER 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 122.847 2.365 . . . . 0.0 113.007 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 59.18 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 133.62 3.41 3.35 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.569 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 46.93 57.25 5.82 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-N 119.688 1.744 . . . . 0.0 109.867 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.803 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -120.49 -168.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.803 ' H ' HG12 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -96.45 172.45 7.93 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 111.5 -2.591 . . . . 0.0 106.99 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.81 -31.29 5.65 Favored Glycine 0 N--CA 1.48 1.608 0 C-N-CA 118.97 -1.586 . . . . 0.0 109.768 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.805 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.6 m95 -62.85 132.83 53.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.084 1.354 . . . . 0.0 111.268 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -147.44 119.4 8.18 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.9 ttpt -70.4 127.21 31.96 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.338 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.5 171.5 11.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.585 0.707 . . . . 0.0 110.729 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.455 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 10.1 t-105 -85.62 144.77 27.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.613 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 1' ' ' ARG . 6.0 t70 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.707 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.964 0.411 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -98.82 160.92 13.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.397 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -171.72 166.63 6.57 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.744 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -114.97 142.09 47.1 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.218 -174.065 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 32.1 t80 -128.38 129.35 46.09 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.413 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.9 t-20 -101.97 113.35 26.49 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -74.92 -22.79 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -71.7 -49.49 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.028 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.32 -20.99 16.25 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.885 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 19.06 67.72 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.088 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -94.35 161.38 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 117.208 0.504 . . . . 0.0 109.8 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.56 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.17 145.91 10.35 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.501 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -166.56 172.42 10.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.921 0.867 . . . . 0.0 112.076 177.361 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -84.05 -24.47 30.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.168 176.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -173.66 1.07 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 122.469 1.128 . . . . 0.0 111.335 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.677 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 40.2 ttp180 -52.81 155.24 4.23 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.723 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.677 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 9.2 Cg_endo -50.67 137.36 41.77 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.702 1.602 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.84 56.16 0.13 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.075 0.94 . . . . 0.0 108.599 179.166 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 144.68 -3.14 1.31 Allowed Glycine 0 CA--C 1.536 1.349 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.356 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.674 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.05 58.36 5.63 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 119.751 1.775 . . . . 0.0 109.789 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -130.97 -168.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.526 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.776 ' H ' HG12 ' A' ' 21' ' ' VAL . 8.0 mmmm -96.87 175.41 6.36 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.941 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.28 -33.34 4.34 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 118.85 -1.643 . . . . 0.0 109.805 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.8 m95 -59.34 135.42 57.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.273 1.429 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -148.61 117.05 6.53 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.014 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 20.6 ttpt -82.41 130.03 35.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 28' ' ' TRP . 16.4 ttp180 -129.37 -58.21 1.12 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.639 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 13.8 t-105 167.46 132.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.15 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 16.7 t70 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.68 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.792 ' C ' ' HG3' ' A' ' 26' ' ' LYS . 24.8 ttm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.758 0.789 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.899 ' CZ3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -128.42 128.41 44.39 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 121.131 3.752 . . . . 0.0 121.131 -173.558 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.87 ' HA ' ' HA ' ' A' ' 14' ' ' PHE 0.385 0.6 OUTLIER 156.92 -21.76 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.323 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER 2.98 114.36 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.606 2.362 . . . . 0.0 115.394 -175.678 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.3 t80 -91.74 123.1 34.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.596 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.764 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 16.6 t-20 -98.16 92.38 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -53.63 -23.88 12.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.518 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.86 -48.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.236 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 p -99.52 -18.52 17.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.385 0.612 . . . . 0.0 111.922 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.56 69.77 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 114.856 -1.065 . . . . 0.0 113.038 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 10.2 mmmm -91.15 179.28 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -169.37 152.89 5.03 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.865 -178.413 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -153.59 126.68 8.43 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.87 ' HA ' ' HA ' ' A' ' 3' ' ' PHE . 2.1 t80 -63.64 -25.12 68.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -176.11 5.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 122.067 0.937 . . . . 0.0 110.169 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.619 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 15.4 ttm180 -50.46 132.07 26.05 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.788 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.729 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.0 Cg_exo -35.82 148.19 0.05 OUTLIER 'Trans proline' 0 CA--C 1.505 -0.964 0 C-N-CA 123.758 2.972 . . . . 0.0 113.986 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.31 53.54 0.14 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 143.34 -0.56 1.3 Allowed Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.167 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.729 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 49.76 52.53 14.42 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.886 1.843 . . . . 0.0 110.654 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.783 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -121.65 -168.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.783 ' H ' HG12 ' A' ' 21' ' ' VAL . 18.7 mttt -92.54 172.97 8.03 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.894 -2.412 . . . . 0.0 107.684 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.33 -32.46 4.42 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.007 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.764 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -65.28 135.45 55.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.136 1.374 . . . . 0.0 112.431 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.502 ' C ' ' HA ' ' A' ' 4' ' ' TYR . 2.5 mp0 -148.32 98.47 2.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.784 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.792 ' HG3' ' C ' ' A' ' 1' ' ' ARG . 0.0 OUTLIER -68.48 172.39 6.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.863 1.316 . . . . 0.0 114.442 -176.234 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.668 ' H ' ' CB ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -126.95 160.79 29.98 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 111.964 -2.38 . . . . 0.0 105.853 177.044 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.899 ' HA ' ' CZ3' ' A' ' 2' ' ' TRP . 26.7 t-105 -104.22 55.56 0.72 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.702 1.239 . . . . 0.0 108.091 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.645 ' N ' ' HZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-N 111.634 -2.53 . . . . 0.0 112.948 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.278 0.561 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.489 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 65.2 m95 -118.58 161.63 19.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.533 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.719 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 176.99 159.81 0.38 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.334 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.727 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -109.08 137.21 47.33 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.221 -173.841 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 24.4 t80 -116.09 124.9 51.56 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.716 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.9 t-20 -99.35 85.92 3.28 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -51.18 -22.93 2.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.156 -178.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -67.73 -48.33 76.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.587 -178.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.686 HG21 ' CD1' ' A' ' 20' ' ' LEU . 18.3 p -106.05 -20.85 13.29 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.15 56.8 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.573 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.657 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 3.1 mmmt -85.34 160.35 19.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.347 0.574 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.615 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.71 139.11 2.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -175.756 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.554 ' HG3' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.17 -179.63 7.22 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.296 1.046 . . . . 0.0 111.774 177.093 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 20.4 t80 -81.09 -17.1 51.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.775 176.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -93.35 -176.8 4.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 122.921 1.343 . . . . 0.0 112.761 -178.347 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.477 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -70.96 151.79 95.02 Favored Pre-proline 0 N--CA 1.425 -1.695 0 CA-C-N 111.799 -2.455 . . . . 0.0 107.051 176.166 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.751 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 40.6 Cg_exo -20.2 134.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 125.005 3.803 . . . . 0.0 116.58 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -58.17 -19.79 35.86 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.756 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.622 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 145.31 38.21 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 112.659 -2.064 . . . . 0.0 112.053 178.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 9' ' ' THR . 1.6 mt -151.5 54.09 0.84 Allowed 'General case' 0 C--N 1.366 1.311 0 CA-C-N 119.139 1.469 . . . . 0.0 113.975 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG23 ' CD ' ' A' ' 22' ' ' LYS . 2.8 m -19.89 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 119.654 3.205 . . . . 0.0 119.654 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.637 ' CD ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -109.25 133.65 52.76 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.048 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.13 -19.82 22.24 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CZ3' ' HB2' ' A' ' 6' ' ' ASN . 84.9 m95 -61.39 136.23 57.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -149.45 97.62 2.67 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.462 178.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.719 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 24.1 ttpt -58.53 135.18 57.24 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HD2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -125.49 144.93 50.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.627 0.727 . . . . 0.0 111.67 -178.506 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -72.78 124.85 26.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.216 179.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.073 -179.99 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.051 0.453 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -100.52 157.84 16.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.774 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -177.99 168.08 2.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.42 178.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.78 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.55 141.67 37.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.629 -173.745 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.699 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.8 t80 -124.42 128.78 49.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.747 -178.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.845 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.1 t-20 -102.42 99.28 9.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -66.12 -2.79 4.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -86.04 -51.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 p -98.62 -22.93 15.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.272 0.558 . . . . 0.0 111.579 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.89 57.41 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.495 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -90.43 168.85 11.54 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.196 0.498 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.699 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 16.6 ptt-85 -176.46 142.72 0.46 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.209 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.556 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -168.01 -174.81 2.47 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.961 0.886 . . . . 0.0 111.498 177.989 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -91.83 -10.62 39.13 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.973 177.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -175.93 6.05 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.566 1.174 . . . . 0.0 112.574 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.556 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 23.3 ttm180 -55.3 144.44 51.4 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 112.497 -2.138 . . . . 0.0 105.912 175.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 19' ' ' GLY . 75.1 Cg_exo -44.63 138.06 8.21 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 110.679 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.446 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -65.45 60.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.058 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 137.38 1.26 2.53 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.827 -178.369 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.556 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.92 61.1 3.14 Favored 'General case' 0 C--N 1.369 1.429 0 CA-C-N 119.901 1.85 . . . . 0.0 110.351 179.897 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -130.56 -168.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.606 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.766 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.2 mtpp -95.67 173.28 7.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 111.496 -2.593 . . . . 0.0 107.106 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.47 -31.84 5.28 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.002 -1.57 . . . . 0.0 109.732 -176.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.845 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.7 m95 -62.21 136.15 57.81 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.458 1.503 . . . . 0.0 111.82 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.8 mp0 -150.79 118.65 6.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.6 ttmt -68.26 125.74 27.36 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.965 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.563 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -126.44 171.2 11.22 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.635 0.731 . . . . 0.0 110.672 -179.535 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.563 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 8.2 t-105 -83.25 151.89 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.476 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.788 179.398 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.541 0.21 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 18.1 p90 -132.75 -177.61 4.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.762 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 1.9 m-85 -132.69 131.38 41.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 120.838 0.351 . . . . 0.0 111.903 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.729 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 36.5 t80 -119.58 126.43 51.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.327 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.771 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.33 110.2 22.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -70.23 -22.61 62.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.692 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.22 -49.57 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -98.54 -21.01 16.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.342 0.592 . . . . 0.0 111.739 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.27 15.18 72.44 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.364 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -96.03 156.26 16.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.054 0.427 . . . . 0.0 110.835 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.729 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -166.14 146.69 6.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.046 0.538 . . . . 0.0 111.648 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -152.11 -175.46 5.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.999 0.904 . . . . 0.0 111.844 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.83 -10.64 47.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.623 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -91.51 -177.51 4.83 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.268 1.032 . . . . 0.0 110.757 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.499 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 12.8 ttm105 -50.04 153.39 2.35 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.154 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 2.6 Cg_endo -40.8 135.79 2.12 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.207 1.938 . . . . 0.0 110.269 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.452 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -67.35 56.2 0.05 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.116 0.96 . . . . 0.0 108.707 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 147.05 -3.59 0.93 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 113.848 -1.523 . . . . 0.0 114.358 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.707 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 50.31 51.39 16.86 Favored 'General case' 0 C--N 1.368 1.375 0 CA-C-N 120.214 2.007 . . . . 0.0 110.724 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -124.6 -169.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.117 1.437 . . . . 0.0 114.744 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.753 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -92.51 167.94 11.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.423 177.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.33 -34.97 4.19 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.706 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.771 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.8 m95 -57.92 138.51 55.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.899 1.279 . . . . 0.0 111.804 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -129.09 124.89 35.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 34.6 ttmt -85.09 114.16 22.03 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -127.13 172.16 10.78 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.908 0.861 . . . . 0.0 111.464 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.534 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 4.1 t-105 -85.21 147.75 26.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.311 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.961 179.518 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.876 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 121.493 0.663 . . . . 0.0 111.274 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 10.9 p90 -179.77 -173.5 0.25 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 -173.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.81 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.83 141.94 40.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 111.558 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.717 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.1 t80 -125.55 130.55 51.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.838 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.01 113.65 27.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -74.52 -22.17 59.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.728 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.56 -49.39 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.12 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 p -99.03 -20.96 16.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.265 0.555 . . . . 0.0 111.904 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.39 16.89 72.69 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 15.7 mmmt -93.45 164.93 13.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.717 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 7.8 ptp180 -172.92 140.54 0.94 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.519 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -162.64 -177.07 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.344 1.068 . . . . 0.0 112.391 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -87.03 -15.46 38.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.204 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.519 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -83.5 -174.7 5.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.358 1.075 . . . . 0.0 111.987 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HD2' HD12 ' A' ' 20' ' ' LEU . 19.4 ttp-105 -52.1 151.21 7.07 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 112.559 -2.11 . . . . 0.0 106.999 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . 40.3 Cg_exo -51.93 138.27 52.04 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 120.824 1.016 . . . . 0.0 109.582 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -64.67 62.07 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 135.36 1.83 3.07 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.815 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' A' ' 16' ' ' ARG . 0.7 OUTLIER 47.11 59.89 3.76 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 119.579 1.689 . . . . 0.0 110.146 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.781 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -126.63 -168.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -177.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.781 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -96.87 172.85 7.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.456 -2.611 . . . . 0.0 107.056 177.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.84 -33.16 4.76 Favored Glycine 0 N--CA 1.481 1.661 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.634 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.838 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -58.66 136.92 57.79 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.518 1.527 . . . . 0.0 111.899 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.4 mp0 -148.02 103.57 3.49 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.605 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.876 ' HG2' ' CZ3' ' A' ' 2' ' ' TRP . 19.6 ttpt -65.11 120.29 12.4 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -116.67 168.0 10.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.426 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.668 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 69.2 t-105 -105.94 42.99 1.17 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.19 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.6 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.5 m95 . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.731 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.3 p90 -174.73 165.95 3.71 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 120.612 0.244 . . . . 0.0 111.283 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.774 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.77 141.44 39.33 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.506 -173.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.706 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.3 t80 -123.69 129.58 51.32 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.591 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.831 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -102.88 110.51 22.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.15 -20.73 63.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.62 -49.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.12 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 p -98.61 -22.28 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.279 0.562 . . . . 0.0 111.788 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.3 13.71 73.16 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.698 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 12.0 mmmt -91.62 166.0 13.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.105 0.452 . . . . 0.0 110.075 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.706 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 4.0 ptp180 -172.57 141.79 1.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.499 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.48 -178.38 5.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.348 1.07 . . . . 0.0 112.095 177.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.82 -17.31 33.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.03 -1.896 . . . . 0.0 109.3 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -79.84 -174.89 4.62 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 122.396 1.093 . . . . 0.0 111.72 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.538 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 29.9 ttm180 -52.84 151.84 7.83 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.266 176.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.726 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.7 Cg_endo -49.02 136.46 29.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.67 1.58 . . . . 0.0 110.217 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -69.4 55.91 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 122.04 0.924 . . . . 0.0 108.566 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 146.46 -4.26 1.08 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.351 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.726 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.46 59.69 4.4 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 119.792 1.796 . . . . 0.0 109.917 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -134.02 -168.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -177.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.759 ' H ' HG12 ' A' ' 21' ' ' VAL . 64.0 mttt -96.89 174.66 6.67 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.429 -2.623 . . . . 0.0 106.884 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.38 -33.22 4.63 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 118.858 -1.639 . . . . 0.0 109.825 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.831 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.5 m95 -60.15 136.74 58.12 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.356 1.462 . . . . 0.0 111.88 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.53 117.29 6.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.683 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.9 ttmt -69.71 124.32 23.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.189 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -124.51 174.4 7.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.581 0.705 . . . . 0.0 110.773 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.44 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 12.7 t-105 -87.86 144.85 26.36 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.066 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.731 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.6 p30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.419 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.1 m95 . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.711 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 2.1 p90 -177.02 170.6 2.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.445 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -108.09 142.59 38.04 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.1 t80 -127.05 127.62 45.01 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.287 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.829 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.4 t-20 -101.67 115.59 30.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -75.79 -22.03 56.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.65 -49.36 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.0 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -99.61 -21.47 15.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.168 0.509 . . . . 0.0 111.92 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.9 70.95 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.2 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 9.6 mmmt -88.56 166.99 13.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 117.208 0.504 . . . . 0.0 109.703 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -168.16 142.14 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -173.71 -176.48 1.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.13 0.967 . . . . 0.0 111.9 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.01 -10.1 31.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.109 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -80.79 -176.6 5.92 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.495 1.14 . . . . 0.0 111.908 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 26.0 ttp-105 -55.93 146.15 49.99 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.928 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.704 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 1.9 Cg_endo -43.26 133.32 6.55 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 122.225 1.95 . . . . 0.0 111.017 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.522 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -66.23 59.51 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.269 1.033 . . . . 0.0 108.284 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 139.22 -2.62 2.62 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 113.528 -1.669 . . . . 0.0 114.2 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.704 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 49.99 58.95 4.9 Favored 'General case' 0 C--N 1.366 1.321 0 CA-C-N 119.939 1.87 . . . . 0.0 109.958 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -129.61 -168.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.775 ' H ' HG12 ' A' ' 21' ' ' VAL . 4.1 mmmt -97.22 175.0 6.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 111.432 -2.622 . . . . 0.0 106.895 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 -33.54 4.4 Favored Glycine 0 N--CA 1.482 1.727 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.84 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.829 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.9 m95 -59.39 136.22 57.9 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.445 1.498 . . . . 0.0 111.867 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.7 114.25 5.27 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.711 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.6 ttmt -67.95 123.45 20.64 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.499 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -123.69 174.19 7.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.672 0.749 . . . . 0.0 111.017 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.433 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 8.9 t-105 -87.08 151.35 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.079 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.909 179.522 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 87.8 m95 . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.508 0.194 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.749 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.8 p90 -169.59 160.97 9.3 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 120.767 0.318 . . . . 0.0 111.175 178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.49 139.03 42.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.856 -173.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.691 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 33.0 t80 -121.76 129.46 52.7 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.295 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.841 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -103.51 100.45 10.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.29 -2.47 4.44 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.2 -52.05 12.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 p -98.07 -23.36 15.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.288 0.566 . . . . 0.0 111.544 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 15.73 59.71 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.651 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 11.6 mmmt -92.31 160.32 15.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.385 0.592 . . . . 0.0 109.918 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.691 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -165.32 143.78 6.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.51 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -163.53 172.39 14.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.986 0.898 . . . . 0.0 112.235 177.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -81.43 -25.77 35.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.93 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -173.39 0.95 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.521 1.153 . . . . 0.0 111.764 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.728 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 12.9 ttp85 -52.95 155.64 4.08 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 112.387 -2.188 . . . . 0.0 107.999 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 11.2 Cg_endo -52.05 138.03 53.32 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.814 1.676 . . . . 0.0 110.479 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -71.53 54.69 0.23 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.063 0.935 . . . . 0.0 108.57 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.45 -3.73 0.89 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.453 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.77 60.82 3.57 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.609 1.705 . . . . 0.0 109.993 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -135.2 -168.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.761 ' H ' HG12 ' A' ' 21' ' ' VAL . 10.0 mttm -97.18 175.13 6.4 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.369 -2.651 . . . . 0.0 106.977 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 -33.85 4.29 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 118.923 -1.608 . . . . 0.0 109.836 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.841 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.0 m95 -58.8 138.97 56.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.289 1.436 . . . . 0.0 111.914 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.2 mt-10 -148.34 120.71 8.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.538 0.209 . . . . 0.0 110.682 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.5 ttmt -76.24 126.72 31.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.807 0.337 . . . . 0.0 110.601 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -129.07 175.07 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.697 0.761 . . . . 0.0 110.706 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.511 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 9.9 t-105 -89.12 143.96 26.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.695 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.749 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.9 p30 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.258 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.913 ' HB2' ' HG2' ' A' ' 26' ' ' LYS 0.261 1.1 p-90 . . . . . 0 CA--C 1.563 1.475 0 CA-C-O 121.219 0.533 . . . . 0.0 111.656 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.878 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER 174.98 -155.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.925 -1.735 . . . . 0.0 112.956 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.571 ' CD1' ' C ' ' A' ' 3' ' ' PHE . 2.3 m-85 -150.69 96.44 2.36 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.74 0.781 . . . . 0.0 110.539 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.702 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 45.1 t80 -98.4 122.23 41.32 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.344 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.805 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.7 t-20 -99.11 106.91 19.17 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -63.7 -18.47 64.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.225 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mm -76.06 -50.1 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.06 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.6 p -97.76 -23.86 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.383 0.611 . . . . 0.0 111.661 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.1 9.92 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.356 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 12.5 mmmt -93.6 160.57 14.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.485 0.642 . . . . 0.0 111.423 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.702 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.59 144.36 7.44 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 123.363 0.665 . . . . 0.0 111.981 -178.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -151.65 173.21 14.94 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.866 0.841 . . . . 0.0 110.648 177.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.664 ' HE1' ' CD1' ' A' ' 28' ' ' TRP . 41.3 m-85 -77.49 -28.79 52.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.72 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -74.14 -177.14 2.83 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.453 1.12 . . . . 0.0 110.691 178.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.617 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 20.5 ttm180 -47.75 157.91 0.56 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 112.457 -2.156 . . . . 0.0 108.907 176.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.688 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 7.6 Cg_endo -47.56 136.67 20.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.335 2.024 . . . . 0.0 110.321 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' CB ' ' HH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -71.84 50.99 0.2 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 159.74 -9.56 0.16 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 114.218 -1.356 . . . . 0.0 114.441 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.688 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 54.29 58.23 5.15 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 119.773 1.786 . . . . 0.0 110.79 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -140.52 -167.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 123.084 1.421 . . . . 0.0 114.812 -178.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.73 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -92.17 173.35 7.87 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.348 177.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 -36.44 3.54 Favored Glycine 0 N--CA 1.482 1.71 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.661 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.805 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 99.0 m95 -58.45 143.12 46.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.2 1.4 . . . . 0.0 112.091 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -136.97 139.12 41.25 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.913 ' HG2' ' HB2' ' A' ' 2' ' ' TRP . 29.9 tttt -92.0 121.58 33.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.297 0.57 . . . . 0.0 111.996 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 21.0 ttp180 179.41 83.95 0.01 OUTLIER 'General case' 0 C--N 1.353 0.741 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.177 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.822 ' HB2' ' O ' ' A' ' 2' ' ' TRP . 1.8 t90 -39.57 -19.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 112.394 -2.185 . . . . 0.0 112.507 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 27' ' ' ARG . 6.4 t70 . . . . . 0 C--N 1.308 -1.239 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.324 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.413 ' CD2' ' HE3' ' A' ' 26' ' ' LYS . 81.1 m95 . . . . . 0 CA--C 1.528 0.13 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.67 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -179.18 166.8 1.54 Allowed 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.707 0.289 . . . . 0.0 111.543 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.64 141.45 39.11 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.467 -173.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.697 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.1 t80 -123.55 130.42 52.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.906 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.838 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.05 111.94 24.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -71.8 -21.08 61.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.64 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.42 -49.84 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 p -98.65 -21.98 16.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 111.821 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.09 72.01 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.535 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HE3' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -93.47 165.98 12.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.958 0.503 . . . . 0.0 109.874 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.697 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 3.8 ptp180 -172.55 142.81 1.28 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.501 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.68 -177.81 5.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.295 1.045 . . . . 0.0 111.979 177.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -87.08 -16.54 35.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.37 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -81.53 -174.36 4.92 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 122.425 1.107 . . . . 0.0 111.773 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.454 ' HD3' HD12 ' A' ' 20' ' ' LEU . 26.5 ttm180 -51.3 150.55 6.05 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.919 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 19' ' ' GLY . 45.6 Cg_exo -51.67 138.69 49.39 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 109.44 -1.023 . . . . 0.0 109.44 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.57 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.71 61.74 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.26 1.028 . . . . 0.0 108.322 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 136.61 1.14 2.79 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.805 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.474 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.9 59.17 4.38 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 119.579 1.689 . . . . 0.0 110.216 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -127.87 -168.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.779 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -96.03 172.48 7.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.135 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.0 -32.89 4.91 Favored Glycine 0 N--CA 1.481 1.673 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.782 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.838 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.7 m95 -60.12 137.04 58.19 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.431 1.492 . . . . 0.0 111.967 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.82 116.64 5.9 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 29.0 tttt -68.84 123.83 22.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -122.96 174.16 7.35 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.53 0.681 . . . . 0.0 110.733 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.442 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 9.1 t-105 -86.56 150.46 24.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.107 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.833 179.625 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 26' ' ' LYS . 81.8 m95 . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.611 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 29.4 p90 174.59 167.36 0.25 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.765 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.5 139.96 40.15 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.472 -175.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.708 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.0 t80 -118.43 129.62 55.5 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.84 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.6 t-20 -102.67 99.29 9.26 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -66.08 -2.15 3.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.19 -52.44 11.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -97.57 -23.6 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.342 0.591 . . . . 0.0 111.496 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.59 15.79 57.8 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.737 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -94.32 159.61 15.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.267 0.533 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.708 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.75 144.25 7.15 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.527 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -160.24 172.68 16.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.05 0.929 . . . . 0.0 112.969 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.3 t80 -80.85 -24.75 38.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.11 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -172.87 2.17 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.421 1.105 . . . . 0.0 111.833 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.666 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 18.5 ttp180 -51.93 157.07 2.22 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 112.42 -2.173 . . . . 0.0 107.948 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.676 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 10.8 Cg_endo -51.9 138.24 51.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.593 1.528 . . . . 0.0 110.267 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -71.36 54.56 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 148.37 -4.08 0.79 Allowed Glycine 0 CA--C 1.537 1.449 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.442 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.676 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.08 59.62 4.4 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 119.661 1.73 . . . . 0.0 109.961 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.76 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -134.94 -168.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.76 ' H ' HG12 ' A' ' 21' ' ' VAL . 35.7 mttp -96.89 174.26 6.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.434 -2.621 . . . . 0.0 107.068 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.03 -31.76 5.2 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.881 -1.628 . . . . 0.0 109.931 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.84 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.9 m95 -61.13 137.05 58.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.313 1.445 . . . . 0.0 111.832 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.6 mp0 -151.55 110.34 3.85 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-O 120.581 0.229 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 1.8 tppt? -58.58 129.12 40.55 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.02 170.83 8.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.0 110.754 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.408 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 7.4 t-105 -107.69 101.97 11.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.592 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.487 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 1.094 ' HB2' ' HB3' ' A' ' 27' ' ' ARG 0.379 0.1 OUTLIER . . . . . 0 CA--C 1.598 2.789 0 CA-C-O 117.461 -1.256 . . . . 0.0 111.324 . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.913 ' N ' ' CB ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -152.25 -171.15 3.85 Favored 'General case' 1 N--CA 1.547 4.424 0 C-N-CA 126.704 2.001 . . . . 0.0 111.839 -174.144 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 6.2 m-85 -64.65 121.38 14.36 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.041 -1.662 . . . . 0.0 111.617 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 28.8 t80 -113.74 121.3 43.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.54 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.653 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.2 t-20 -101.01 85.3 2.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 23.3 ptt180 -46.95 -32.96 4.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.471 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 1.6 mm -65.73 -44.47 93.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.902 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 1.058 HG21 HD22 ' A' ' 20' ' ' LEU . 32.2 p -101.77 -14.12 17.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 111.969 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' ASN . . . 75.88 13.66 82.9 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.686 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' HD13 ' A' ' 20' ' ' LEU . 21.7 mmmt -81.72 165.17 21.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.893 0.347 . . . . 0.0 110.255 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.799 ' HD3' ' CE1' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -161.91 136.24 6.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.334 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -142.04 154.07 44.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.597 ' HD1' ' HB3' ' A' ' 29' ' ' ASP . 45.3 m-85 -80.23 -34.08 37.51 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.025 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 16' ' ' ARG . 3.3 tp10 -89.33 177.01 6.7 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.742 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 11.0 ttm105 -56.56 138.96 75.98 Favored Pre-proline 0 C--N 1.283 -2.292 0 CA-C-N 113.713 -1.585 . . . . 0.0 106.984 176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.548 ' HG3' ' NE1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -12.17 145.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 1 C-N-CA 126.17 4.58 . . . . 0.0 117.969 -177.011 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -77.5 22.23 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.972 177.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.59 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 89.41 37.96 6.85 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.269 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.058 HD22 HG21 ' A' ' 9' ' ' THR . 9.9 mt -154.63 91.8 1.42 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 119.211 -0.995 . . . . 0.0 113.151 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.989 HG13 ' HD1' ' A' ' 24' ' ' TRP . 2.2 t -95.04 -168.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 CA-C-O 121.889 0.852 . . . . 0.0 110.863 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.92 ' H ' HG12 ' A' ' 21' ' ' VAL . 5.2 mttp 55.46 86.54 0.06 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.71 -15.36 4.1 Favored Glycine 0 C--N 1.296 -1.682 0 CA-C-N 111.447 -2.615 . . . . 0.0 112.247 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.989 ' HD1' HG13 ' A' ' 21' ' ' VAL . 39.8 m95 -62.33 141.01 58.51 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.545 1.172 . . . . 0.0 111.886 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.0 mp0 -138.31 102.02 4.53 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 27.2 ttpt -48.68 130.16 17.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 1.094 ' HB3' ' HB2' ' A' ' 2' ' ' TRP 0.301 14.9 mtp180 -120.66 176.66 5.41 Favored 'General case' 1 N--CA 1.362 -4.874 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 166.933 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.594 ' N ' ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -41.56 -35.33 0.71 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -172.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 2' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.111 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.92 ' CH2' ' HG3' ' A' ' 26' ' ' LYS 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 121.399 0.619 . . . . 0.0 110.65 . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.3 p90 -178.37 172.07 1.54 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.21 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.784 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -100.3 143.99 29.84 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 124.098 0.874 . . . . 0.0 112.745 -175.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.735 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 39.7 t80 -127.56 129.77 47.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.372 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.831 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -103.16 102.29 12.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -67.34 -1.99 5.46 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.54 -52.49 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 p -97.68 -23.21 16.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.292 0.568 . . . . 0.0 111.526 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.37 59.83 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.727 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 2.3 mmmm -91.94 164.3 13.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 117.238 0.519 . . . . 0.0 109.632 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.735 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 21.9 ptt-85 -173.0 140.73 0.92 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.505 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -161.4 -177.47 6.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 122.339 1.066 . . . . 0.0 112.191 177.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -86.16 -16.49 37.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.281 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.505 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.27 5.16 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.396 1.093 . . . . 0.0 112.097 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 21.1 ttm105 -51.22 151.76 4.72 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.103 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 19' ' ' GLY . 31.2 Cg_exo -52.82 138.4 60.34 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 CA-C-N 119.842 0.979 . . . . 0.0 109.558 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -65.55 61.45 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 108.2 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 138.71 0.05 2.35 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.923 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 48.49 60.97 3.29 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.61 1.705 . . . . 0.0 110.257 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.769 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -131.09 -168.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.769 ' H ' HG12 ' A' ' 21' ' ' VAL . 14.5 mttp -96.0 175.01 6.64 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.536 -2.575 . . . . 0.0 107.048 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.56 -34.23 4.1 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.71 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.831 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.5 m95 -58.15 133.92 56.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.308 1.443 . . . . 0.0 111.766 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.3 mp0 -156.22 105.7 2.33 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.92 ' HG3' ' CH2' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -72.0 154.42 41.17 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.755 0.788 . . . . 0.0 112.506 -178.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -124.16 151.75 43.63 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.525 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.494 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 55.3 t-105 -100.61 106.08 17.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.429 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 C--O 1.251 1.18 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.758 -179.251 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.512 ' HB3' ' CE ' ' A' ' 26' ' ' LYS . 70.5 m95 . . . . . 0 C--O 1.228 -0.056 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 178.91 174.53 0.68 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.497 0.665 . . . . 0.0 111.817 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.962 ' HB2' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -104.5 163.99 12.06 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.298 -173.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 45.1 t80 -149.33 133.3 17.1 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.451 -1.405 . . . . 0.0 112.175 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.87 ' HB2' ' CE2' ' A' ' 24' ' ' TRP . 22.9 t-20 -105.25 128.27 53.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -82.38 -26.3 32.99 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -83.57 -45.52 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -104.4 -16.77 15.01 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 53.1 37.52 54.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.195 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.529 ' C ' ' HH2' ' A' ' 24' ' ' TRP . 22.7 mmmt -102.68 42.5 1.14 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.76 148.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.884 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.769 ' H ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -155.07 -157.51 0.76 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 123.31 1.529 . . . . 0.0 109.726 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -131.32 0.43 4.1 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.596 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.736 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -87.22 179.14 6.69 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.854 1.312 . . . . 0.0 113.894 -177.423 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.879 ' HG3' HD12 ' A' ' 20' ' ' LEU . 46.6 ttp180 -49.71 -34.75 10.15 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-N 111.953 -2.385 . . . . 0.0 116.947 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.77 ' CD ' ' N ' ' A' ' 16' ' ' ARG . 9.8 Cg_endo -80.59 170.82 15.34 Favored 'Trans proline' 0 CA--C 1.455 -3.453 1 C-N-CA 127.075 5.183 . . . . 0.0 107.636 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 1.127 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 3.3 pttt 65.19 11.26 7.07 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-O 123.079 1.419 . . . . 0.0 108.902 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.435 ' N ' ' C ' ' A' ' 17' ' ' PRO . . . -143.18 -48.76 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.879 HD12 ' HG3' ' A' ' 16' ' ' ARG . 5.2 mt -97.23 36.75 1.41 Allowed 'General case' 0 C--N 1.359 0.98 0 CA-C-O 122.038 0.923 . . . . 0.0 109.309 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.842 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 70.0 t -139.86 165.43 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.002 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.564 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -91.42 152.82 20.23 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.486 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.3 -27.15 7.9 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 1.127 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 95.1 m95 -69.61 144.31 53.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.484 1.514 . . . . 0.0 115.013 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 5' ' ' PHE . 4.8 mp0 -150.72 115.14 5.14 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 69.5 tttt -66.09 127.53 32.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -121.44 170.77 9.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.431 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 11.7 t-105 -89.74 141.5 28.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.97 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.788 179.436 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.403 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 86.7 m95 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 121.04 0.448 . . . . 0.0 112.163 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -163.04 160.45 24.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.809 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.736 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -104.36 131.9 51.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.054 -173.325 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.664 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.6 t80 -114.97 123.27 48.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.251 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.705 ' CG ' HD13 ' A' ' 20' ' ' LEU . 25.4 t-20 -102.16 92.82 4.92 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -53.83 -21.25 7.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.18 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -67.86 -49.42 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.65 HG21 HD21 ' A' ' 20' ' ' LEU . 20.2 p -105.27 -21.39 13.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 112.29 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.38 16.78 56.68 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.221 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 8.3 mmmm -86.82 155.91 20.1 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.383 0.591 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.664 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -161.78 135.68 6.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.578 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.18 179.92 8.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 122.152 0.977 . . . . 0.0 111.851 177.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CE2' ' O ' ' A' ' 2' ' ' TRP . 0.3 OUTLIER -87.26 -16.27 35.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.201 175.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.578 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -94.65 -174.1 3.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.596 1.188 . . . . 0.0 111.822 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 45.9 ttp180 -66.54 155.0 89.94 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.251 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.674 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 25.0 Cg_exo -24.84 145.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 125.086 3.857 . . . . 0.0 115.402 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -87.88 30.68 0.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.55 ' C ' ' HG ' ' A' ' 20' ' ' LEU . . . 114.17 36.7 1.32 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-N 113.842 -1.526 . . . . 0.0 111.5 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.768 ' C ' HG22 ' A' ' 21' ' ' VAL . 2.8 mt -144.06 -161.72 1.33 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 117.964 0.882 . . . . 0.0 110.154 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.768 HG22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -170.35 -43.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 122.023 0.916 . . . . 0.0 113.137 -178.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.571 ' HD3' ' HB ' ' A' ' 21' ' ' VAL . 3.2 mmtm -106.56 139.95 40.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.339 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.21 -24.37 20.97 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.686 ' CE3' ' HB2' ' A' ' 6' ' ' ASN . 80.8 m95 -60.26 140.77 56.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.33 1.052 . . . . 0.0 112.936 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.01 105.14 3.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.751 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 12.2 ttpt -69.15 126.12 28.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.204 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.686 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.89 174.15 9.04 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 110.656 -178.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.525 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 6.6 t-105 -85.42 151.79 23.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.67 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.773 179.437 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.73 ' CE3' ' HG2' ' A' ' 26' ' ' LYS 0.284 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.723 0 CA-C-O 122.48 1.134 . . . . 0.0 110.135 . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.725 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 30.6 p90 -137.2 -179.21 5.58 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.359 -2.201 . . . . 0.0 113.829 -173.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.717 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -102.19 138.19 39.47 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 32.5 t80 -116.88 117.29 29.32 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.589 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.779 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 20.5 t-20 -102.55 89.04 3.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 22.5 ptt180 -45.93 -29.68 1.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.719 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.432 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 1.5 mm -65.84 -45.56 91.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.488 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.633 HG21 ' HA2' ' A' ' 19' ' ' GLY . 30.5 p -101.48 -17.09 16.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 112.044 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.44 13.79 79.8 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.239 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 18' ' ' LYS . 6.1 mmmm -89.3 156.3 18.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 117.192 0.496 . . . . 0.0 109.854 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.641 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -154.51 131.65 11.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.515 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -167.81 173.03 8.64 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.061 0.934 . . . . 0.0 113.154 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.55 -23.47 37.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.099 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -72.34 -176.43 1.85 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.846 1.307 . . . . 0.0 111.985 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 34.0 ttt-85 -62.51 151.44 83.23 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.048 -2.342 . . . . 0.0 109.529 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.556 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 2.0 Cg_endo -40.21 119.06 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 124.276 3.317 . . . . 0.0 117.264 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 15.4 mmtt -98.52 36.73 1.58 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 172.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -164.66 -30.58 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.377 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.65 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.2 mt 81.28 90.86 0.04 OUTLIER 'General case' 0 C--N 1.366 1.293 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.649 ' HA ' ' HD1' ' A' ' 24' ' ' TRP . 14.7 t 44.51 -49.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 119.615 3.191 . . . . 0.0 119.615 173.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.476 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -87.68 123.83 32.92 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.623 -178.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.84 -16.91 25.52 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.266 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.779 ' CZ3' ' HB2' ' A' ' 6' ' ' ASN . 81.2 m95 -69.82 143.7 52.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.01 88.55 1.32 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.833 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.73 ' HG2' ' CE3' ' A' ' 2' ' ' TRP . 52.3 tttt -63.63 127.31 30.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.363 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 2' ' ' TRP . 4.2 ttp180 -115.49 161.52 18.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.072 0.939 . . . . 0.0 111.447 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.681 ' CE3' ' HB2' ' A' ' 2' ' ' TRP . 61.2 t-105 -101.73 116.74 33.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.711 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.278 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.1 m95 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.831 0.348 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.679 ' CE2' ' HD2' ' A' ' 12' ' ' ARG . 1.8 p90 -160.93 -167.17 1.76 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.008 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.877 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 3.1 m-85 -128.09 142.57 51.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.648 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 38.0 t80 -123.69 124.25 42.33 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.795 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 18.3 t-20 -98.43 119.57 37.34 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -76.5 -25.83 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -76.49 -49.81 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.207 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.0 p -100.21 -21.02 15.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.015 0.436 . . . . 0.0 112.053 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.629 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 66.1 30.38 76.8 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.757 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.18 46.42 0.99 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.679 ' HD2' ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -32.3 137.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 17' ' ' PRO . 5.6 mt-30 -135.52 168.31 19.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.459 0.647 . . . . 0.0 110.726 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.43 -7.89 57.15 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.784 174.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.814 ' C ' ' HD3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.89 -164.45 0.8 Allowed 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.661 0.785 . . . . 0.0 110.035 178.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.5 ttm105 -101.38 65.08 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.183 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.814 ' HD3' ' C ' ' A' ' 15' ' ' GLU . 17.7 Cg_endo -88.14 -46.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 125.033 3.822 . . . . 0.0 111.03 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.954 ' HA ' ' CB ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -67.76 -18.12 64.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.018 178.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.0 -34.78 7.45 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 173.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 3.2 mt -67.99 -44.13 77.34 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -138.28 -177.27 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.579 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -90.11 167.37 12.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 111.443 -2.617 . . . . 0.0 109.392 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.11 -31.13 5.82 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.954 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 98.9 m95 -66.21 151.23 47.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.167 1.387 . . . . 0.0 112.599 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 5' ' ' PHE . 2.8 mp0 -153.67 109.94 3.32 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 32.0 ttmt -59.42 132.89 55.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -137.72 163.67 30.75 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.693 0.758 . . . . 0.0 111.17 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -77.5 151.6 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.539 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.663 178.754 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.53 ' HE3' ' HD2' ' A' ' 26' ' ' LYS . 77.3 m95 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.75 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER 178.33 173.32 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 178.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.973 ' CD2' ' HG3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -108.76 164.84 12.02 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.167 -174.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 52.3 t80 -149.53 135.4 18.74 Favored 'General case' 0 C--O 1.22 -0.487 0 O-C-N 121.993 -0.442 . . . . 0.0 111.921 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.814 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 23.1 t-20 -105.44 123.49 47.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -78.86 -23.0 45.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -81.6 -46.87 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.632 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -102.46 -19.59 14.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 61.2 31.79 78.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.125 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 9' ' ' THR . 3.9 mmmm -114.23 61.77 0.67 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.474 ' HA ' ' HZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -37.54 136.89 0.47 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.71 0.804 . . . . 0.0 109.452 177.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.891 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -139.49 92.83 2.61 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.962 0.905 . . . . 0.0 113.078 -175.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.608 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 10.5 t80 -39.26 -25.58 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.797 -0.565 . . . . 0.0 111.086 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.633 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -57.38 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.105 0.955 . . . . 0.0 109.467 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.805 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 24.2 ttm105 -46.54 -60.63 3.48 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.032 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 16' ' ' ARG . 29.5 Cg_endo -65.81 157.2 60.24 Favored 'Trans proline' 0 CA--C 1.479 -2.266 1 C-N-CA 127.559 5.506 . . . . 0.0 109.301 178.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 1.05 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER 99.7 -12.19 0.04 OUTLIER 'General case' 0 N--CA 1.395 -3.206 0 CA-C-N 111.79 -2.459 . . . . 0.0 105.618 -171.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.67 -38.14 0.22 Allowed Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.226 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.758 HD12 ' HG3' ' A' ' 16' ' ' ARG . 4.0 mt -96.97 41.4 1.11 Allowed 'General case' 0 C--N 1.36 1.031 0 CA-C-N 118.212 1.006 . . . . 0.0 111.43 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.941 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 44.3 t -145.84 172.15 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.574 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -81.41 151.88 27.69 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.591 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.83 -29.71 4.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 1.05 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 97.2 m95 -67.64 146.91 53.38 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.624 1.57 . . . . 0.0 114.729 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.6 mp0 -151.29 106.62 3.33 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.1 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -60.61 129.31 40.91 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.29 173.59 7.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.425 0.631 . . . . 0.0 110.592 -179.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.442 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 6.5 t-105 -115.41 124.88 52.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.333 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.898 179.285 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.421 ' O ' ' HD1' ' A' ' 14' ' ' PHE . 77.3 m95 . . . . . 0 CA--C 1.529 0.166 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 34.4 p90 176.52 165.76 0.46 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.64 140.65 39.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.987 -174.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.683 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.5 t80 -120.45 129.69 53.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.849 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.19 112.44 25.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -72.62 -20.69 61.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.543 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.79 -50.0 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.063 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 p -98.61 -22.68 15.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.271 0.557 . . . . 0.0 111.866 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.69 15.12 71.48 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.946 -1.024 . . . . 0.0 113.711 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 9.0 mmmm -95.05 158.1 15.61 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 117.326 0.563 . . . . 0.0 109.832 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.683 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.09 144.61 9.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -165.14 -179.85 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.473 1.13 . . . . 0.0 112.547 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.2 t80 -85.33 -16.95 38.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.283 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.506 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.62 5.37 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.382 1.087 . . . . 0.0 112.16 -179.218 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.589 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 23.4 ttp-105 -51.94 153.75 4.3 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 112.402 -2.181 . . . . 0.0 107.059 175.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.727 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.6 Cg_endo -49.86 136.7 35.74 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.531 1.487 . . . . 0.0 110.491 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.35 55.27 0.15 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 148.71 -5.03 0.8 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-N 113.933 -1.485 . . . . 0.0 114.431 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.727 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.24 59.94 4.17 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-N 119.798 1.799 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.762 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -135.52 -168.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.762 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.3 mttm -97.59 174.61 6.56 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 111.388 -2.642 . . . . 0.0 106.852 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.53 -33.15 4.69 Favored Glycine 0 N--CA 1.481 1.678 0 C-N-CA 118.811 -1.662 . . . . 0.0 109.782 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.849 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -59.23 137.46 57.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.42 1.488 . . . . 0.0 111.998 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -150.35 112.27 4.56 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.502 0.191 . . . . 0.0 110.673 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 68.5 tttt -66.05 128.97 38.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.31 165.64 14.59 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.792 0.806 . . . . 0.0 111.55 -179.388 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -98.05 103.63 15.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.765 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.409 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.4 m95 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.964 0.412 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -162.49 -171.54 2.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.548 178.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 1.8 m-85 -133.54 137.34 45.51 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 122.629 0.372 . . . . 0.0 111.489 -175.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.657 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 32.6 t80 -122.97 125.6 45.59 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.771 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.789 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.3 t-20 -101.3 112.09 24.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.65 -23.35 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.829 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -71.32 -49.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.959 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.2 p -98.58 -20.76 16.84 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.82 17.45 72.67 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.146 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -92.27 159.74 15.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.191 0.496 . . . . 0.0 110.105 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.657 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.34 144.56 4.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -161.08 -174.68 4.48 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.975 0.893 . . . . 0.0 112.027 178.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.71 -8.93 48.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.153 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -91.75 179.04 5.74 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.591 1.186 . . . . 0.0 111.584 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.573 ' HD3' ' CD1' ' A' ' 20' ' ' LEU . 24.4 ttm180 -52.09 145.02 19.31 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.371 175.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.627 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 6.8 Cg_exo -35.49 135.21 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.855 2.37 . . . . 0.0 111.776 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -65.78 58.55 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 141.54 -2.1 1.93 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.219 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.627 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 49.34 52.4 14.52 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 120.187 1.994 . . . . 0.0 110.448 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -122.52 -169.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 123.115 1.436 . . . . 0.0 114.789 -178.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.779 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -92.8 173.69 7.63 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 111.77 -2.468 . . . . 0.0 107.166 177.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.47 -36.34 3.45 Favored Glycine 0 N--CA 1.482 1.715 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.728 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.789 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -56.49 140.61 45.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.97 1.308 . . . . 0.0 111.682 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -142.75 108.77 5.19 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.55 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.4 ttpt -62.62 131.12 47.96 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.55 166.22 24.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.045 0.926 . . . . 0.0 111.615 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -84.64 148.07 26.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.453 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.828 179.478 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 81.0 m95 . . . . . 0 N--CA 1.457 -0.098 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.671 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.7 p90 -175.93 167.48 3.04 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.77 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.39 140.02 40.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.611 -173.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 29.6 t80 -120.8 128.81 53.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.404 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.805 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.28 106.3 17.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.82 -22.4 62.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.084 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -69.64 -49.0 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.761 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -101.0 -19.51 15.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.231 0.538 . . . . 0.0 112.013 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 19.2 62.57 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.7 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.14 178.07 5.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 117.009 0.405 . . . . 0.0 110.078 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.576 ' HD3' ' CE2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -163.1 139.68 7.3 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.638 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -147.29 155.06 41.71 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -86.85 -29.9 21.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.277 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.21 -170.37 2.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.791 0.805 . . . . 0.0 111.689 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.638 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -38.88 124.12 1.21 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 113.332 -1.758 . . . . 0.0 107.763 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.569 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 87.6 Cg_exo -39.02 151.04 0.06 OUTLIER 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 122.847 2.365 . . . . 0.0 113.007 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 59.18 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 133.62 3.41 3.35 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.569 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 46.93 57.25 5.82 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-N 119.688 1.744 . . . . 0.0 109.867 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.803 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -120.49 -168.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.803 ' H ' HG12 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -96.45 172.45 7.93 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 111.5 -2.591 . . . . 0.0 106.99 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.81 -31.29 5.65 Favored Glycine 0 N--CA 1.48 1.608 0 C-N-CA 118.97 -1.586 . . . . 0.0 109.768 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.805 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.6 m95 -62.85 132.83 53.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.084 1.354 . . . . 0.0 111.268 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -147.44 119.4 8.18 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.9 ttpt -70.4 127.21 31.96 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.338 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.5 171.5 11.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.585 0.707 . . . . 0.0 110.729 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.455 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 10.1 t-105 -85.62 144.77 27.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.613 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.707 179.069 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.4 m95 . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -171.72 166.63 6.57 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.744 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -114.97 142.09 47.1 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.218 -174.065 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 32.1 t80 -128.38 129.35 46.09 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.413 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.9 t-20 -101.97 113.35 26.49 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -74.92 -22.79 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -71.7 -49.49 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.028 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.32 -20.99 16.25 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.885 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 19.06 67.72 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.088 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -94.35 161.38 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 117.208 0.504 . . . . 0.0 109.8 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.56 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.17 145.91 10.35 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.501 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -166.56 172.42 10.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.921 0.867 . . . . 0.0 112.076 177.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -84.05 -24.47 30.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.168 176.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -173.66 1.07 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 122.469 1.128 . . . . 0.0 111.335 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.677 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 40.2 ttp180 -52.81 155.24 4.23 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.723 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.677 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 9.2 Cg_endo -50.67 137.36 41.77 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.702 1.602 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.84 56.16 0.13 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.075 0.94 . . . . 0.0 108.599 179.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 144.68 -3.14 1.31 Allowed Glycine 0 CA--C 1.536 1.349 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.356 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.674 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.05 58.36 5.63 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 119.751 1.775 . . . . 0.0 109.789 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -130.97 -168.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.776 ' H ' HG12 ' A' ' 21' ' ' VAL . 8.0 mmmm -96.87 175.41 6.36 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.941 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.28 -33.34 4.34 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 118.85 -1.643 . . . . 0.0 109.805 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.8 m95 -59.34 135.42 57.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.273 1.429 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -148.61 117.05 6.53 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.014 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 20.6 ttpt -82.41 130.03 35.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 28' ' ' TRP . 16.4 ttp180 -129.37 -58.21 1.12 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.639 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 13.8 t-105 167.46 132.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.15 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 16.7 t70 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.68 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.899 ' CZ3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.564 1.495 0 N-CA-C 121.131 3.752 . . . . 0.0 121.131 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.87 ' HA ' ' HA ' ' A' ' 14' ' ' PHE 0.385 0.6 OUTLIER 156.92 -21.76 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.323 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER 2.98 114.36 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.606 2.362 . . . . 0.0 115.394 -175.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.3 t80 -91.74 123.1 34.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.596 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.764 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 16.6 t-20 -98.16 92.38 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -53.63 -23.88 12.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.518 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.86 -48.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.236 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 p -99.52 -18.52 17.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.385 0.612 . . . . 0.0 111.922 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.56 69.77 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 114.856 -1.065 . . . . 0.0 113.038 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 10.2 mmmm -91.15 179.28 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -169.37 152.89 5.03 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.865 -178.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -153.59 126.68 8.43 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.87 ' HA ' ' HA ' ' A' ' 3' ' ' PHE . 2.1 t80 -63.64 -25.12 68.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -176.11 5.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 122.067 0.937 . . . . 0.0 110.169 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.619 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 15.4 ttm180 -50.46 132.07 26.05 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.788 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.729 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.0 Cg_exo -35.82 148.19 0.05 OUTLIER 'Trans proline' 0 CA--C 1.505 -0.964 0 C-N-CA 123.758 2.972 . . . . 0.0 113.986 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.31 53.54 0.14 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 143.34 -0.56 1.3 Allowed Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.167 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.729 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 49.76 52.53 14.42 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.886 1.843 . . . . 0.0 110.654 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.783 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -121.65 -168.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.783 ' H ' HG12 ' A' ' 21' ' ' VAL . 18.7 mttt -92.54 172.97 8.03 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.894 -2.412 . . . . 0.0 107.684 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.33 -32.46 4.42 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.007 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.764 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -65.28 135.45 55.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.136 1.374 . . . . 0.0 112.431 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.502 ' C ' ' HA ' ' A' ' 4' ' ' TYR . 2.5 mp0 -148.32 98.47 2.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.784 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.663 ' N ' ' HA ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -68.48 172.39 6.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.863 1.316 . . . . 0.0 114.442 -176.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.668 ' H ' ' CB ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -126.95 160.79 29.98 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 111.964 -2.38 . . . . 0.0 105.853 177.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.899 ' HA ' ' CZ3' ' A' ' 2' ' ' TRP . 26.7 t-105 -104.22 55.56 0.72 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.702 1.239 . . . . 0.0 108.091 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.645 ' N ' ' HZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-N 111.634 -2.53 . . . . 0.0 112.948 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.489 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 65.2 m95 . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.719 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 176.99 159.81 0.38 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.334 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.727 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -109.08 137.21 47.33 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.221 -173.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 24.4 t80 -116.09 124.9 51.56 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.716 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.9 t-20 -99.35 85.92 3.28 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -51.18 -22.93 2.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.156 -178.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -67.73 -48.33 76.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.587 -178.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.686 HG21 ' CD1' ' A' ' 20' ' ' LEU . 18.3 p -106.05 -20.85 13.29 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.15 56.8 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.573 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.657 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 3.1 mmmt -85.34 160.35 19.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.347 0.574 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.615 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.71 139.11 2.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -175.756 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.554 ' HG3' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.17 -179.63 7.22 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.296 1.046 . . . . 0.0 111.774 177.093 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 20.4 t80 -81.09 -17.1 51.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.775 176.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -93.35 -176.8 4.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 122.921 1.343 . . . . 0.0 112.761 -178.347 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.477 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -70.96 151.79 95.02 Favored Pre-proline 0 N--CA 1.425 -1.695 0 CA-C-N 111.799 -2.455 . . . . 0.0 107.051 176.166 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.751 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 40.6 Cg_exo -20.2 134.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 125.005 3.803 . . . . 0.0 116.58 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -58.17 -19.79 35.86 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.756 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.622 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 145.31 38.21 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 112.659 -2.064 . . . . 0.0 112.053 178.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 9' ' ' THR . 1.6 mt -151.5 54.09 0.84 Allowed 'General case' 0 C--N 1.366 1.311 0 CA-C-N 119.139 1.469 . . . . 0.0 113.975 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.637 HG23 ' CD ' ' A' ' 22' ' ' LYS . 2.8 m -19.89 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 119.654 3.205 . . . . 0.0 119.654 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.637 ' CD ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -109.25 133.65 52.76 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.048 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.13 -19.82 22.24 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CZ3' ' HB2' ' A' ' 6' ' ' ASN . 84.9 m95 -61.39 136.23 57.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -149.45 97.62 2.67 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.462 178.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.719 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 24.1 ttpt -58.53 135.18 57.24 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HD2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -125.49 144.93 50.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.627 0.727 . . . . 0.0 111.67 -178.506 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -72.78 124.85 26.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.216 179.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.073 -179.99 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 86.4 m95 . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 120.416 0.15 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -177.99 168.08 2.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.42 178.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.78 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.55 141.67 37.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.629 -173.745 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.699 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.8 t80 -124.42 128.78 49.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.747 -178.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.845 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.1 t-20 -102.42 99.28 9.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -66.12 -2.79 4.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -86.04 -51.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 p -98.62 -22.93 15.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.272 0.558 . . . . 0.0 111.579 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.89 57.41 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.495 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -90.43 168.85 11.54 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.196 0.498 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.699 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 16.6 ptt-85 -176.46 142.72 0.46 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.556 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -168.01 -174.81 2.47 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.961 0.886 . . . . 0.0 111.498 177.989 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -91.83 -10.62 39.13 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.973 177.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -175.93 6.05 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.566 1.174 . . . . 0.0 112.574 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.556 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 23.3 ttm180 -55.3 144.44 51.4 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 112.497 -2.138 . . . . 0.0 105.912 175.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 19' ' ' GLY . 75.1 Cg_exo -44.63 138.06 8.21 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 110.679 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.446 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -65.45 60.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.058 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 137.38 1.26 2.53 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.827 -178.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.556 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.92 61.1 3.14 Favored 'General case' 0 C--N 1.369 1.429 0 CA-C-N 119.901 1.85 . . . . 0.0 110.351 179.897 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -130.56 -168.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.606 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.766 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.2 mtpp -95.67 173.28 7.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 111.496 -2.593 . . . . 0.0 107.106 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.47 -31.84 5.28 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.002 -1.57 . . . . 0.0 109.732 -176.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.845 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.7 m95 -62.21 136.15 57.81 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.458 1.503 . . . . 0.0 111.82 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.8 mp0 -150.79 118.65 6.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.6 ttmt -68.26 125.74 27.36 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.965 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.563 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -126.44 171.2 11.22 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.635 0.731 . . . . 0.0 110.672 -179.535 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.563 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 8.2 t-105 -83.25 151.89 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.476 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.788 179.398 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.541 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.107 0.479 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -86.57 151.95 23.03 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.991 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 18.1 p90 -132.75 -177.61 4.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.762 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 1.9 m-85 -132.69 131.38 41.22 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 120.838 0.351 . . . . 0.0 111.903 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.729 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 36.5 t80 -119.58 126.43 51.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.327 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.771 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.33 110.2 22.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -70.23 -22.61 62.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.692 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.22 -49.57 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -98.54 -21.01 16.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.342 0.592 . . . . 0.0 111.739 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.27 15.18 72.44 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.364 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -96.03 156.26 16.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.054 0.427 . . . . 0.0 110.835 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.729 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -166.14 146.69 6.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.046 0.538 . . . . 0.0 111.648 -177.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -152.11 -175.46 5.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.999 0.904 . . . . 0.0 111.844 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 1' ' ' ARG . 0.1 OUTLIER -88.83 -10.64 47.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.623 177.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -91.51 -177.51 4.83 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.268 1.032 . . . . 0.0 110.757 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.499 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 12.8 ttm105 -50.04 153.39 2.35 Favored Pre-proline 0 C--N 1.299 -1.605 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.154 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 2.6 Cg_endo -40.8 135.79 2.12 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.207 1.938 . . . . 0.0 110.269 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -67.35 56.2 0.05 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.116 0.96 . . . . 0.0 108.707 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 147.05 -3.59 0.93 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 113.848 -1.523 . . . . 0.0 114.358 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.707 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 50.31 51.39 16.86 Favored 'General case' 0 C--N 1.368 1.375 0 CA-C-N 120.214 2.007 . . . . 0.0 110.724 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -124.6 -169.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.117 1.437 . . . . 0.0 114.744 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.753 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -92.51 167.94 11.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 111.813 -2.449 . . . . 0.0 107.423 177.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.33 -34.97 4.19 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.706 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.771 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.8 m95 -57.92 138.51 55.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.899 1.279 . . . . 0.0 111.804 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -129.09 124.89 35.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.798 0.333 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 34.6 ttmt -85.09 114.16 22.03 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -127.13 172.16 10.78 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.908 0.861 . . . . 0.0 111.464 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.534 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 4.1 t-105 -85.21 147.75 26.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.311 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.961 179.518 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.595 0.712 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.876 ' CZ3' ' HG2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -161.7 158.84 26.54 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.274 -174.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 10.9 p90 -179.77 -173.5 0.25 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.358 -173.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.81 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.83 141.94 40.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 111.558 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.717 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.1 t80 -125.55 130.55 51.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.838 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.01 113.65 27.29 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -74.52 -22.17 59.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.728 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.56 -49.39 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.12 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 p -99.03 -20.96 16.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.265 0.555 . . . . 0.0 111.904 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.39 16.89 72.69 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.283 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 15.7 mmmt -93.45 164.93 13.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.717 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 7.8 ptp180 -172.92 140.54 0.94 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -162.64 -177.07 5.35 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.344 1.068 . . . . 0.0 112.391 177.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -87.03 -15.46 38.59 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.204 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.519 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -83.5 -174.7 5.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.358 1.075 . . . . 0.0 111.987 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HD2' HD12 ' A' ' 20' ' ' LEU . 19.4 ttp-105 -52.1 151.21 7.07 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 112.559 -2.11 . . . . 0.0 106.999 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . 40.3 Cg_exo -51.93 138.27 52.04 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 120.824 1.016 . . . . 0.0 109.582 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -64.67 62.07 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 135.36 1.83 3.07 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 113.518 -1.674 . . . . 0.0 113.815 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' A' ' 16' ' ' ARG . 0.7 OUTLIER 47.11 59.89 3.76 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 119.579 1.689 . . . . 0.0 110.146 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.781 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -126.63 -168.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -177.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.781 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -96.87 172.85 7.61 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 111.456 -2.611 . . . . 0.0 107.056 177.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.84 -33.16 4.76 Favored Glycine 0 N--CA 1.481 1.661 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.634 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.838 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -58.66 136.92 57.79 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.518 1.527 . . . . 0.0 111.899 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.4 mp0 -148.02 103.57 3.49 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.605 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.876 ' HG2' ' CZ3' ' A' ' 2' ' ' TRP . 19.6 ttpt -65.11 120.29 12.4 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -116.67 168.0 10.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.426 -178.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.668 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 69.2 t-105 -105.94 42.99 1.17 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.19 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.6 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.145 0.498 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -108.6 159.49 16.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.561 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.731 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.3 p90 -174.73 165.95 3.71 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 120.612 0.244 . . . . 0.0 111.283 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.774 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.77 141.44 39.33 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.506 -173.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.706 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.3 t80 -123.69 129.58 51.32 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.591 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.831 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -102.88 110.51 22.45 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.15 -20.73 63.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.62 -49.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.12 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 p -98.61 -22.28 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.279 0.562 . . . . 0.0 111.788 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.3 13.71 73.16 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.698 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 12.0 mmmt -91.62 166.0 13.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.105 0.452 . . . . 0.0 110.075 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.706 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 4.0 ptp180 -172.57 141.79 1.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.499 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.48 -178.38 5.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.348 1.07 . . . . 0.0 112.095 177.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.82 -17.31 33.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.03 -1.896 . . . . 0.0 109.3 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -79.84 -174.89 4.62 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 122.396 1.093 . . . . 0.0 111.72 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.538 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 29.9 ttm180 -52.84 151.84 7.83 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.266 176.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.726 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.7 Cg_endo -49.02 136.46 29.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.67 1.58 . . . . 0.0 110.217 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -69.4 55.91 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 122.04 0.924 . . . . 0.0 108.566 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 146.46 -4.26 1.08 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 113.95 -1.477 . . . . 0.0 114.351 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.726 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.46 59.69 4.4 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 119.792 1.796 . . . . 0.0 109.917 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -134.02 -168.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -177.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.759 ' H ' HG12 ' A' ' 21' ' ' VAL . 64.0 mttt -96.89 174.66 6.67 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.429 -2.623 . . . . 0.0 106.884 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.38 -33.22 4.63 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 118.858 -1.639 . . . . 0.0 109.825 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.831 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.5 m95 -60.15 136.74 58.12 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.356 1.462 . . . . 0.0 111.88 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.53 117.29 6.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.683 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.9 ttmt -69.71 124.32 23.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.189 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -124.51 174.4 7.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.581 0.705 . . . . 0.0 110.773 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.44 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 12.7 t-105 -87.86 144.85 26.36 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.066 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.731 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.6 p30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.419 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.969 0.414 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -95.85 156.99 16.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.547 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.711 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 2.1 p90 -177.02 170.6 2.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.445 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -108.09 142.59 38.04 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.1 t80 -127.05 127.62 45.01 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.287 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.829 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.4 t-20 -101.67 115.59 30.87 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -75.79 -22.03 56.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -72.65 -49.36 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.0 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -99.61 -21.47 15.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.168 0.509 . . . . 0.0 111.92 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.9 70.95 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.2 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 9.6 mmmt -88.56 166.99 13.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 117.208 0.504 . . . . 0.0 109.703 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -168.16 142.14 3.35 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -173.71 -176.48 1.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.13 0.967 . . . . 0.0 111.9 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.01 -10.1 31.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.473 -1.694 . . . . 0.0 110.109 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' O ' ' CE2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -80.79 -176.6 5.92 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.495 1.14 . . . . 0.0 111.908 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 26.0 ttp-105 -55.93 146.15 49.99 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.928 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.704 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 1.9 Cg_endo -43.26 133.32 6.55 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 122.225 1.95 . . . . 0.0 111.017 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.522 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -66.23 59.51 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.269 1.033 . . . . 0.0 108.284 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 139.22 -2.62 2.62 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 113.528 -1.669 . . . . 0.0 114.2 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.704 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 49.99 58.95 4.9 Favored 'General case' 0 C--N 1.366 1.321 0 CA-C-N 119.939 1.87 . . . . 0.0 109.958 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -129.61 -168.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.775 ' H ' HG12 ' A' ' 21' ' ' VAL . 4.1 mmmt -97.22 175.0 6.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 111.432 -2.622 . . . . 0.0 106.895 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 -33.54 4.4 Favored Glycine 0 N--CA 1.482 1.727 0 C-N-CA 118.81 -1.662 . . . . 0.0 109.84 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.829 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.9 m95 -59.39 136.22 57.9 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.445 1.498 . . . . 0.0 111.867 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.7 114.25 5.27 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.711 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 25.6 ttmt -67.95 123.45 20.64 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.499 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -123.69 174.19 7.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.672 0.749 . . . . 0.0 111.017 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.433 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 8.9 t-105 -87.08 151.35 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.079 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.909 179.522 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.085 0.469 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -105.44 157.58 17.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.016 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.749 ' CE1' ' HB3' ' A' ' 29' ' ' ASP . 1.8 p90 -169.59 160.97 9.3 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 120.767 0.318 . . . . 0.0 111.175 178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.49 139.03 42.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.856 -173.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.691 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 33.0 t80 -121.76 129.46 52.7 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.295 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.841 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -103.51 100.45 10.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.29 -2.47 4.44 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.2 -52.05 12.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 p -98.07 -23.36 15.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.288 0.566 . . . . 0.0 111.544 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 15.73 59.71 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.651 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 11.6 mmmt -92.31 160.32 15.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.385 0.592 . . . . 0.0 109.918 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.691 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -165.32 143.78 6.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.51 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -163.53 172.39 14.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.986 0.898 . . . . 0.0 112.235 177.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -81.43 -25.77 35.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.93 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -173.39 0.95 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.521 1.153 . . . . 0.0 111.764 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.728 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 12.9 ttp85 -52.95 155.64 4.08 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 112.387 -2.188 . . . . 0.0 107.999 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 11.2 Cg_endo -52.05 138.03 53.32 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.814 1.676 . . . . 0.0 110.479 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -71.53 54.69 0.23 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.063 0.935 . . . . 0.0 108.57 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.45 -3.73 0.89 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.453 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.637 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.77 60.82 3.57 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.609 1.705 . . . . 0.0 109.993 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -135.2 -168.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.761 ' H ' HG12 ' A' ' 21' ' ' VAL . 10.0 mttm -97.18 175.13 6.4 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 111.369 -2.651 . . . . 0.0 106.977 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 -33.85 4.29 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 118.923 -1.608 . . . . 0.0 109.836 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.841 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.0 m95 -58.8 138.97 56.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.289 1.436 . . . . 0.0 111.914 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.2 mt-10 -148.34 120.71 8.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.538 0.209 . . . . 0.0 110.682 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.5 ttmt -76.24 126.72 31.51 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.807 0.337 . . . . 0.0 110.601 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -129.07 175.07 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.697 0.761 . . . . 0.0 110.706 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.511 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 9.9 t-105 -89.12 143.96 26.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.695 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.749 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 2.9 p30 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.258 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.933 ' HG2' ' CG ' ' A' ' 28' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.855 0.836 . . . . 0.0 110.91 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.913 ' HB2' ' HG2' ' A' ' 26' ' ' LYS 0.261 1.1 p-90 -148.21 178.74 8.3 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.656 -175.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.878 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER 174.98 -155.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.925 -1.735 . . . . 0.0 112.956 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.571 ' CD1' ' C ' ' A' ' 3' ' ' PHE . 2.3 m-85 -150.69 96.44 2.36 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.74 0.781 . . . . 0.0 110.539 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.702 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 45.1 t80 -98.4 122.23 41.32 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.344 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.805 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.7 t-20 -99.11 106.91 19.17 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -63.7 -18.47 64.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.225 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mm -76.06 -50.1 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.06 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.6 p -97.76 -23.86 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.383 0.611 . . . . 0.0 111.661 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.1 9.92 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.356 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 12.5 mmmt -93.6 160.57 14.72 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.485 0.642 . . . . 0.0 111.423 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.702 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.59 144.36 7.44 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 123.363 0.665 . . . . 0.0 111.981 -178.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.564 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -151.65 173.21 14.94 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.866 0.841 . . . . 0.0 110.648 177.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.664 ' HE1' ' CD1' ' A' ' 28' ' ' TRP . 41.3 m-85 -77.49 -28.79 52.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.72 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -74.14 -177.14 2.83 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.453 1.12 . . . . 0.0 110.691 178.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.617 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 20.5 ttm180 -47.75 157.91 0.56 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 112.457 -2.156 . . . . 0.0 108.907 176.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.688 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 7.6 Cg_endo -47.56 136.67 20.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.335 2.024 . . . . 0.0 110.321 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' CB ' ' HH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -71.84 50.99 0.2 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 159.74 -9.56 0.16 Allowed Glycine 0 CA--C 1.541 1.717 0 CA-C-N 114.218 -1.356 . . . . 0.0 114.441 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.688 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 54.29 58.23 5.15 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 119.773 1.786 . . . . 0.0 110.79 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -140.52 -167.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 123.084 1.421 . . . . 0.0 114.812 -178.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.73 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -92.17 173.35 7.87 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.829 -2.441 . . . . 0.0 107.348 177.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 -36.44 3.54 Favored Glycine 0 N--CA 1.482 1.71 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.661 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.805 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 99.0 m95 -58.45 143.12 46.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.2 1.4 . . . . 0.0 112.091 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -136.97 139.12 41.25 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.913 ' HG2' ' HB2' ' A' ' 2' ' ' TRP . 29.9 tttt -92.0 121.58 33.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.297 0.57 . . . . 0.0 111.996 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 21.0 ttp180 179.41 83.95 0.01 OUTLIER 'General case' 0 C--N 1.353 0.741 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.177 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.933 ' CG ' ' HG2' ' A' ' 1' ' ' ARG . 1.8 t90 -39.57 -19.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 112.394 -2.185 . . . . 0.0 112.507 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 27' ' ' ARG . 6.4 t70 . . . . . 0 C--N 1.308 -1.239 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.324 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.003 0.43 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.413 ' CD2' ' HE3' ' A' ' 26' ' ' LYS . 81.1 m95 -104.4 159.17 15.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.599 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.67 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -179.18 166.8 1.54 Allowed 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.707 0.289 . . . . 0.0 111.543 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.64 141.45 39.11 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.467 -173.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.697 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.1 t80 -123.55 130.42 52.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.906 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.838 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.05 111.94 24.54 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -71.8 -21.08 61.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.64 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.42 -49.84 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 p -98.65 -21.98 16.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 111.821 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.09 72.01 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.535 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HE3' ' HG3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -93.47 165.98 12.49 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.958 0.503 . . . . 0.0 109.874 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.697 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 3.8 ptp180 -172.55 142.81 1.28 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.501 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.68 -177.81 5.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.295 1.045 . . . . 0.0 111.979 177.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -87.08 -16.54 35.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.37 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -81.53 -174.36 4.92 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 122.425 1.107 . . . . 0.0 111.773 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.454 ' HD3' HD12 ' A' ' 20' ' ' LEU . 26.5 ttm180 -51.3 150.55 6.05 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.919 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 19' ' ' GLY . 45.6 Cg_exo -51.67 138.69 49.39 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 109.44 -1.023 . . . . 0.0 109.44 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.57 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.71 61.74 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.26 1.028 . . . . 0.0 108.322 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 136.61 1.14 2.79 Favored Glycine 0 CA--C 1.538 1.516 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.805 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.474 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.9 59.17 4.38 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 119.579 1.689 . . . . 0.0 110.216 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -127.87 -168.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -177.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.779 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -96.03 172.48 7.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.521 -2.581 . . . . 0.0 107.135 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.0 -32.89 4.91 Favored Glycine 0 N--CA 1.481 1.673 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.782 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.838 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 94.7 m95 -60.12 137.04 58.19 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.431 1.492 . . . . 0.0 111.967 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.7 mp0 -149.82 116.64 5.9 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 29.0 tttt -68.84 123.83 22.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -122.96 174.16 7.35 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.53 0.681 . . . . 0.0 110.733 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.442 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 9.1 t-105 -86.56 150.46 24.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.107 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.833 179.625 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.188 0.518 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 26' ' ' LYS . 81.8 m95 -116.03 160.39 20.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.228 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.611 ' C ' ' HD1' ' A' ' 4' ' ' TYR . 29.4 p90 174.59 167.36 0.25 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.765 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.5 139.96 40.15 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.472 -175.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.708 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.0 t80 -118.43 129.62 55.5 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.84 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.6 t-20 -102.67 99.29 9.26 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -66.08 -2.15 3.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.19 -52.44 11.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -97.57 -23.6 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.342 0.591 . . . . 0.0 111.496 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.59 15.79 57.8 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.737 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -94.32 159.61 15.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 117.267 0.533 . . . . 0.0 110.05 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.708 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -164.75 144.25 7.15 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.527 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -160.24 172.68 16.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.05 0.929 . . . . 0.0 112.969 178.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.3 t80 -80.85 -24.75 38.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.11 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -172.87 2.17 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.421 1.105 . . . . 0.0 111.833 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.666 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 18.5 ttp180 -51.93 157.07 2.22 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 112.42 -2.173 . . . . 0.0 107.948 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.676 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 10.8 Cg_endo -51.9 138.24 51.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.593 1.528 . . . . 0.0 110.267 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -71.36 54.56 0.21 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 148.37 -4.08 0.79 Allowed Glycine 0 CA--C 1.537 1.449 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.442 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.676 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.08 59.62 4.4 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 119.661 1.73 . . . . 0.0 109.961 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.76 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -134.94 -168.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.76 ' H ' HG12 ' A' ' 21' ' ' VAL . 35.7 mttp -96.89 174.26 6.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 111.434 -2.621 . . . . 0.0 107.068 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.03 -31.76 5.2 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.881 -1.628 . . . . 0.0 109.931 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.84 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.9 m95 -61.13 137.05 58.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.313 1.445 . . . . 0.0 111.832 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.6 mp0 -151.55 110.34 3.85 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-O 120.581 0.229 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 1.8 tppt? -58.58 129.12 40.55 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.02 170.83 8.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.0 110.754 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.408 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 7.4 t-105 -107.69 101.97 11.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.592 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.487 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.752 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 15.3 ttm105 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.86 0.362 . . . . 0.0 110.656 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 1.094 ' HB2' ' HB3' ' A' ' 27' ' ' ARG 0.379 0.1 OUTLIER -113.61 179.16 4.04 Favored 'General case' 0 CA--C 1.598 2.789 0 CA-C-O 117.461 -1.256 . . . . 0.0 111.324 -178.343 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.913 ' N ' ' CB ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -152.25 -171.15 3.85 Favored 'General case' 1 N--CA 1.547 4.424 0 C-N-CA 126.704 2.001 . . . . 0.0 111.839 -174.144 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 6.2 m-85 -64.65 121.38 14.36 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.041 -1.662 . . . . 0.0 111.617 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 28.8 t80 -113.74 121.3 43.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.54 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.653 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.2 t-20 -101.01 85.3 2.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 23.3 ptt180 -46.95 -32.96 4.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.471 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 1.6 mm -65.73 -44.47 93.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.902 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 1.058 HG21 HD22 ' A' ' 20' ' ' LEU . 32.2 p -101.77 -14.12 17.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.328 0.585 . . . . 0.0 111.969 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' ASN . . . 75.88 13.66 82.9 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.686 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' HD13 ' A' ' 20' ' ' LEU . 21.7 mmmt -81.72 165.17 21.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.893 0.347 . . . . 0.0 110.255 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.799 ' HD3' ' CE1' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -161.91 136.24 6.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.334 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -142.04 154.07 44.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.597 ' HD1' ' HB3' ' A' ' 29' ' ' ASP . 45.3 m-85 -80.23 -34.08 37.51 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.025 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 16' ' ' ARG . 3.3 tp10 -89.33 177.01 6.7 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.742 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 11.0 ttm105 -56.56 138.96 75.98 Favored Pre-proline 0 C--N 1.283 -2.292 0 CA-C-N 113.713 -1.585 . . . . 0.0 106.984 176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.548 ' HG3' ' NE1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -12.17 145.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 1 C-N-CA 126.17 4.58 . . . . 0.0 117.969 -177.011 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -77.5 22.23 0.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.972 177.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.59 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 89.41 37.96 6.85 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.269 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.058 HD22 HG21 ' A' ' 9' ' ' THR . 9.9 mt -154.63 91.8 1.42 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 119.211 -0.995 . . . . 0.0 113.151 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.989 HG13 ' HD1' ' A' ' 24' ' ' TRP . 2.2 t -95.04 -168.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.208 0 CA-C-O 121.889 0.852 . . . . 0.0 110.863 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.92 ' H ' HG12 ' A' ' 21' ' ' VAL . 5.2 mttp 55.46 86.54 0.06 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.71 -15.36 4.1 Favored Glycine 0 C--N 1.296 -1.682 0 CA-C-N 111.447 -2.615 . . . . 0.0 112.247 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.989 ' HD1' HG13 ' A' ' 21' ' ' VAL . 39.8 m95 -62.33 141.01 58.51 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 118.545 1.172 . . . . 0.0 111.886 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.0 mp0 -138.31 102.02 4.53 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 27.2 ttpt -48.68 130.16 17.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 1.094 ' HB3' ' HB2' ' A' ' 2' ' ' TRP 0.301 14.9 mtp180 -120.66 176.66 5.41 Favored 'General case' 1 N--CA 1.362 -4.874 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 166.933 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.752 ' CE3' ' HA ' ' A' ' 1' ' ' ARG . 0.0 OUTLIER -41.56 -35.33 0.71 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -172.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' A' ' 2' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.111 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.393 0.616 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.92 ' CH2' ' HG3' ' A' ' 26' ' ' LYS 0.256 0.0 OUTLIER -167.88 161.08 12.82 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.65 -174.359 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.3 p90 -178.37 172.07 1.54 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.21 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.784 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -100.3 143.99 29.84 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 124.098 0.874 . . . . 0.0 112.745 -175.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.735 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 39.7 t80 -127.56 129.77 47.91 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.372 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.831 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.5 t-20 -103.16 102.29 12.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -67.34 -1.99 5.46 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.54 -52.49 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 p -97.68 -23.21 16.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.292 0.568 . . . . 0.0 111.526 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.37 59.83 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.727 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 2.3 mmmm -91.94 164.3 13.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 117.238 0.519 . . . . 0.0 109.632 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.735 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 21.9 ptt-85 -173.0 140.73 0.92 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.505 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -161.4 -177.47 6.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 122.339 1.066 . . . . 0.0 112.191 177.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -86.16 -16.49 37.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.084 -1.871 . . . . 0.0 109.281 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.505 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.27 5.16 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.396 1.093 . . . . 0.0 112.097 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 21.1 ttm105 -51.22 151.76 4.72 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.103 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 19' ' ' GLY . 31.2 Cg_exo -52.82 138.4 60.34 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 CA-C-N 119.842 0.979 . . . . 0.0 109.558 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -65.55 61.45 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 108.2 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 138.71 0.05 2.35 Favored Glycine 0 CA--C 1.539 1.577 0 CA-C-N 113.534 -1.666 . . . . 0.0 113.923 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 48.49 60.97 3.29 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.61 1.705 . . . . 0.0 110.257 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.769 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -131.09 -168.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.769 ' H ' HG12 ' A' ' 21' ' ' VAL . 14.5 mttp -96.0 175.01 6.64 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 111.536 -2.575 . . . . 0.0 107.048 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.56 -34.23 4.1 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 118.952 -1.594 . . . . 0.0 109.71 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.831 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.5 m95 -58.15 133.92 56.03 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.308 1.443 . . . . 0.0 111.766 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.3 mp0 -156.22 105.7 2.33 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.92 ' HG3' ' CH2' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -72.0 154.42 41.17 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.755 0.788 . . . . 0.0 112.506 -178.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -124.16 151.75 43.63 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.525 -179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.494 ' CE3' ' CB ' ' A' ' 2' ' ' TRP . 55.3 t-105 -100.61 106.08 17.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.429 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 C--O 1.251 1.18 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.758 -179.251 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.064 0.459 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.512 ' HB3' ' CE ' ' A' ' 26' ' ' LYS . 70.5 m95 -116.99 158.86 23.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.725 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 178.91 174.53 0.68 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.497 0.665 . . . . 0.0 111.817 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.962 ' HB2' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -104.5 163.99 12.06 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.298 -173.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 45.1 t80 -149.33 133.3 17.1 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.451 -1.405 . . . . 0.0 112.175 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.87 ' HB2' ' CE2' ' A' ' 24' ' ' TRP . 22.9 t-20 -105.25 128.27 53.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -82.38 -26.3 32.99 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -83.57 -45.52 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -104.4 -16.77 15.01 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.589 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 53.1 37.52 54.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.195 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.529 ' C ' ' HH2' ' A' ' 24' ' ' TRP . 22.7 mmmt -102.68 42.5 1.14 Allowed 'General case' 0 C--N 1.357 0.909 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.76 148.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.884 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.769 ' H ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -155.07 -157.51 0.76 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 123.31 1.529 . . . . 0.0 109.726 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -131.32 0.43 4.1 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.596 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.736 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -87.22 179.14 6.69 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.854 1.312 . . . . 0.0 113.894 -177.423 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.879 ' HG3' HD12 ' A' ' 20' ' ' LEU . 46.6 ttp180 -49.71 -34.75 10.15 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-N 111.953 -2.385 . . . . 0.0 116.947 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.77 ' CD ' ' N ' ' A' ' 16' ' ' ARG . 9.8 Cg_endo -80.59 170.82 15.34 Favored 'Trans proline' 0 CA--C 1.455 -3.453 1 C-N-CA 127.075 5.183 . . . . 0.0 107.636 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 1.127 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 3.3 pttt 65.19 11.26 7.07 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-O 123.079 1.419 . . . . 0.0 108.902 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.435 ' N ' ' C ' ' A' ' 17' ' ' PRO . . . -143.18 -48.76 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.503 -3.039 . . . . 0.0 105.503 177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.879 HD12 ' HG3' ' A' ' 16' ' ' ARG . 5.2 mt -97.23 36.75 1.41 Allowed 'General case' 0 C--N 1.359 0.98 0 CA-C-O 122.038 0.923 . . . . 0.0 109.309 174.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.842 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 70.0 t -139.86 165.43 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.002 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.564 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -91.42 152.82 20.23 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.486 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.3 -27.15 7.9 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 1.127 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 95.1 m95 -69.61 144.31 53.03 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.484 1.514 . . . . 0.0 115.013 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 5' ' ' PHE . 4.8 mp0 -150.72 115.14 5.14 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.73 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 69.5 tttt -66.09 127.53 32.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -121.44 170.77 9.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.431 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 11.7 t-105 -89.74 141.5 28.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.97 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.788 179.436 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.563 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 17.6 mtm180 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.044 0.45 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.403 ' O ' ' CE2' ' A' ' 14' ' ' PHE . 86.7 m95 -103.94 151.77 22.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.163 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -163.04 160.45 24.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.809 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.736 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -104.36 131.9 51.2 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.054 -173.325 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.664 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 29.6 t80 -114.97 123.27 48.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.251 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.705 ' CG ' HD13 ' A' ' 20' ' ' LEU . 25.4 t-20 -102.16 92.82 4.92 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -53.83 -21.25 7.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.18 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -67.86 -49.42 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.65 HG21 HD21 ' A' ' 20' ' ' LEU . 20.2 p -105.27 -21.39 13.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 112.29 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.38 16.78 56.68 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.221 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 8.3 mmmm -86.82 155.91 20.1 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.383 0.591 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.664 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -161.78 135.68 6.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.578 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.18 179.92 8.5 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 122.152 0.977 . . . . 0.0 111.851 177.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 1' ' ' ARG . 0.3 OUTLIER -87.26 -16.27 35.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.201 175.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.578 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -94.65 -174.1 3.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.596 1.188 . . . . 0.0 111.822 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 45.9 ttp180 -66.54 155.0 89.94 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.251 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.674 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 25.0 Cg_exo -24.84 145.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 125.086 3.857 . . . . 0.0 115.402 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -87.88 30.68 0.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.55 ' C ' ' HG ' ' A' ' 20' ' ' LEU . . . 114.17 36.7 1.32 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-N 113.842 -1.526 . . . . 0.0 111.5 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.768 ' C ' HG22 ' A' ' 21' ' ' VAL . 2.8 mt -144.06 -161.72 1.33 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 117.964 0.882 . . . . 0.0 110.154 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.768 HG22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -170.35 -43.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 122.023 0.916 . . . . 0.0 113.137 -178.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.571 ' HD3' ' HB ' ' A' ' 21' ' ' VAL . 3.2 mmtm -106.56 139.95 40.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.992 -1.458 . . . . 0.0 107.339 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.21 -24.37 20.97 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.686 ' CE3' ' HB2' ' A' ' 6' ' ' ASN . 80.8 m95 -60.26 140.77 56.87 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.33 1.052 . . . . 0.0 112.936 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.01 105.14 3.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.751 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 12.2 ttpt -69.15 126.12 28.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.204 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.686 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.89 174.15 9.04 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 110.656 -178.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.525 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 6.6 t-105 -85.42 151.79 23.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.67 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.773 179.437 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.414 ' HD2' ' H ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.465 0.65 . . . . 0.0 111.198 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.73 ' CE3' ' HG2' ' A' ' 26' ' ' LYS 0.284 0.0 OUTLIER -168.83 124.85 0.94 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.135 -173.766 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.725 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 30.6 p90 -137.2 -179.21 5.58 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.359 -2.201 . . . . 0.0 113.829 -173.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.717 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -102.19 138.19 39.47 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 32.5 t80 -116.88 117.29 29.32 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.589 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.779 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 20.5 t-20 -102.55 89.04 3.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 22.5 ptt180 -45.93 -29.68 1.5 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.719 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.432 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 1.5 mm -65.84 -45.56 91.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.488 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.633 HG21 ' HA2' ' A' ' 19' ' ' GLY . 30.5 p -101.48 -17.09 16.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 112.044 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.44 13.79 79.8 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.239 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 18' ' ' LYS . 6.1 mmmm -89.3 156.3 18.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 117.192 0.496 . . . . 0.0 109.854 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.641 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -154.51 131.65 11.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.515 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -167.81 173.03 8.64 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.061 0.934 . . . . 0.0 113.154 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.55 -23.47 37.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.528 -1.669 . . . . 0.0 108.099 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -72.34 -176.43 1.85 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.846 1.307 . . . . 0.0 111.985 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 34.0 ttt-85 -62.51 151.44 83.23 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 112.048 -2.342 . . . . 0.0 109.529 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.556 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 2.0 Cg_endo -40.21 119.06 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 124.276 3.317 . . . . 0.0 117.264 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 15.4 mmtt -98.52 36.73 1.58 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 172.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . -164.66 -30.58 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.377 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.65 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.2 mt 81.28 90.86 0.04 OUTLIER 'General case' 0 C--N 1.366 1.293 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.649 ' HA ' ' HD1' ' A' ' 24' ' ' TRP . 14.7 t 44.51 -49.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 119.615 3.191 . . . . 0.0 119.615 173.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.476 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -87.68 123.83 32.92 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.623 -178.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.84 -16.91 25.52 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.266 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.779 ' CZ3' ' HB2' ' A' ' 6' ' ' ASN . 81.2 m95 -69.82 143.7 52.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.01 88.55 1.32 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.833 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.73 ' HG2' ' CE3' ' A' ' 2' ' ' TRP . 52.3 tttt -63.63 127.31 30.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.363 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 2' ' ' TRP . 4.2 ttp180 -115.49 161.52 18.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.072 0.939 . . . . 0.0 111.447 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.681 ' CE3' ' HB2' ' A' ' 2' ' ' TRP . 61.2 t-105 -101.73 116.74 33.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.711 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.441 -0.79 . . . . 0.0 111.278 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.934 0.397 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -51.55 155.32 1.59 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.718 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.679 ' CE2' ' HD2' ' A' ' 12' ' ' ARG . 1.8 p90 -160.93 -167.17 1.76 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.008 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.877 ' HB3' ' CB ' ' A' ' 18' ' ' LYS . 3.1 m-85 -128.09 142.57 51.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.648 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 38.0 t80 -123.69 124.25 42.33 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.795 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 18.3 t-20 -98.43 119.57 37.34 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -76.5 -25.83 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -76.49 -49.81 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.207 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.0 p -100.21 -21.02 15.66 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.015 0.436 . . . . 0.0 112.053 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.629 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 66.1 30.38 76.8 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.757 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.18 46.42 0.99 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.679 ' HD2' ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -32.3 137.97 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 17' ' ' PRO . 5.6 mt-30 -135.52 168.31 19.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.459 0.647 . . . . 0.0 110.726 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.43 -7.89 57.15 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.784 174.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.814 ' C ' ' HD3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.89 -164.45 0.8 Allowed 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.661 0.785 . . . . 0.0 110.035 178.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.5 ttm105 -101.38 65.08 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.183 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.814 ' HD3' ' C ' ' A' ' 15' ' ' GLU . 17.7 Cg_endo -88.14 -46.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 125.033 3.822 . . . . 0.0 111.03 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.954 ' HA ' ' CB ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -67.76 -18.12 64.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.018 178.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.0 -34.78 7.45 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 173.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 3.2 mt -67.99 -44.13 77.34 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -138.28 -177.27 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.579 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -90.11 167.37 12.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 111.443 -2.617 . . . . 0.0 109.392 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.11 -31.13 5.82 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.954 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 98.9 m95 -66.21 151.23 47.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.167 1.387 . . . . 0.0 112.599 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 5' ' ' PHE . 2.8 mp0 -153.67 109.94 3.32 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 32.0 ttmt -59.42 132.89 55.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -137.72 163.67 30.75 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.693 0.758 . . . . 0.0 111.17 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.4 t-105 -77.5 151.6 34.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.539 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.663 178.754 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.241 0.543 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.53 ' HE3' ' HD2' ' A' ' 26' ' ' LYS . 77.3 m95 -114.5 155.96 25.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.533 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.75 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER 178.33 173.32 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 178.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.973 ' CD2' ' HG3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -108.76 164.84 12.02 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.167 -174.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.793 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 52.3 t80 -149.53 135.4 18.74 Favored 'General case' 0 C--O 1.22 -0.487 0 O-C-N 121.993 -0.442 . . . . 0.0 111.921 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.814 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 23.1 t-20 -105.44 123.49 47.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -78.86 -23.0 45.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -81.6 -46.87 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.632 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 27.2 p -102.46 -19.59 14.85 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 61.2 31.79 78.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.125 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 9' ' ' THR . 3.9 mmmm -114.23 61.77 0.67 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.474 ' HA ' ' HZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -37.54 136.89 0.47 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.71 0.804 . . . . 0.0 109.452 177.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.891 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -139.49 92.83 2.61 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.962 0.905 . . . . 0.0 113.078 -175.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.608 ' N ' ' HE2' ' A' ' 18' ' ' LYS . 10.5 t80 -39.26 -25.58 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.797 -0.565 . . . . 0.0 111.086 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.633 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -57.38 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.105 0.955 . . . . 0.0 109.467 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.805 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 24.2 ttm105 -46.54 -60.63 3.48 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.032 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 16' ' ' ARG . 29.5 Cg_endo -65.81 157.2 60.24 Favored 'Trans proline' 0 CA--C 1.479 -2.266 1 C-N-CA 127.559 5.506 . . . . 0.0 109.301 178.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 1.05 ' HA ' ' CD2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER 99.7 -12.19 0.04 OUTLIER 'General case' 0 N--CA 1.395 -3.206 0 CA-C-N 111.79 -2.459 . . . . 0.0 105.618 -171.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.67 -38.14 0.22 Allowed Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.226 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.758 HD12 ' HG3' ' A' ' 16' ' ' ARG . 4.0 mt -96.97 41.4 1.11 Allowed 'General case' 0 C--N 1.36 1.031 0 CA-C-N 118.212 1.006 . . . . 0.0 111.43 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.941 ' HB ' ' CD1' ' A' ' 24' ' ' TRP . 44.3 t -145.84 172.15 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.574 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -81.41 151.88 27.69 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.591 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.83 -29.71 4.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 1.05 ' CD2' ' HA ' ' A' ' 18' ' ' LYS . 97.2 m95 -67.64 146.91 53.38 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.624 1.57 . . . . 0.0 114.729 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 5' ' ' PHE . 3.6 mp0 -151.29 106.62 3.33 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.1 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -60.61 129.31 40.91 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.29 173.59 7.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.425 0.631 . . . . 0.0 110.592 -179.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.442 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 6.5 t-105 -115.41 124.88 52.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.333 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.898 179.285 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.064 0.459 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.421 ' O ' ' HD1' ' A' ' 14' ' ' PHE . 77.3 m95 -117.6 160.23 21.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.081 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 34.4 p90 176.52 165.76 0.46 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.763 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.64 140.65 39.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.987 -174.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.683 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 30.5 t80 -120.45 129.69 53.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.849 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.8 t-20 -103.19 112.44 25.3 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -72.62 -20.69 61.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.543 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -73.79 -50.0 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.063 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 p -98.61 -22.68 15.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.271 0.557 . . . . 0.0 111.866 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.69 15.12 71.48 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.946 -1.024 . . . . 0.0 113.711 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 9.0 mmmm -95.05 158.1 15.61 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 117.326 0.563 . . . . 0.0 109.832 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.683 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.09 144.61 9.82 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HB2' ' H ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -165.14 -179.85 5.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.473 1.13 . . . . 0.0 112.547 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 7.2 t80 -85.33 -16.95 38.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.874 -1.967 . . . . 0.0 109.283 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.506 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -82.87 -174.62 5.37 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 122.382 1.087 . . . . 0.0 112.16 -179.218 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.589 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 23.4 ttp-105 -51.94 153.75 4.3 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 112.402 -2.181 . . . . 0.0 107.059 175.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.727 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.6 Cg_endo -49.86 136.7 35.74 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.531 1.487 . . . . 0.0 110.491 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.35 55.27 0.15 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 148.71 -5.03 0.8 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-N 113.933 -1.485 . . . . 0.0 114.431 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.727 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 52.24 59.94 4.17 Favored 'General case' 0 C--N 1.364 1.197 0 CA-C-N 119.798 1.799 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.762 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -135.52 -168.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -177.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.762 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.3 mttm -97.59 174.61 6.56 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 111.388 -2.642 . . . . 0.0 106.852 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.53 -33.15 4.69 Favored Glycine 0 N--CA 1.481 1.678 0 C-N-CA 118.811 -1.662 . . . . 0.0 109.782 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.849 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.5 m95 -59.23 137.46 57.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.42 1.488 . . . . 0.0 111.998 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -150.35 112.27 4.56 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.502 0.191 . . . . 0.0 110.673 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 4' ' ' TYR . 68.5 tttt -66.05 128.97 38.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -120.31 165.64 14.59 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.792 0.806 . . . . 0.0 111.55 -179.388 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -98.05 103.63 15.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.765 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.409 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.518 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 8.9 mtt180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.145 0.498 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -112.11 153.74 26.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.956 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -162.49 -171.54 2.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.548 178.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 1.8 m-85 -133.54 137.34 45.51 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 122.629 0.372 . . . . 0.0 111.489 -175.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.657 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 32.6 t80 -122.97 125.6 45.59 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.771 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.789 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.3 t-20 -101.3 112.09 24.5 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.65 -23.35 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.829 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -71.32 -49.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.959 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.2 p -98.58 -20.76 16.84 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.266 0.555 . . . . 0.0 111.776 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.82 17.45 72.67 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.146 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -92.27 159.74 15.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.191 0.496 . . . . 0.0 110.105 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.657 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.34 144.56 4.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -161.08 -174.68 4.48 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.975 0.893 . . . . 0.0 112.027 178.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 1' ' ' ARG . 0.7 OUTLIER -90.71 -8.93 48.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.153 177.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -91.75 179.04 5.74 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.591 1.186 . . . . 0.0 111.584 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.573 ' HD3' ' CD1' ' A' ' 20' ' ' LEU . 24.4 ttm180 -52.09 145.02 19.31 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.371 175.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.627 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 6.8 Cg_exo -35.49 135.21 0.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.855 2.37 . . . . 0.0 111.776 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HB2' ' HH2' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -65.78 58.55 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 141.54 -2.1 1.93 Allowed Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.219 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.627 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 49.34 52.4 14.52 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-N 120.187 1.994 . . . . 0.0 110.448 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.779 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -122.52 -169.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 123.115 1.436 . . . . 0.0 114.789 -178.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.779 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -92.8 173.69 7.63 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 111.77 -2.468 . . . . 0.0 107.166 177.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.47 -36.34 3.45 Favored Glycine 0 N--CA 1.482 1.715 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.728 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.789 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -56.49 140.61 45.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.97 1.308 . . . . 0.0 111.682 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -142.75 108.77 5.19 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.55 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.4 ttpt -62.62 131.12 47.96 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.55 166.22 24.03 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.045 0.926 . . . . 0.0 111.615 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -84.64 148.07 26.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.453 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.828 179.478 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' A' ' 29' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.178 0.513 . . . . 0.0 111.18 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.467 ' N ' ' HD2' ' A' ' 1' ' ' ARG . 81.0 m95 -113.45 156.33 23.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.063 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.671 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.7 p90 -175.93 167.48 3.04 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.77 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -107.39 140.02 40.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.611 -173.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 29.6 t80 -120.8 128.81 53.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.404 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.805 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 15.2 t-20 -100.28 106.3 17.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -70.82 -22.4 62.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.084 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -69.64 -49.0 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.761 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -101.0 -19.51 15.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.231 0.538 . . . . 0.0 112.013 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 19.2 62.57 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.7 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.14 178.07 5.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 117.009 0.405 . . . . 0.0 110.078 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.576 ' HD3' ' CE2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -163.1 139.68 7.3 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.638 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -147.29 155.06 41.71 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -86.85 -29.9 21.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.277 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.21 -170.37 2.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.791 0.805 . . . . 0.0 111.689 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.638 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -38.88 124.12 1.21 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 113.332 -1.758 . . . . 0.0 107.763 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.569 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 87.6 Cg_exo -39.02 151.04 0.06 OUTLIER 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 122.847 2.365 . . . . 0.0 113.007 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 59.18 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 133.62 3.41 3.35 Favored Glycine 0 CA--C 1.538 1.48 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.569 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER 46.93 57.25 5.82 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-N 119.688 1.744 . . . . 0.0 109.867 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.803 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -120.49 -168.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.803 ' H ' HG12 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -96.45 172.45 7.93 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 111.5 -2.591 . . . . 0.0 106.99 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.81 -31.29 5.65 Favored Glycine 0 N--CA 1.48 1.608 0 C-N-CA 118.97 -1.586 . . . . 0.0 109.768 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.805 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 92.6 m95 -62.85 132.83 53.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.084 1.354 . . . . 0.0 111.268 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -147.44 119.4 8.18 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 19.9 ttpt -70.4 127.21 31.96 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.338 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -126.5 171.5 11.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.585 0.707 . . . . 0.0 110.729 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.455 ' H ' ' CD ' ' A' ' 27' ' ' ARG . 10.1 t-105 -85.62 144.77 27.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.613 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 1' ' ' ARG . 6.0 t70 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.707 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.964 0.411 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -98.82 160.92 13.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.397 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -171.72 166.63 6.57 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.744 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -114.97 142.09 47.1 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.218 -174.065 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 32.1 t80 -128.38 129.35 46.09 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.413 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.9 t-20 -101.97 113.35 26.49 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -74.92 -22.79 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -71.7 -49.49 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.028 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.32 -20.99 16.25 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.885 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 19.06 67.72 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.088 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HE2' ' HG3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -94.35 161.38 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 117.208 0.504 . . . . 0.0 109.8 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.56 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -163.17 145.91 10.35 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.501 ' CD ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -166.56 172.42 10.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.921 0.867 . . . . 0.0 112.076 177.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -84.05 -24.47 30.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.168 176.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -173.66 1.07 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 122.469 1.128 . . . . 0.0 111.335 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.677 ' HG3' ' HD2' ' A' ' 17' ' ' PRO . 40.2 ttp180 -52.81 155.24 4.23 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.723 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.677 ' HD2' ' HG3' ' A' ' 16' ' ' ARG . 9.2 Cg_endo -50.67 137.36 41.77 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.702 1.602 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' HG3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.84 56.16 0.13 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.075 0.94 . . . . 0.0 108.599 179.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 144.68 -3.14 1.31 Allowed Glycine 0 CA--C 1.536 1.349 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.356 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.674 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 51.05 58.36 5.63 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 119.751 1.775 . . . . 0.0 109.789 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -130.97 -168.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.776 ' H ' HG12 ' A' ' 21' ' ' VAL . 8.0 mmmm -96.87 175.41 6.36 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.941 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.28 -33.34 4.34 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 118.85 -1.643 . . . . 0.0 109.805 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 93.8 m95 -59.34 135.42 57.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.273 1.429 . . . . 0.0 111.4 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.5 mp0 -148.61 117.05 6.53 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.014 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 20.6 ttpt -82.41 130.03 35.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.639 ' O ' ' HB2' ' A' ' 28' ' ' TRP . 16.4 ttp180 -129.37 -58.21 1.12 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.639 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 13.8 t-105 167.46 132.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.15 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 16.7 t70 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.68 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.792 ' C ' ' HG3' ' A' ' 26' ' ' LYS . 24.8 ttm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.758 0.789 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.899 ' CZ3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -128.42 128.41 44.39 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 121.131 3.752 . . . . 0.0 121.131 -173.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.87 ' HA ' ' HA ' ' A' ' 14' ' ' PHE 0.385 0.6 OUTLIER 156.92 -21.76 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -178.323 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER 2.98 114.36 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 127.606 2.362 . . . . 0.0 115.394 -175.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 34.3 t80 -91.74 123.1 34.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.596 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.764 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 16.6 t-20 -98.16 92.38 5.71 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -53.63 -23.88 12.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.518 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.86 -48.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.236 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 p -99.52 -18.52 17.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.385 0.612 . . . . 0.0 111.922 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.4 12.56 69.77 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 114.856 -1.065 . . . . 0.0 113.038 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 11' ' ' LYS . 10.2 mmmm -91.15 179.28 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -169.37 152.89 5.03 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.865 -178.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -153.59 126.68 8.43 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.87 ' HA ' ' HA ' ' A' ' 3' ' ' PHE . 2.1 t80 -63.64 -25.12 68.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 -176.11 5.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 122.067 0.937 . . . . 0.0 110.169 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.619 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 15.4 ttm180 -50.46 132.07 26.05 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.788 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.729 ' HG2' ' HA ' ' A' ' 20' ' ' LEU . 9.0 Cg_exo -35.82 148.19 0.05 OUTLIER 'Trans proline' 0 CA--C 1.505 -0.964 0 C-N-CA 123.758 2.972 . . . . 0.0 113.986 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.31 53.54 0.14 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' PRO . . . 143.34 -0.56 1.3 Allowed Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.167 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.729 ' HA ' ' HG2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 49.76 52.53 14.42 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.886 1.843 . . . . 0.0 110.654 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.783 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -121.65 -168.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.783 ' H ' HG12 ' A' ' 21' ' ' VAL . 18.7 mttt -92.54 172.97 8.03 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 111.894 -2.412 . . . . 0.0 107.684 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.33 -32.46 4.42 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.007 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.764 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 96.0 m95 -65.28 135.45 55.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.136 1.374 . . . . 0.0 112.431 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.502 ' C ' ' HA ' ' A' ' 4' ' ' TYR . 2.5 mp0 -148.32 98.47 2.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.784 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.792 ' HG3' ' C ' ' A' ' 1' ' ' ARG . 0.0 OUTLIER -68.48 172.39 6.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.863 1.316 . . . . 0.0 114.442 -176.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.668 ' H ' ' CB ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -126.95 160.79 29.98 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 111.964 -2.38 . . . . 0.0 105.853 177.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.899 ' HA ' ' CZ3' ' A' ' 2' ' ' TRP . 26.7 t-105 -104.22 55.56 0.72 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.702 1.239 . . . . 0.0 108.091 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.645 ' N ' ' HZ3' ' A' ' 2' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-N 111.634 -2.53 . . . . 0.0 112.948 179.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.278 0.561 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.489 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 65.2 m95 -118.58 161.63 19.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.533 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.719 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER 176.99 159.81 0.38 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.334 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.727 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -109.08 137.21 47.33 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.221 -173.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 24' ' ' TRP . 24.4 t80 -116.09 124.9 51.56 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.716 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.819 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 16.9 t-20 -99.35 85.92 3.28 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -51.18 -22.93 2.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.156 -178.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mm -67.73 -48.33 76.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.587 -178.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.686 HG21 ' CD1' ' A' ' 20' ' ' LEU . 18.3 p -106.05 -20.85 13.29 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.15 56.8 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.573 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.657 ' HG3' ' HD3' ' A' ' 18' ' ' LYS . 3.1 mmmt -85.34 160.35 19.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.347 0.574 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.615 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -167.71 139.11 2.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -175.756 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.554 ' HG3' ' C ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.17 -179.63 7.22 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.296 1.046 . . . . 0.0 111.774 177.093 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 2' ' ' TRP . 20.4 t80 -81.09 -17.1 51.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.179 -1.828 . . . . 0.0 108.775 176.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -93.35 -176.8 4.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 122.921 1.343 . . . . 0.0 112.761 -178.347 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.477 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -70.96 151.79 95.02 Favored Pre-proline 0 N--CA 1.425 -1.695 0 CA-C-N 111.799 -2.455 . . . . 0.0 107.051 176.166 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.751 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 40.6 Cg_exo -20.2 134.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 125.005 3.803 . . . . 0.0 116.58 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -58.17 -19.79 35.86 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.756 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.622 ' O ' ' HG ' ' A' ' 20' ' ' LEU . . . 145.31 38.21 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 112.659 -2.064 . . . . 0.0 112.053 178.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 9' ' ' THR . 1.6 mt -151.5 54.09 0.84 Allowed 'General case' 0 C--N 1.366 1.311 0 CA-C-N 119.139 1.469 . . . . 0.0 113.975 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG23 ' CD ' ' A' ' 22' ' ' LYS . 2.8 m -19.89 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 119.654 3.205 . . . . 0.0 119.654 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.637 ' CD ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -109.25 133.65 52.76 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.048 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.13 -19.82 22.24 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -177.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.819 ' CZ3' ' HB2' ' A' ' 6' ' ' ASN . 84.9 m95 -61.39 136.23 57.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -149.45 97.62 2.67 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.462 178.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.719 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 24.1 ttpt -58.53 135.18 57.24 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HD2' ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -125.49 144.93 50.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.627 0.727 . . . . 0.0 111.67 -178.506 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -72.78 124.85 26.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.216 179.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.073 -179.99 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.051 0.453 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -100.52 157.84 16.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.774 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 p90 -177.99 168.08 2.03 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.42 178.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.78 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -106.55 141.67 37.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.629 -173.745 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.699 ' HD1' ' HB3' ' A' ' 12' ' ' ARG . 31.8 t80 -124.42 128.78 49.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.747 -178.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.845 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 14.1 t-20 -102.42 99.28 9.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -66.12 -2.79 4.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mm -86.04 -51.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 p -98.62 -22.93 15.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.272 0.558 . . . . 0.0 111.579 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.89 57.41 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.495 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -90.43 168.85 11.54 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 117.196 0.498 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.699 ' HB3' ' HD1' ' A' ' 5' ' ' PHE . 16.6 ptt-85 -176.46 142.72 0.46 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.556 ' NE2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -168.01 -174.81 2.47 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.961 0.886 . . . . 0.0 111.498 177.989 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -91.83 -10.62 39.13 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.973 177.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -175.93 6.05 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.566 1.174 . . . . 0.0 112.574 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.556 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 23.3 ttm180 -55.3 144.44 51.4 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 112.497 -2.138 . . . . 0.0 105.912 175.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 19' ' ' GLY . 75.1 Cg_exo -44.63 138.06 8.21 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 110.679 -177.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.446 ' N ' ' CZ2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -65.45 60.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.058 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . 137.38 1.26 2.53 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.827 -178.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.556 ' N ' ' HB2' ' A' ' 17' ' ' PRO . 0.7 OUTLIER 47.92 61.1 3.14 Favored 'General case' 0 C--N 1.369 1.429 0 CA-C-N 119.901 1.85 . . . . 0.0 110.351 179.897 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -130.56 -168.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.606 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.766 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.2 mtpp -95.67 173.28 7.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 111.496 -2.593 . . . . 0.0 107.106 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.47 -31.84 5.28 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.002 -1.57 . . . . 0.0 109.732 -176.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.845 ' CD2' ' HB2' ' A' ' 6' ' ' ASN . 95.7 m95 -62.21 136.15 57.81 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.458 1.503 . . . . 0.0 111.82 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' PHE . 1.8 mp0 -150.79 118.65 6.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 27.6 ttmt -68.26 125.74 27.36 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.594 -0.443 . . . . 0.0 109.965 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.563 ' HD2' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -126.44 171.2 11.22 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.635 0.731 . . . . 0.0 110.672 -179.535 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.563 ' H ' ' HD2' ' A' ' 27' ' ' ARG . 8.2 t-105 -83.25 151.89 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.476 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.788 179.398 . . . . . . . . 0 0 . 1 stop_ save_